pathway_name,pathway_source,num_overlapping_genes,overlapping_genes,num_all_pathway_genes,P_genes,Q_genes,num_overlapping_metabolites,overlapping_metabolites,num_all_pathway_metabolites,P_metabolites,Q_metabolites,P_joint,Q_joint
Metabolism,Reactome,52,HEXA;GSTM3;GSTM4;ATP5MC2;PKLR;IDO2;DPYS;FASN;UPB1;NUDT7;PON1;SLC10A1;BPHL;COMT;PYGL;ASPG;SLCO2B1;CYP8B1;INMT;INPP5D;CSAD;FDX1;UGT2A3;CYP27A1;AOX1;ACSM1;AKR1D1;AACS;ACSL1;TM7SF2;MVK;GBE1;ACSM5;HAAO;CYP7B1;HACL1;APOA2;KHK;GCK;ALDH1L1;ACADSB;LBR;ACSS2;CTPS1;GNMT;ME1;HNMT;SLC2A2;ALDH7A1;SLC27A5;CA3;CA5A,1952 (1954),2.02e-22,9.46e-19,9,HMDB0000036;HMDB0010404;HMDB0006752;HMDB0001860;HMDB0010711;HMDB0000128;HMDB0000273;HMDB0013461;HMDB0002183,863 (1411),0.231,1,2.45e-21,2.82e-18
Metabolism of steroids,Reactome,11,TM7SF2;FDX1;CYP7B1;CYP8B1;SLC27A5;FASN;MVK;CYP27A1;LBR;SLC10A1;AKR1D1,124 (124),4.1e-10,9.58e-07,1,HMDB0000036,113 (142),0.607,1,5.74e-09,3.31e-06
Metabolism of lipids,Reactome,19,AACS;ACSL1;GSTM4;MVK;HEXA;PON1;CYP7B1;HACL1;CYP8B1;SLC27A5;FASN;INPP5D;FDX1;NUDT7;CYP27A1;SLC10A1;TM7SF2;LBR;AKR1D1,645 (646),2.2e-08,2.13e-05,6,HMDB0000036;HMDB0010404;HMDB0006752;HMDB0010711;HMDB0013461;HMDB0002183,352 (626),0.0532,1,2.53e-08,9.7e-06
Biological oxidations,Reactome,12,COMT;GSTM3;GSTM4;CYP7B1;ACSM5;CYP8B1;ACSS2;FDX1;UGT2A3;CYP27A1;ACSM1;BPHL,219 (219),1.58e-08,2.13e-05,1,HMDB0001860,231 (320),0.858,1,2.59e-07,3.68e-05
Bile acid biosynthesis,EHMN,7,CYP7B1;CYP8B1;ALDH7A1;SLC27A5;CYP27A1;SLC10A1;AKR1D1,53 (53),4.53e-08,2.13e-05,1,HMDB0000036,47 (55),0.318,1,2.75e-07,3.68e-05
Primary bile acid biosynthesis - Homo sapiens (human),KEGG,5,CYP27A1;AKR1D1;CYP7B1;SLC27A5;CYP8B1,17 (17),5.9e-08,2.13e-05,1,HMDB0000036,40 (47),0.278,1,3.1e-07,3.68e-05
Bile Acid Biosynthesis,SMPDB,5,CYP27A1;CYP8B1;CYP7B1;SLC27A5;AKR1D1,17 (17),5.9e-08,2.13e-05,1,HMDB0000036,58 (64),0.377,1,4.15e-07,3.68e-05
27-Hydroxylase Deficiency,SMPDB,5,CYP27A1;CYP8B1;CYP7B1;SLC27A5;AKR1D1,17 (17),5.9e-08,2.13e-05,1,HMDB0000036,58 (64),0.377,1,4.15e-07,3.68e-05
Congenital Bile Acid Synthesis Defect Type II,SMPDB,5,CYP27A1;CYP8B1;CYP7B1;SLC27A5;AKR1D1,17 (17),5.9e-08,2.13e-05,1,HMDB0000036,58 (64),0.377,1,4.15e-07,3.68e-05
Cerebrotendinous Xanthomatosis (CTX),SMPDB,5,CYP27A1;CYP8B1;CYP7B1;SLC27A5;AKR1D1,17 (17),5.9e-08,2.13e-05,1,HMDB0000036,58 (64),0.377,1,4.15e-07,3.68e-05
Zellweger Syndrome,SMPDB,5,CYP27A1;CYP8B1;CYP7B1;SLC27A5;AKR1D1,17 (17),5.9e-08,2.13e-05,1,HMDB0000036,58 (64),0.377,1,4.15e-07,3.68e-05
Familial Hypercholanemia (FHCA),SMPDB,5,CYP27A1;CYP8B1;CYP7B1;SLC27A5;AKR1D1,17 (17),5.9e-08,2.13e-05,1,HMDB0000036,58 (64),0.377,1,4.15e-07,3.68e-05
Congenital Bile Acid Synthesis Defect Type III,SMPDB,5,CYP27A1;CYP8B1;CYP7B1;SLC27A5;AKR1D1,17 (17),5.9e-08,2.13e-05,1,HMDB0000036,58 (64),0.377,1,4.15e-07,3.68e-05
Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol,Reactome,5,SLC27A5;CYP27A1;CYP7B1;AKR1D1;CYP8B1,20 (20),1.46e-07,4.87e-05,1,HMDB0000036,43 (49),0.295,1,7.73e-07,6.36e-05
Metapathway biotransformation Phase I and II,Wikipathways,10,COMT;GSTM3;GSTM4;HNMT;CYP7B1;CYP8B1;INMT;UGT2A3;CYP27A1;AKR1D1,186 (186),3.23e-07,9.45e-05,0,,0 (0),1,1,3.23e-07,9.45e-05
Bile acid and bile salt metabolism,Reactome,6,CYP7B1;CYP8B1;SLC27A5;CYP27A1;SLC10A1;AKR1D1,43 (43),3.12e-07,9.45e-05,1,HMDB0000036,59 (79),0.382,1,2.02e-06,0.000155
Synthesis of bile acids and bile salts,Reactome,5,SLC27A5;CYP27A1;CYP7B1;AKR1D1;CYP8B1,30 (30),1.27e-06,0.000313,1,HMDB0000036,55 (75),0.362,1,7.18e-06,0.000497
Cholesterol metabolism (includes both Bloch and Kandutsch-Russell pathways),Wikipathways,6,ACSL1;TM7SF2;FASN;MVK;CYP27A1;LBR,46 (46),4.71e-07,0.00013,0,,4 (4),1,1,7.34e-06,0.000497
Synthesis of bile acids and bile salts via 27-hydroxycholesterol,Reactome,4,CYP27A1;CYP7B1;AKR1D1;CYP8B1,11 (11),5.23e-07,0.000136,0,,14 (16),1,1,8.09e-06,0.000518
bile acid biosynthesis_ neutral pathway,HumanCyc,4,SLC27A5;CYP27A1;AKR1D1;CYP8B1,15 (15),2.12e-06,0.000451,1,HMDB0000036,38 (44),0.266,1,8.68e-06,0.000526
Farnesoid X receptor pathway,Wikipathways,4,SLC10A1;CYP8B1;SLC27A5;SLCO2B1,19 (19),5.9e-06,0.000854,0,,0 (1),1,1,5.9e-06,0.000854
Nuclear Receptors Meta-Pathway,Wikipathways,11,GSTM3;EGFR;FASN;ME1;SLCO2B1;CYP8B1;APOA2;SLC2A2;SLC27A5;GSTM4;SLC10A1,317 (317),6.02e-06,0.000854,0,,0 (0),1,1,6.02e-06,0.000854
Synthesis of bile acids and bile salts via 24-hydroxycholesterol,Reactome,4,SLC27A5;CYP27A1;AKR1D1;CYP8B1,14 (14),1.56e-06,0.000366,0,,20 (29),1,1,2.25e-05,0.00129
Oxysterols derived from cholesterol,Wikipathways,4,CYP27A1;CYP8B1;SLC27A5;AKR1D1,15 (15),2.12e-06,0.000451,0,,5 (10),1,1,2.98e-05,0.00164
Pyruvate metabolism,INOH,5,LDHD;PKLR;ALDH7A1;ACSS2;ME1,34 (34),2.43e-06,0.000495,0,,30 (31),1,1,3.39e-05,0.00178
Sialuria or French Type Sialuria,SMPDB,4,NPL;HEXA;AMDHD2;GFPT1,17 (17),3.66e-06,0.000591,0,,31 (32),1,1,4.95e-05,0.00204
Sialuria or French Type Sialuria,SMPDB,4,NPL;HEXA;AMDHD2;GFPT1,17 (17),3.66e-06,0.000591,0,,31 (32),1,1,4.95e-05,0.00204
Amino Sugar Metabolism,SMPDB,4,NPL;HEXA;AMDHD2;GFPT1,17 (17),3.66e-06,0.000591,0,,31 (32),1,1,4.95e-05,0.00204
G(M2)-Gangliosidosis: Variant B_ Tay-sachs disease,SMPDB,4,NPL;HEXA;AMDHD2;GFPT1,17 (17),3.66e-06,0.000591,0,,31 (32),1,1,4.95e-05,0.00204
Tay-Sachs Disease,SMPDB,4,NPL;HEXA;AMDHD2;GFPT1,17 (17),3.66e-06,0.000591,0,,31 (32),1,1,4.95e-05,0.00204
Salla Disease/Infantile Sialic Acid Storage Disease,SMPDB,4,NPL;HEXA;AMDHD2;GFPT1,17 (17),3.66e-06,0.000591,0,,31 (32),1,1,4.95e-05,0.00204
Endogenous sterols,Reactome,4,CYP27A1;CYP7B1;FDX1;CYP8B1,18 (18),4.68e-06,0.000731,0,,31 (40),1,1,6.22e-05,0.00247
PPAR signaling pathway,Wikipathways,6,ACSL1;ME1;CYP8B1;APOA2;SLC27A5;CYP27A1,68 (68),4.92e-06,0.000742,0,,1 (7),1,1,6.5e-05,0.0025
Butanoate metabolism - Homo sapiens (human),KEGG,4,AACS;ABAT;ACSM5;ACSM1,28 (28),2.98e-05,0.00279,1,HMDB0001290,28 (42),0.203,1,7.9e-05,0.00293
Tryptophan metabolism - Homo sapiens (human),KEGG,5,INMT;HAAO;IDO2;AOX1;ALDH7A1,42 (42),7.14e-06,0.000984,0,,59 (83),1,1,9.18e-05,0.00331
PPAR signaling pathway - Homo sapiens (human),KEGG,6,ACSL1;ME1;CYP8B1;APOA2;SLC27A5;CYP27A1,74 (76),8.07e-06,0.00108,0,,5 (5),1,1,0.000103,0.00357
beta-Alanine metabolism - Homo sapiens (human),KEGG,4,ABAT;ALDH7A1;UPB1;DPYS,30 (30),3.95e-05,0.00363,1,HMDB0006805,29 (32),0.21,1,0.000105,0.00357
Pyruvate Dehydrogenase Complex Deficiency,SMPDB,4,PKLR;ME1;ACSS2;LDHD,22 (22),1.1e-05,0.00125,0,,43 (46),1,1,0.000136,0.00393
Primary hyperoxaluria II_ PH2,SMPDB,4,PKLR;ME1;ACSS2;LDHD,22 (22),1.1e-05,0.00125,0,,43 (46),1,1,0.000136,0.00393
Pyruvate kinase deficiency,SMPDB,4,PKLR;ME1;ACSS2;LDHD,22 (22),1.1e-05,0.00125,0,,43 (46),1,1,0.000136,0.00393
Leigh Syndrome,SMPDB,4,PKLR;ME1;ACSS2;LDHD,22 (22),1.1e-05,0.00125,0,,43 (46),1,1,0.000136,0.00393
Pyruvate Metabolism,SMPDB,4,PKLR;ME1;ACSS2;LDHD,22 (22),1.1e-05,0.00125,0,,43 (46),1,1,0.000136,0.00393
Pyruvate Decarboxylase E1 Component Deficiency (PDHE1 Deficiency),SMPDB,4,PKLR;ME1;ACSS2;LDHD,22 (22),1.1e-05,0.00125,0,,43 (46),1,1,0.000136,0.00393
Pyruvate metabolism - Homo sapiens (human),KEGG,5,LDHD;ME1;ALDH7A1;ACSS2;PKLR,47 (47),1.26e-05,0.0014,0,,26 (32),1,1,0.000154,0.00434
Valine_ leucine and isoleucine degradation - Homo sapiens (human),KEGG,5,AOX1;ABAT;ACADSB;ALDH7A1;AACS,48 (48),1.39e-05,0.00148,0,,34 (42),1,1,0.00017,0.00455
Amino sugar and nucleotide sugar metabolism - Homo sapiens (human),KEGG,5,NPL;HEXA;AMDHD2;GCK;GFPT1,48 (48),1.39e-05,0.00148,0,,49 (108),1,1,0.00017,0.00455
Methylation Pathways,Wikipathways,3,COMT;INMT;HNMT,9 (9),2.14e-05,0.00205,0,,5 (5),1,1,0.000252,0.00604
Carnosinuria_ carnosinemia,SMPDB,3,ABAT;UPB1;DPYS,9 (9),2.14e-05,0.00205,0,,34 (34),1,1,0.000252,0.00604
Ureidopropionase deficiency,SMPDB,3,ABAT;UPB1;DPYS,9 (9),2.14e-05,0.00205,0,,34 (34),1,1,0.000252,0.00604
GABA-Transaminase Deficiency,SMPDB,3,ABAT;UPB1;DPYS,9 (9),2.14e-05,0.00205,0,,34 (34),1,1,0.000252,0.00604
Beta-Alanine Metabolism,SMPDB,3,ABAT;UPB1;DPYS,9 (9),2.14e-05,0.00205,0,,34 (34),1,1,0.000252,0.00604
Phase I - Functionalization of compounds,Reactome,6,CYP7B1;CYP8B1;BPHL;FDX1;CYP27A1;ACSS2,101 (101),4.8e-05,0.00432,1,HMDB0001860,143 (191),0.695,1,0.000377,0.00887
Phase II - Conjugation of compounds,Reactome,6,COMT;GSTM3;GSTM4;ACSM5;UGT2A3;ACSM1,111 (111),8.15e-05,0.00693,1,HMDB0001860,115 (149),0.613,1,0.000545,0.0126
Pathways in clear cell renal cell carcinoma,Wikipathways,5,LDHD;PKLR;FASN;EGFR;ME1,86 (86),0.000234,0.0153,0,,0 (1),1,1,0.000234,0.0153
Valproic acid pathway,Wikipathways,3,ABAT;ACADSB;ACSM1,13 (13),7.16e-05,0.00621,0,,14 (14),1,1,0.000755,0.0167
eicosapentaenoate biosynthesis,HumanCyc,3,ACSL1;ACSM5;ACSM1,13 (13),7.16e-05,0.00621,0,,13 (17),1,1,0.000755,0.0167
&gamma;-linolenate biosynthesis,HumanCyc,3,ACSL1;ACSM5;ACSM1,14 (14),9.07e-05,0.00758,0,,9 (9),1,1,0.000935,0.0203
Pyrimidine nucleotides nucleosides metabolism,INOH,4,ABAT;CTPS1;UPB1;DPYS,51 (51),0.000325,0.0208,1,HMDB0000273,53 (56),0.351,1,0.00115,0.0245
uracil degradation,HumanCyc,2,UPB1;DPYS,3 (3),0.000124,0.01,0,,10 (10),1,1,0.00124,0.0255
thymine degradation,HumanCyc,2,UPB1;DPYS,3 (3),0.000124,0.01,0,,10 (10),1,1,0.00124,0.0255
Tryptophan metabolism,Wikipathways,4,CYP7B1;HAAO;AOX1;INMT,42 (42),0.000152,0.0121,0,,30 (38),1,1,0.00149,0.0282
Pyrimidine Metabolism,SMPDB,3,DPYS;UPB1;CTPS1,23 (23),0.000423,0.0244,1,HMDB0000273,56 (57),0.367,1,0.00152,0.0282
UMP Synthase Deiciency (Orotic Aciduria),SMPDB,3,DPYS;UPB1;CTPS1,23 (23),0.000423,0.0244,1,HMDB0000273,56 (57),0.367,1,0.00152,0.0282
MNGIE (Mitochondrial Neurogastrointestinal Encephalopathy),SMPDB,3,DPYS;UPB1;CTPS1,23 (23),0.000423,0.0244,1,HMDB0000273,56 (57),0.367,1,0.00152,0.0282
Beta Ureidopropionase Deficiency,SMPDB,3,DPYS;UPB1;CTPS1,23 (23),0.000423,0.0244,1,HMDB0000273,56 (57),0.367,1,0.00152,0.0282
Dihydropyrimidinase Deficiency,SMPDB,3,DPYS;UPB1;CTPS1,23 (23),0.000423,0.0244,1,HMDB0000273,56 (57),0.367,1,0.00152,0.0282
Drug metabolism - other enzymes - Homo sapiens (human),KEGG,5,GSTM3;GSTM4;UPB1;UGT2A3;DPYS,80 (80),0.000166,0.0126,0,,39 (52),1,1,0.00162,0.0287
Nitrogen metabolism - Homo sapiens (human),KEGG,3,CA3;CA5A;CA8,17 (17),0.000167,0.0126,0,,16 (19),1,1,0.00162,0.0287
Butanoate metabolism,INOH,3,AACS;ACSM1;ACSS2,17 (17),0.000167,0.0126,0,,21 (23),1,1,0.00162,0.0287
Glycogen synthetase deficiency,SMPDB,3,GBE1;PYGL;GCK,18 (18),0.0002,0.0134,0,,29 (29),1,1,0.0019,0.03
Glycogenosis_ Type III. Cori disease_ Debrancher glycogenosis,SMPDB,3,GBE1;PYGL;GCK,18 (18),0.0002,0.0134,0,,29 (29),1,1,0.0019,0.03
Mucopolysaccharidosis VI. Sly syndrome,SMPDB,3,GBE1;PYGL;GCK,18 (18),0.0002,0.0134,0,,29 (29),1,1,0.0019,0.03
Sucrase-isomaltase deficiency,SMPDB,3,GBE1;PYGL;GCK,18 (18),0.0002,0.0134,0,,29 (29),1,1,0.0019,0.03
Glycogenosis_ Type IV. Amylopectinosis_ Anderson disease,SMPDB,3,GBE1;PYGL;GCK,18 (18),0.0002,0.0134,0,,29 (29),1,1,0.0019,0.03
Glycogenosis_ Type VI. Hers disease,SMPDB,3,GBE1;PYGL;GCK,18 (18),0.0002,0.0134,0,,29 (29),1,1,0.0019,0.03
Starch and Sucrose Metabolism,SMPDB,3,GBE1;PYGL;GCK,18 (18),0.0002,0.0134,0,,29 (29),1,1,0.0019,0.03
Glycolysis Gluconeogenesis,INOH,4,LDHD;PKLR;GCK;ME1,45 (46),0.0002,0.0134,0,,32 (34),1,1,0.0019,0.03
Activation of gene expression by SREBF (SREBP),Reactome,3,FASN;TM7SF2;MVK,26 (26),0.000612,0.0319,0,,0 (0),1,1,0.000612,0.0319
Maturity onset diabetes of the young - Homo sapiens (human),KEGG,3,PKLR;SLC2A2;GCK,26 (26),0.000612,0.0319,0,,0 (0),1,1,0.000612,0.0319
Tryptophan Metabolism,SMPDB,3,INMT;HAAO;AOX1,19 (19),0.000236,0.0153,0,,58 (60),1,1,0.00221,0.0343
Cytochrome P450 - arranged by substrate type,Reactome,4,CYP27A1;CYP7B1;FDX1;CYP8B1,57 (57),0.000499,0.0285,1,HMDB0001860,87 (120),0.511,1,0.00236,0.0363
Metabolism of amino acids and derivatives,Reactome,9,GNMT;ACADSB;HNMT;ASPG;HAAO;IDO2;INMT;CSAD;ALDH7A1,339 (339),0.000339,0.0214,1,HMDB0000128,222 (286),0.847,1,0.00263,0.0398
Fatty Acid Biosynthesis,Wikipathways,3,FASN;ACSL1;ACSS2,22 (22),0.00037,0.0231,0,,4 (14),1,1,0.00329,0.0492
Sphingolipid metabolism - Homo sapiens (human),KEGG,0,,49 (49),1,1,3,HMDB0010711;HMDB0006752;HMDB0013461,19 (25),0.000401,1,0.00354,0.0522
fatty acid &alpha;-oxidation,HumanCyc,2,ACSL1;HACL1,5 (5),0.000409,0.0244,0,,19 (20),1,1,0.0036,0.0525
Fatty acid metabolism,Reactome,6,PON1;HACL1;CYP8B1;FASN;NUDT7;ACSL1,176 (177),0.000975,0.0397,2,HMDB0010404;HMDB0002183,182 (257),0.436,1,0.00373,0.0537
superpathway of cholesterol biosynthesis,HumanCyc,3,LBR;TM7SF2;MVK,25 (25),0.000544,0.0296,0,,40 (62),1,1,0.00464,0.0636
Cholesterol biosynthesis,Reactome,3,LBR;TM7SF2;MVK,25 (25),0.000544,0.0296,0,,40 (46),1,1,0.00464,0.0636
Alanine Aspartate Asparagine metabolism,INOH,3,PKLR;ABAT;UPB1,25 (25),0.000544,0.0296,0,,39 (45),1,1,0.00464,0.0636
Disulfiram Action Pathway,SMPDB,3,COMT;HAAO;ACSS2,25 (25),0.000544,0.0296,0,,72 (77),1,1,0.00464,0.0636
pyrimidine ribonucleosides degradation,HumanCyc,2,UPB1;DPYS,6 (6),0.000611,0.0319,0,,14 (14),1,1,0.00514,0.0688
zymosterol biosynthesis,HumanCyc,2,LBR;TM7SF2,6 (6),0.000611,0.0319,0,,16 (22),1,1,0.00514,0.0688
Steroid hormone biosynthesis - Homo sapiens (human),KEGG,4,COMT;CYP7B1;AKR1D1;UGT2A3,61 (61),0.000646,0.0332,0,,87 (99),1,1,0.00539,0.0714
Insulin resistance - Homo sapiens (human),KEGG,5,GFPT1;SLC2A2;PYGL;SLC27A5;OGT,108 (108),0.00067,0.0341,0,,12 (20),1,1,0.00557,0.0729
Pyrimidine catabolism,Reactome,2,UPB1;DPYS,12 (12),0.00262,0.0937,1,HMDB0000273,37 (39),0.26,1,0.00565,0.0732
Peroxisome - Homo sapiens (human),KEGG,4,ACSL1;HACL1;MVK;NUDT7,82 (82),0.00195,0.0738,0,,0 (0),1,1,0.00195,0.0738
Recycling of bile acids and salts,Reactome,2,SLC10A1;SLC27A5,16 (16),0.00469,0.137,1,HMDB0000036,20 (20),0.15,1,0.0058,0.0742
tryptophan degradation to 2-amino-3-carboxymuconate semialdehyde,HumanCyc,2,HAAO;IDO2,7 (7),0.000852,0.0385,0,,12 (13),1,1,0.00688,0.0756
Tryptophan degradation,INOH,4,INMT;HAAO;AOX1;ALDH7A1,66 (66),0.000871,0.0385,0,,56 (62),1,1,0.00701,0.0756
Phosphatidylinositol Phosphate Metabolism,SMPDB,2,INPP5D;EGFR,23 (23),0.0096,0.201,1,HMDB0009888,12 (12),0.0926,1,0.00713,0.0756
Joubert syndrome,SMPDB,2,INPP5D;EGFR,23 (23),0.0096,0.201,1,HMDB0009888,12 (12),0.0926,1,0.00713,0.0756
Glycolysis / Gluconeogenesis - Homo sapiens (human),KEGG,4,PKLR;GCK;ACSS2;ALDH7A1,67 (67),0.000922,0.0385,0,,25 (31),1,1,0.00736,0.0756
3-Methylglutaconic Aciduria Type I,SMPDB,3,AOX1;ABAT;ACADSB,30 (30),0.000939,0.0385,0,,54 (58),1,1,0.00748,0.0756
Ascorbate and aldarate metabolism - Homo sapiens (human),KEGG,3,RGN;ALDH7A1;UGT2A3,30 (30),0.000939,0.0385,0,,28 (57),1,1,0.00748,0.0756
Fructose Mannose metabolism,INOH,3,GFPT1;KHK;GCK,30 (30),0.000939,0.0385,0,,28 (33),1,1,0.00748,0.0756
Valine_ Leucine and Isoleucine Degradation,SMPDB,3,AOX1;ABAT;ACADSB,30 (30),0.000939,0.0385,0,,54 (58),1,1,0.00748,0.0756
2-Methyl-3-Hydroxybutryl CoA Dehydrogenase Deficiency,SMPDB,3,AOX1;ABAT;ACADSB,30 (30),0.000939,0.0385,0,,54 (58),1,1,0.00748,0.0756
Isovaleric Aciduria,SMPDB,3,AOX1;ABAT;ACADSB,30 (30),0.000939,0.0385,0,,54 (58),1,1,0.00748,0.0756
3-Methylcrotonyl Coa Carboxylase Deficiency Type I,SMPDB,3,AOX1;ABAT;ACADSB,30 (30),0.000939,0.0385,0,,54 (58),1,1,0.00748,0.0756
Propionic Acidemia,SMPDB,3,AOX1;ABAT;ACADSB,30 (30),0.000939,0.0385,0,,54 (58),1,1,0.00748,0.0756
Maple Syrup Urine Disease,SMPDB,3,AOX1;ABAT;ACADSB,30 (30),0.000939,0.0385,0,,54 (58),1,1,0.00748,0.0756
3-Hydroxy-3-Methylglutaryl-CoA Lyase Deficiency,SMPDB,3,AOX1;ABAT;ACADSB,30 (30),0.000939,0.0385,0,,54 (58),1,1,0.00748,0.0756
Isobutyryl-coa dehydrogenase deficiency,SMPDB,3,AOX1;ABAT;ACADSB,30 (30),0.000939,0.0385,0,,54 (58),1,1,0.00748,0.0756
3-hydroxyisobutyric aciduria,SMPDB,3,AOX1;ABAT;ACADSB,30 (30),0.000939,0.0385,0,,54 (58),1,1,0.00748,0.0756
3-hydroxyisobutyric acid dehydrogenase deficiency,SMPDB,3,AOX1;ABAT;ACADSB,30 (30),0.000939,0.0385,0,,54 (58),1,1,0.00748,0.0756
Isovaleric acidemia,SMPDB,3,AOX1;ABAT;ACADSB,30 (30),0.000939,0.0385,0,,54 (58),1,1,0.00748,0.0756
Methylmalonate Semialdehyde Dehydrogenase Deficiency,SMPDB,3,AOX1;ABAT;ACADSB,30 (30),0.000939,0.0385,0,,54 (58),1,1,0.00748,0.0756
Methylmalonic Aciduria,SMPDB,3,AOX1;ABAT;ACADSB,30 (30),0.000939,0.0385,0,,54 (58),1,1,0.00748,0.0756
3-Methylglutaconic Aciduria Type IV,SMPDB,3,AOX1;ABAT;ACADSB,30 (30),0.000939,0.0385,0,,54 (58),1,1,0.00748,0.0756
3-Methylglutaconic Aciduria Type III,SMPDB,3,AOX1;ABAT;ACADSB,30 (30),0.000939,0.0385,0,,54 (58),1,1,0.00748,0.0756
Beta-Ketothiolase Deficiency,SMPDB,3,AOX1;ABAT;ACADSB,30 (30),0.000939,0.0385,0,,54 (58),1,1,0.00748,0.0756
Regulation of cholesterol biosynthesis by SREBP (SREBF),Reactome,3,FASN;TM7SF2;MVK,31 (31),0.00103,0.0417,0,,1 (1),1,1,0.00814,0.0816
Diltiazem Action Pathway,SMPDB,1,MYLK,61 (61),0.328,1,2,HMDB0009888;HMDB0014487,11 (11),0.00325,1,0.00835,0.0829
Drug metabolism - cytochrome P450 - Homo sapiens (human),KEGG,4,AOX1;GSTM3;GSTM4;UGT2A3,70 (72),0.00109,0.0435,0,,83 (88),1,1,0.0085,0.0837
Synthesis of UDP-N-acetyl-glucosamine,Reactome,2,GFPT1;AMDHD2,8 (8),0.00113,0.0449,0,,18 (21),1,1,0.00881,0.086
One-carbon metabolism and related pathways,Wikipathways,3,GNMT;GPX7;CSAD,52 (52),0.00461,0.137,1,HMDB0000036,37 (42),0.26,1,0.00926,0.0897
tryptophan degradation,HumanCyc,2,HAAO;IDO2,9 (9),0.00145,0.0556,0,,21 (22),1,1,0.0109,0.102
Conjugation of carboxylic acids,Reactome,2,ACSM5;ACSM1,9 (9),0.00145,0.0556,0,,12 (16),1,1,0.0109,0.102
Amino Acid conjugation,Reactome,2,ACSM5;ACSM1,9 (9),0.00145,0.0556,0,,12 (16),1,1,0.0109,0.102
Metabolism of ingested SeMet_ Sec_ MeSec into H2Se,Reactome,2,GNMT;HNMT,9 (9),0.00145,0.0556,0,,30 (33),1,1,0.0109,0.102
FOXA2 and FOXA3 transcription factor networks,PID,3,PKLR;SLC2A2;GCK,45 (45),0.00306,0.103,0,,0 (0),1,1,0.00306,0.103
7-oxo-C and 7beta-HC pathways,Wikipathways,2,CYP27A1;SLC27A5,13 (13),0.00309,0.103,0,,0 (0),1,1,0.00309,0.103
Starch and sucrose metabolism - Homo sapiens (human),KEGG,3,GBE1;PYGL;GCK,36 (36),0.00161,0.0611,0,,16 (37),1,1,0.0119,0.111
Splicing factor NOVA regulated synaptic proteins,Wikipathways,1,EPB41L1,42 (42),0.239,1,1,HMDB0009888,1 (1),0.00805,1,0.014,0.129
Pyrimidine metabolism - Homo sapiens (human),KEGG,3,CTPS1;UPB1;DPYS,57 (57),0.00597,0.161,1,HMDB0000273,49 (65),0.329,1,0.0142,0.13
Valproic Acid Metabolism Pathway,SMPDB,2,ACADSB;ACSM1,11 (11),0.0022,0.0822,0,,29 (30),1,1,0.0156,0.142
Cholesterol metabolism - Homo sapiens (human),KEGG,2,APOA2;CYP27A1,50 (50),0.0416,0.567,1,HMDB0000036,7 (10),0.055,1,0.0162,0.146
Omega-9 FA synthesis,Wikipathways,2,FASN;ACSL1,12 (12),0.00262,0.0937,0,,1 (1),1,1,0.0182,0.158
Reversible hydration of carbon dioxide,Reactome,2,CA3;CA5A,12 (12),0.00262,0.0937,0,,4 (5),1,1,0.0182,0.158
NAD <i>de novo</i> biosynthesis,HumanCyc,2,HAAO;IDO2,12 (12),0.00262,0.0937,0,,23 (24),1,1,0.0182,0.158
Trehalose Degradation,SMPDB,2,SLC2A2;GCK,12 (12),0.00262,0.0937,0,,10 (10),1,1,0.0182,0.158
Oxidation of Branched Chain Fatty Acids,SMPDB,2,ACSL1;HACL1,12 (12),0.00262,0.0937,0,,23 (25),1,1,0.0182,0.158
Metabolism of Spingolipids in ER and Golgi apparatus,Wikipathways,0,,12 (12),1,1,2,HMDB0010711;HMDB0006752,10 (21),0.00267,1,0.0185,0.159
Fatty acid degradation - Homo sapiens (human),KEGG,3,ACADSB;ACSL1;ALDH7A1,43 (43),0.00269,0.0952,0,,40 (50),1,1,0.0186,0.159
Glycolysis and Gluconeogenesis,Wikipathways,3,PKLR;SLC2A2;GCK,45 (45),0.00306,0.103,0,,14 (18),1,1,0.0208,0.167
cholesterol biosynthesis III (via desmosterol),HumanCyc,2,LBR;TM7SF2,13 (13),0.00309,0.103,0,,24 (32),1,1,0.0209,0.167
L-kynurenine degradation,HumanCyc,2,HAAO;IDO2,13 (13),0.00309,0.103,0,,29 (30),1,1,0.0209,0.167
cholesterol biosynthesis I,HumanCyc,2,LBR;TM7SF2,13 (13),0.00309,0.103,0,,24 (32),1,1,0.0209,0.167
cholesterol biosynthesis II (via 24_25-dihydrolanosterol),HumanCyc,2,LBR;TM7SF2,13 (13),0.00309,0.103,0,,19 (32),1,1,0.0209,0.167
sarcosine oncometabolite pathway ,SMPDB,2,GNMT;ALDH7A1,13 (13),0.00309,0.103,0,,25 (26),1,1,0.0209,0.167
Fabry disease,SMPDB,0,,22 (22),1,1,3,HMDB0010711;HMDB0013461;HMDB0006752,38 (40),0.00316,1,0.0214,0.167
Sphingolipid Metabolism,SMPDB,0,,22 (22),1,1,3,HMDB0010711;HMDB0013461;HMDB0006752,38 (40),0.00316,1,0.0214,0.167
Gaucher Disease,SMPDB,0,,22 (22),1,1,3,HMDB0010711;HMDB0013461;HMDB0006752,38 (40),0.00316,1,0.0214,0.167
Globoid Cell Leukodystrophy,SMPDB,0,,22 (22),1,1,3,HMDB0010711;HMDB0013461;HMDB0006752,38 (40),0.00316,1,0.0214,0.167
Metachromatic Leukodystrophy (MLD),SMPDB,0,,22 (22),1,1,3,HMDB0010711;HMDB0013461;HMDB0006752,38 (40),0.00316,1,0.0214,0.167
Krabbe disease,SMPDB,0,,22 (22),1,1,3,HMDB0010711;HMDB0013461;HMDB0006752,38 (40),0.00316,1,0.0214,0.167
Panitumumab Action Pathway,SMPDB,1,EGFR,1 (1),0.00648,0.167,0,,0 (0),1,1,0.00648,0.167
Cetuximab Action Pathway,SMPDB,1,EGFR,1 (1),0.00648,0.167,0,,0 (0),1,1,0.00648,0.167
Trastuzumab Action Pathway,SMPDB,1,EGFR,1 (1),0.00648,0.167,0,,0 (0),1,1,0.00648,0.167
Gefitinib Action Pathway,SMPDB,1,EGFR,1 (1),0.00648,0.167,0,,0 (1),1,1,0.00648,0.167
Type II diabetes mellitus - Homo sapiens (human),KEGG,3,PKLR;SLC2A2;GCK,46 (46),0.00326,0.108,0,,4 (6),1,1,0.0219,0.171
Cerebral organic acidurias_ including diseases,Wikipathways,1,ALDH7A1,3 (3),0.0193,0.329,1,HMDB0001290,23 (27),0.17,1,0.0221,0.171
Tryptophan catabolism,Reactome,2,HAAO;IDO2,14 (14),0.00359,0.11,0,,31 (34),1,1,0.0238,0.171
Very-long-chain acyl coa dehydrogenase deficiency (VLCAD),SMPDB,2,ACADSB;ACSL1,14 (14),0.00359,0.11,0,,43 (43),1,1,0.0238,0.171
Medium chain acyl-coa dehydrogenase deficiency (MCAD),SMPDB,2,ACADSB;ACSL1,14 (14),0.00359,0.11,0,,43 (43),1,1,0.0238,0.171
Long chain acyl-CoA dehydrogenase deficiency (LCAD),SMPDB,2,ACADSB;ACSL1,14 (14),0.00359,0.11,0,,43 (43),1,1,0.0238,0.171
Trifunctional protein deficiency,SMPDB,2,ACADSB;ACSL1,14 (14),0.00359,0.11,0,,43 (43),1,1,0.0238,0.171
Carnitine palmitoyl transferase deficiency (II),SMPDB,2,ACADSB;ACSL1,14 (14),0.00359,0.11,0,,43 (43),1,1,0.0238,0.171
Short Chain Acyl CoA Dehydrogenase Deficiency (SCAD Deficiency),SMPDB,2,ACADSB;ACSL1,14 (14),0.00359,0.11,0,,43 (43),1,1,0.0238,0.171
Fatty acid Metabolism,SMPDB,2,ACADSB;ACSL1,14 (14),0.00359,0.11,0,,43 (43),1,1,0.0238,0.171
Glutaric Aciduria Type I,SMPDB,2,ACADSB;ACSL1,14 (14),0.00359,0.11,0,,43 (43),1,1,0.0238,0.171
Ethylmalonic Encephalopathy,SMPDB,2,ACADSB;ACSL1,14 (14),0.00359,0.11,0,,43 (43),1,1,0.0238,0.171
Carnitine palmitoyl transferase deficiency (I),SMPDB,2,ACADSB;ACSL1,14 (14),0.00359,0.11,0,,43 (43),1,1,0.0238,0.171
Glycosphingolipid metabolism,EHMN,0,,69 (69),1,1,3,HMDB0010711;HMDB0006752;HMDB0013461,40 (52),0.00366,1,0.0242,0.173
Sphingolipid metabolism,Reactome,1,HEXA,87 (87),0.433,1,3,HMDB0010711;HMDB0013461;HMDB0006752,54 (65),0.00856,1,0.0244,0.174
Valine_ leucine and isoleucine degradation,EHMN,3,ABAT;ACADSB;ALDH7A1,49 (49),0.0039,0.119,0,,52 (62),1,1,0.0255,0.18
Senescence and Autophagy in Cancer,Wikipathways,1,GSN,106 (106),0.499,1,1,HMDB0009888,1 (1),0.00805,1,0.0262,0.184
Glycolysis,SMPDB,2,PKLR;SLC2A2,15 (15),0.00412,0.124,0,,21 (24),1,1,0.0268,0.185
Glycogenosis_ Type VII. Tarui disease,SMPDB,2,PKLR;SLC2A2,15 (15),0.00412,0.124,0,,21 (24),1,1,0.0268,0.185
Fanconi-bickel syndrome,SMPDB,2,PKLR;SLC2A2,15 (15),0.00412,0.124,0,,21 (24),1,1,0.0268,0.185
Pyrimidine metabolism,Wikipathways,3,DPYS;UPB1;CTPS1,84 (84),0.0172,0.314,1,HMDB0000273,35 (40),0.248,1,0.0274,0.188
Extracellular vesicles in the crosstalk of cardiac cells,Wikipathways,2,EGFR;SORBS2,22 (22),0.0088,0.193,0,,0 (0),1,1,0.0088,0.193
Sphingolipid pathway,Wikipathways,0,,28 (28),1,1,2,HMDB0010711;HMDB0006752,13 (14),0.00456,1,0.0291,0.199
Bile secretion - Homo sapiens (human),KEGG,3,SLC10A1;SLC27A5;UGT2A3,90 (90),0.0206,0.345,2,HMDB0000036;HMDB0014487,112 (161),0.227,1,0.0297,0.2
FOXA2 pathway,Wikipathways,2,FASN;SLC27A5,16 (16),0.00469,0.137,0,,1 (1),1,1,0.0298,0.2
Phytanic acid peroxisomal oxidation,EHMN,2,ACSL1;HACL1,16 (16),0.00469,0.137,0,,21 (22),1,1,0.0298,0.2
nicotine degradation IV,HumanCyc,2,INMT;AOX1,17 (17),0.00529,0.154,0,,16 (28),1,1,0.033,0.22
Propanoate metabolism - Homo sapiens (human),KEGG,2,ABAT;ACSS2,34 (34),0.0203,0.342,1,HMDB0006805,38 (48),0.266,1,0.0336,0.223
Metabolism of water-soluble vitamins and cofactors,Reactome,4,ALDH1L1;FASN;AOX1;CYP8B1,111 (111),0.00581,0.161,0,,91 (125),1,1,0.0357,0.227
Propanoate metabolism,EHMN,2,ACADSB;ALDH7A1,18 (18),0.00593,0.161,0,,29 (33),1,1,0.0363,0.227
Tyrosine Metabolism,SMPDB,2,COMT;HAAO,18 (18),0.00593,0.161,0,,62 (67),1,1,0.0363,0.227
Fatty acid biosynthesis - Homo sapiens (human),KEGG,2,FASN;ACSL1,18 (18),0.00593,0.161,0,,10 (58),1,1,0.0363,0.227
Tyrosinemia_ transient_ of the newborn,SMPDB,2,COMT;HAAO,18 (18),0.00593,0.161,0,,62 (67),1,1,0.0363,0.227
Dopamine beta-hydroxylase deficiency,SMPDB,2,COMT;HAAO,18 (18),0.00593,0.161,0,,62 (67),1,1,0.0363,0.227
Alkaptonuria,SMPDB,2,COMT;HAAO,18 (18),0.00593,0.161,0,,62 (67),1,1,0.0363,0.227
Monoamine oxidase-a deficiency (MAO-A),SMPDB,2,COMT;HAAO,18 (18),0.00593,0.161,0,,62 (67),1,1,0.0363,0.227
Hawkinsinuria,SMPDB,2,COMT;HAAO,18 (18),0.00593,0.161,0,,62 (67),1,1,0.0363,0.227
Tyrosinemia Type I,SMPDB,2,COMT;HAAO,18 (18),0.00593,0.161,0,,62 (67),1,1,0.0363,0.227
Glutathione metabolism - Homo sapiens (human),KEGG,3,GPX7;GSTM3;GSTM4,57 (57),0.00597,0.161,0,,21 (38),1,1,0.0365,0.227
Sphingolipid signaling pathway - Homo sapiens (human),KEGG,0,,119 (119),1,1,2,HMDB0006752;HMDB0013461,15 (15),0.00608,1,0.0371,0.23
Metabolism of vitamins and cofactors,Reactome,5,APOA2;ALDH1L1;FASN;AOX1;CYP8B1,180 (180),0.00623,0.167,0,,136 (188),1,1,0.0379,0.233
Glycosphingolipid metabolism,Reactome,1,HEXA,46 (46),0.259,1,2,HMDB0010711;HMDB0013461,31 (38),0.0249,1,0.039,0.236
L-dopa degradation,HumanCyc,1,COMT,1 (1),0.00648,0.167,0,,13 (13),1,1,0.0391,0.236
Methylation of MeSeH for excretion,Reactome,1,INMT,1 (1),0.00648,0.167,0,,5 (6),1,1,0.0391,0.236
methylglyoxal degradation VI,HumanCyc,1,LDHD,1 (1),0.00648,0.167,0,,9 (9),1,1,0.0391,0.236
MTHFR deficiency,Wikipathways,1,COMT,10 (10),0.0629,0.701,1,HMDB0013461,14 (21),0.107,1,0.0405,0.243
PPAR-alpha pathway,Wikipathways,2,APOA2;CYP8B1,26 (26),0.0122,0.247,0,,0 (1),1,1,0.0122,0.247
Metabolism of xenobiotics by cytochrome P450 - Homo sapiens (human),KEGG,3,GSTM3;GSTM4;UGT2A3,76 (78),0.0131,0.25,1,HMDB0060326,95 (121),0.542,1,0.0423,0.253
Steroid biosynthesis - Homo sapiens (human),KEGG,2,LBR;TM7SF2,20 (20),0.0073,0.187,0,,40 (58),1,1,0.0432,0.255
Aminosugars metabolism,INOH,2,GFPT1;GCK,20 (20),0.0073,0.187,0,,30 (32),1,1,0.0432,0.255
Transport of organic anions,Reactome,1,SLCO2B1,12 (12),0.075,0.755,1,HMDB0000036,13 (15),0.0999,1,0.0442,0.255
Oxidation by Cytochrome P450,Wikipathways,3,CYP27A1;CYP7B1;CYP8B1,62 (62),0.00754,0.192,0,,8 (8),1,1,0.0444,0.255
Synthesis of substrates in N-glycan biosythesis,Reactome,3,NPL;GFPT1;AMDHD2,63 (63),0.00788,0.193,0,,56 (69),1,1,0.046,0.255
fatty acid activation,HumanCyc,1,ACSL1,8 (8),0.0507,0.616,1,HMDB0002183,21 (38),0.157,1,0.0463,0.255
Glycine_ serine and threonine metabolism - Homo sapiens (human),KEGG,2,GNMT;ALDH7A1,40 (40),0.0276,0.426,1,HMDB0000128,42 (50),0.29,1,0.0466,0.255
Mono-unsaturated fatty acid beta-oxidation,EHMN,2,ACSL1;ACADSB,21 (21),0.00804,0.193,0,,12 (12),1,1,0.0468,0.255
Pantothenate and CoA biosynthesis - Homo sapiens (human),KEGG,2,UPB1;DPYS,21 (21),0.00804,0.193,0,,24 (30),1,1,0.0468,0.255
PI3K-AKT-mTOR signaling pathway and therapeutic opportunities,Wikipathways,0,,30 (30),1,1,1,HMDB0009888,1 (1),0.00805,1,0.0468,0.255
Histidine metabolism - Homo sapiens (human),KEGG,2,HNMT;ALDH7A1,22 (22),0.0088,0.193,0,,36 (47),1,1,0.0505,0.255
glutathione-mediated detoxification,HumanCyc,2,GSTM3;GSTM4,22 (22),0.0088,0.193,0,,14 (14),1,1,0.0505,0.255
Simvastatin Action Pathway,SMPDB,2,TM7SF2;MVK,22 (22),0.0088,0.193,0,,43 (47),1,1,0.0505,0.255
Pravastatin Action Pathway,SMPDB,2,TM7SF2;MVK,22 (22),0.0088,0.193,0,,44 (47),1,1,0.0505,0.255
Atorvastatin Action Pathway,SMPDB,2,TM7SF2;MVK,22 (22),0.0088,0.193,0,,44 (47),1,1,0.0505,0.255
Hyper-IgD syndrome,SMPDB,2,TM7SF2;MVK,22 (22),0.0088,0.193,0,,43 (46),1,1,0.0505,0.255
Cholesteryl ester storage disease,SMPDB,2,TM7SF2;MVK,22 (22),0.0088,0.193,0,,43 (46),1,1,0.0505,0.255
Lysosomal Acid Lipase Deficiency (Wolman Disease),SMPDB,2,TM7SF2;MVK,22 (22),0.0088,0.193,0,,43 (46),1,1,0.0505,0.255
Alendronate Action Pathway,SMPDB,2,TM7SF2;MVK,22 (22),0.0088,0.193,0,,44 (47),1,1,0.0505,0.255
Rosuvastatin Action Pathway,SMPDB,2,TM7SF2;MVK,22 (22),0.0088,0.193,0,,43 (47),1,1,0.0505,0.255
Lovastatin Action Pathway,SMPDB,2,TM7SF2;MVK,22 (22),0.0088,0.193,0,,44 (47),1,1,0.0505,0.255
Mevalonic aciduria,SMPDB,2,TM7SF2;MVK,22 (22),0.0088,0.193,0,,43 (46),1,1,0.0505,0.255
Wolman disease,SMPDB,2,TM7SF2;MVK,22 (22),0.0088,0.193,0,,43 (46),1,1,0.0505,0.255
Risedronate Action Pathway,SMPDB,2,TM7SF2;MVK,22 (22),0.0088,0.193,0,,44 (47),1,1,0.0505,0.255
Cerivastatin Action Pathway,SMPDB,2,TM7SF2;MVK,22 (22),0.0088,0.193,0,,43 (47),1,1,0.0505,0.255
Pamidronate Action Pathway,SMPDB,2,TM7SF2;MVK,22 (22),0.0088,0.193,0,,44 (47),1,1,0.0505,0.255
Fluvastatin Action Pathway,SMPDB,2,TM7SF2;MVK,22 (22),0.0088,0.193,0,,44 (47),1,1,0.0505,0.255
Smith-Lemli-Opitz Syndrome (SLOS),SMPDB,2,TM7SF2;MVK,22 (22),0.0088,0.193,0,,43 (46),1,1,0.0505,0.255
Chondrodysplasia Punctata II_ X Linked Dominant (CDPX2),SMPDB,2,TM7SF2;MVK,22 (22),0.0088,0.193,0,,43 (46),1,1,0.0505,0.255
CHILD Syndrome,SMPDB,2,TM7SF2;MVK,22 (22),0.0088,0.193,0,,43 (46),1,1,0.0505,0.255
Desmosterolosis,SMPDB,2,TM7SF2;MVK,22 (22),0.0088,0.193,0,,43 (46),1,1,0.0505,0.255
Hypercholesterolemia,SMPDB,2,TM7SF2;MVK,22 (22),0.0088,0.193,0,,43 (46),1,1,0.0505,0.255
Steroid Biosynthesis,SMPDB,2,TM7SF2;MVK,22 (22),0.0088,0.193,0,,43 (46),1,1,0.0505,0.255
Zoledronate Action Pathway,SMPDB,2,TM7SF2;MVK,22 (22),0.0088,0.193,0,,43 (47),1,1,0.0505,0.255
Ibandronate Action Pathway,SMPDB,2,TM7SF2;MVK,22 (22),0.0088,0.193,0,,43 (46),1,1,0.0505,0.255
NRF2 pathway,Wikipathways,4,SLC2A2;GSTM3;GSTM4;ME1,143 (143),0.0139,0.262,0,,0 (1),1,1,0.0139,0.262
Taurine and hypotaurine metabolism - Homo sapiens (human),KEGG,1,CSAD,11 (11),0.069,0.729,1,HMDB0000036,18 (22),0.136,1,0.0531,0.262
Butanoate metabolism,EHMN,2,ALDH7A1;ACSM1,23 (23),0.0096,0.201,0,,34 (36),1,1,0.0542,0.262
RHO GTPases activate PAKs,Reactome,2,PPP1R12A;MYLK,23 (23),0.0096,0.201,0,,6 (6),1,1,0.0542,0.262
2-Hydroxyglutric Aciduria (D And L Form),SMPDB,2,GFPT1;ABAT,23 (23),0.0096,0.201,0,,47 (49),1,1,0.0542,0.262
Homocarnosinosis,SMPDB,2,GFPT1;ABAT,23 (23),0.0096,0.201,0,,47 (49),1,1,0.0542,0.262
Hyperinsulinism-Hyperammonemia Syndrome,SMPDB,2,GFPT1;ABAT,23 (23),0.0096,0.201,0,,47 (49),1,1,0.0542,0.262
Succinic semialdehyde dehydrogenase deficiency,SMPDB,2,GFPT1;ABAT,23 (23),0.0096,0.201,0,,47 (49),1,1,0.0542,0.262
4-Hydroxybutyric Aciduria/Succinic Semialdehyde Dehydrogenase Deficiency,SMPDB,2,GFPT1;ABAT,23 (23),0.0096,0.201,0,,47 (49),1,1,0.0542,0.262
Glutamate Metabolism,SMPDB,2,GFPT1;ABAT,23 (23),0.0096,0.201,0,,47 (49),1,1,0.0542,0.262
Histidine degradation,INOH,2,HNMT;ALDH7A1,23 (23),0.0096,0.201,0,,26 (28),1,1,0.0542,0.262
Metabolism of carbohydrates,Reactome,6,PKLR;HEXA;GBE1;PYGL;KHK;GCK,284 (285),0.0102,0.213,0,,90 (157),1,1,0.0572,0.276
glycolysis,HumanCyc,2,PKLR;GCK,24 (25),0.0104,0.215,0,,17 (20),1,1,0.058,0.277
Glycogen metabolism,Reactome,2,GBE1;PYGL,24 (24),0.0104,0.215,0,,14 (16),1,1,0.058,0.277
Central carbon metabolism in cancer - Homo sapiens (human),KEGG,3,SLC2A2;EGFR;GCK,70 (70),0.0105,0.216,0,,35 (37),1,1,0.0584,0.278
Nucleobase catabolism,Reactome,2,UPB1;DPYS,36 (36),0.0226,0.375,1,HMDB0000273,78 (99),0.473,1,0.0593,0.281
Propanoate metabolism,INOH,2,ALDH7A1;ACSS2,25 (25),0.0113,0.231,0,,24 (26),1,1,0.0619,0.292
Insulin signaling pathway - Homo sapiens (human),KEGG,4,PKLR;FASN;PYGL;GCK,137 (137),0.012,0.244,0,,2 (4),1,1,0.0651,0.306
Plasma lipoprotein remodeling,Reactome,1,APOA2,26 (26),0.156,1,1,HMDB0010404,10 (16),0.0777,1,0.0655,0.307
protein <i>O</i>-[<i>N</i>-acetyl]-glucosylation,HumanCyc,1,OGT,2 (2),0.0129,0.248,0,,4 (5),1,1,0.0691,0.307
histamine degradation,HumanCyc,1,HNMT,2 (2),0.0129,0.248,0,,13 (13),1,1,0.0691,0.307
4-aminobutyrate degradation,HumanCyc,1,ABAT,2 (2),0.0129,0.248,0,,9 (9),1,1,0.0691,0.307
Enzymatic degradation of Dopamine by monoamine oxidase,Reactome,1,COMT,2 (2),0.0129,0.248,0,,9 (10),1,1,0.0691,0.307
Conjugation of phenylacetate with glutamine,Reactome,1,ACSM1,2 (2),0.0129,0.248,0,,7 (9),1,1,0.0691,0.307
Degradation of GABA,Reactome,1,ABAT,2 (2),0.0129,0.248,0,,8 (10),1,1,0.0691,0.307
&beta;-alanine degradation,HumanCyc,1,ABAT,2 (2),0.0129,0.248,0,,11 (11),1,1,0.0691,0.307
fatty acid elongation -- saturated,HumanCyc,1,FASN,2 (2),0.0129,0.248,0,,5 (5),1,1,0.0691,0.307
Sterols are 12-hydroxylated by CYP8B1,Reactome,1,CYP8B1,2 (2),0.0129,0.248,0,,9 (12),1,1,0.0691,0.307
choline degradation,HumanCyc,1,ALDH7A1,2 (2),0.0129,0.248,0,,7 (7),1,1,0.0691,0.307
Biosynthesis of maresin conjugates in tissue regeneration (MCTR),Reactome,1,GSTM4,2 (2),0.0129,0.248,0,,4 (9),1,1,0.0691,0.307
Biosynthesis of DHA-derived sulfido conjugates,Reactome,1,GSTM4,2 (2),0.0129,0.248,0,,7 (22),1,1,0.0691,0.307
Fatty Acid Biosynthesis,SMPDB,1,FASN,2 (2),0.0129,0.248,0,,31 (33),1,1,0.0691,0.307
Glutamate Glutamine metabolism,INOH,2,ABAT;ALDH7A1,27 (27),0.0131,0.25,0,,28 (34),1,1,0.0699,0.31
Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide_ LLO) and transfer to a nascent protein,Reactome,3,NPL;GFPT1;AMDHD2,77 (77),0.0136,0.258,0,,59 (82),1,1,0.072,0.318
alpha-linolenic acid (ALA) metabolism,Reactome,1,ACSL1,13 (13),0.081,0.765,1,HMDB0002183,23 (32),0.17,1,0.0729,0.32
Biosynthesis of DHA-derived SPMs,Reactome,1,GSTM4,17 (17),0.105,0.894,1,HMDB0002183,18 (75),0.136,1,0.0746,0.326
Drug Induction of Bile Acid Pathway,Wikipathways,1,SLC10A1,17 (17),0.105,0.894,1,HMDB0000036,18 (28),0.136,1,0.0746,0.326
rho cell motility signaling pathway,BioCarta,2,GSN;MYLK,32 (32),0.0181,0.329,0,,0 (0),1,1,0.0181,0.329
Gastric Cancer Network 2,Wikipathways,2,LBR;EGFR,32 (32),0.0181,0.329,0,,0 (0),1,1,0.0181,0.329
Lipid Metabolism Pathway,Wikipathways,2,FASN;ACSS2,29 (29),0.015,0.283,0,,8 (14),1,1,0.0781,0.34
Heroin metabolism,Wikipathways,0,,3 (3),1,1,1,HMDB0041812,2 (3),0.016,1,0.0823,0.352
ceramide signaling pathway,BioCarta,0,,33 (33),1,1,1,HMDB0013461,2 (2),0.016,1,0.0823,0.352
Peroxisomal lipid metabolism,Reactome,2,HACL1;NUDT7,30 (30),0.016,0.299,0,,38 (61),1,1,0.0823,0.352
mcalpain and friends in cell motility,BioCarta,2,EGFR;MYLK,30 (30),0.016,0.299,0,,3 (3),1,1,0.0823,0.352
Phenytoin (Antiarrhythmic) Action Pathway,SMPDB,2,COMT;MYLK,82 (82),0.0988,0.86,1,HMDB0009888,22 (22),0.163,1,0.0828,0.353
Chemical carcinogenesis - Homo sapiens (human),KEGG,3,GSTM3;GSTM4;UGT2A3,83 (83),0.0166,0.308,0,,57 (99),1,1,0.0847,0.359
Regulation of Actin Cytoskeleton,Wikipathways,4,PPP1R12A;EGFR;MYLK;GSN,151 (151),0.0166,0.308,0,,4 (5),1,1,0.0847,0.359
erk and pi-3 kinase are necessary for collagen binding in corneal epithelia,BioCarta,2,GSN;MYLK,31 (31),0.0171,0.313,0,,1 (1),1,1,0.0865,0.364
Folate metabolism,INOH,2,ALDH1L1;PKLR,31 (31),0.0171,0.313,0,,43 (46),1,1,0.0865,0.364
alpha-linolenic (omega3) and linoleic (omega6) acid metabolism,Reactome,1,ACSL1,13 (13),0.081,0.765,1,HMDB0002183,31 (42),0.223,1,0.0905,0.373
Metabolism of nucleotides,Reactome,3,CTPS1;UPB1;DPYS,102 (102),0.0285,0.438,1,HMDB0000273,125 (154),0.645,1,0.0917,0.373
Arginine Proline metabolism,INOH,2,ABAT;ALDH7A1,55 (55),0.0493,0.616,1,HMDB0000128,58 (68),0.377,1,0.0928,0.373
Androgen and estrogen biosynthesis and metabolism,EHMN,3,SLC10A1;SLCO2B1;AKR1D1,87 (87),0.0188,0.329,0,,53 (62),1,1,0.0936,0.373
Phospholipid Biosynthesis,SMPDB,0,,28 (28),1,1,2,HMDB0009888;HMDB0010404,27 (27),0.0192,1,0.095,0.373
Endothelin Pathways,Wikipathways,1,MYLK,33 (33),0.193,1,1,HMDB0009888,13 (13),0.0999,1,0.0955,0.373
acetate conversion to acetyl-CoA,HumanCyc,1,ACSS2,3 (3),0.0193,0.329,0,,6 (6),1,1,0.0955,0.373
UTP and CTP dephosphorylation I,HumanCyc,1,CTPS1,3 (3),0.0193,0.329,0,,15 (15),1,1,0.0955,0.373
Signaling by MST1,Reactome,1,HPN,3 (3),0.0193,0.329,0,,3 (3),1,1,0.0955,0.373
fatty acid &alpha;-oxidation III,HumanCyc,1,HACL1,3 (3),0.0193,0.329,0,,18 (23),1,1,0.0955,0.373
Enzymatic degradation of dopamine by COMT,Reactome,1,COMT,3 (3),0.0193,0.329,0,,10 (10),1,1,0.0955,0.373
Vitamins B6 activation to pyridoxal phosphate,Reactome,1,AOX1,3 (3),0.0193,0.329,0,,16 (18),1,1,0.0955,0.373
Intestinal hexose absorption,Reactome,1,SLC2A2,3 (3),0.0193,0.329,0,,3 (5),1,1,0.0955,0.373
Uptake and function of diphtheria toxin,Reactome,1,CD9,3 (3),0.0193,0.329,0,,2 (2),1,1,0.0955,0.373
taurine biosynthesis,HumanCyc,1,CSAD,3 (3),0.0193,0.329,0,,11 (11),1,1,0.0955,0.373
<i>N</i>-acetylglucosamine degradation I,HumanCyc,1,AMDHD2,3 (3),0.0193,0.329,0,,3 (5),1,1,0.0955,0.373
Phenylacetate Metabolism,SMPDB,1,ACSM1,3 (3),0.0193,0.329,0,,9 (9),1,1,0.0955,0.373
Electron transport from NADPH to Ferredoxin,Reactome,1,FDX1,3 (3),0.0193,0.329,0,,5 (7),1,1,0.0955,0.373
Erlotinib Action Pathway,SMPDB,1,EGFR,3 (3),0.0193,0.329,0,,4 (5),1,1,0.0955,0.373
Pyruvaldehyde Degradation,SMPDB,1,LDHD,3 (3),0.0193,0.329,0,,9 (9),1,1,0.0955,0.373
methylglyoxal degradation I,HumanCyc,1,LDHD,3 (3),0.0193,0.329,0,,10 (11),1,1,0.0955,0.373
Transport of vitamins_ nucleosides_ and related molecules,Reactome,1,SLCO2B1,44 (44),0.249,1,2,HMDB0000036;HMDB0000273,59 (63),0.0802,1,0.0981,0.382
Fluoropyrimidine Activity,Wikipathways,2,UPB1;DPYS,34 (34),0.0203,0.342,0,,11 (16),1,1,0.0996,0.385
Fatty acid beta-oxidation,Wikipathways,2,ACSL1;ACSS2,34 (34),0.0203,0.342,0,,32 (34),1,1,0.0996,0.385
Histidine metabolism,EHMN,2,ABAT;ALDH7A1,35 (35),0.0215,0.359,0,,43 (45),1,1,0.104,0.399
Glycogen Synthesis and Degradation,Wikipathways,2,GBE1;PYGL,36 (36),0.0226,0.375,0,,5 (6),1,1,0.108,0.399
Tyrosine metabolism - Homo sapiens (human),KEGG,2,COMT;AOX1,36 (36),0.0226,0.375,0,,58 (78),1,1,0.108,0.399
Fatty acyl-CoA biosynthesis,Reactome,2,FASN;ACSL1,37 (37),0.0238,0.389,0,,29 (42),1,1,0.113,0.399
Squalene and cholesterol biosynthesis,EHMN,2,TM7SF2;MVK,37 (37),0.0238,0.389,0,,38 (42),1,1,0.113,0.399
Alanine_ aspartate and glutamate metabolism - Homo sapiens (human),KEGG,2,GFPT1;ABAT,37 (37),0.0238,0.389,0,,25 (28),1,1,0.113,0.399
Glutathione conjugation,Reactome,2,GSTM3;GSTM4,37 (37),0.0238,0.389,0,,25 (31),1,1,0.113,0.399
T-Cell antigen Receptor (TCR) pathway during Staphylococcus aureus infection,Wikipathways,0,,63 (63),1,1,1,HMDB0009888,3 (3),0.024,1,0.113,0.399
resolvin D biosynthesis,HumanCyc,0,,2 (2),1,1,1,HMDB0002183,3 (5),0.024,1,0.113,0.399
aspirin triggered resolvin D biosynthesis,HumanCyc,0,,2 (2),1,1,1,HMDB0002183,3 (7),0.024,1,0.113,0.399
Sphingolipid de novo biosynthesis,Reactome,0,,41 (41),1,1,2,HMDB0013461;HMDB0006752,31 (35),0.0249,1,0.117,0.399
Arbutamine Action Pathway,SMPDB,1,MYLK,61 (61),0.328,1,1,HMDB0009888,10 (11),0.0777,1,0.119,0.399
Alprenolol Action Pathway,SMPDB,1,MYLK,61 (61),0.328,1,1,HMDB0009888,10 (11),0.0777,1,0.119,0.399
Muscle/Heart Contraction,SMPDB,1,MYLK,61 (61),0.328,1,1,HMDB0009888,10 (10),0.0777,1,0.119,0.399
Felodipine Action Pathway,SMPDB,1,MYLK,61 (61),0.328,1,1,HMDB0009888,10 (11),0.0777,1,0.119,0.399
Vitamin B6-dependent and responsive disorders,Wikipathways,1,ALDH7A1,4 (4),0.0257,0.398,0,,12 (19),1,1,0.12,0.399
Amino acid conjugation of benzoic acid,Wikipathways,1,ACSS2,4 (4),0.0257,0.398,0,,9 (11),1,1,0.12,0.399
Polyol Pathway,Wikipathways,1,KHK,4 (4),0.0257,0.398,0,,7 (8),1,1,0.12,0.399
PLCG1 events in ERBB2 signaling,Reactome,1,EGFR,4 (4),0.0257,0.398,0,,2 (2),1,1,0.12,0.399
MET Receptor Activation,Reactome,1,HPN,4 (4),0.0257,0.398,0,,3 (3),1,1,0.12,0.399
lysine degradation I (saccharopine pathway),HumanCyc,1,ALDH7A1,4 (4),0.0257,0.398,0,,16 (16),1,1,0.12,0.399
Dopamine clearance from the synaptic cleft,Reactome,1,COMT,4 (4),0.0257,0.398,0,,12 (13),1,1,0.12,0.399
fatty acid biosynthesis initiation,HumanCyc,1,FASN,4 (4),0.0257,0.398,0,,7 (9),1,1,0.12,0.399
UTP and CTP dephosphorylation II,HumanCyc,1,CTPS1,4 (4),0.0257,0.398,0,,11 (11),1,1,0.12,0.399
trehalose degradation,HumanCyc,1,GCK,4 (4),0.0257,0.398,0,,8 (8),1,1,0.12,0.399
Vitamin B6 metabolism,INOH,1,AOX1,4 (4),0.0257,0.398,0,,17 (17),1,1,0.12,0.399
Mitochondrial ABC transporters,Reactome,1,ABCB10,4 (4),0.0257,0.398,0,,5 (6),1,1,0.12,0.399
Intestinal absorption,Reactome,1,SLC2A2,4 (4),0.0257,0.398,0,,4 (8),1,1,0.12,0.399
Lipoic acid metabolism - Homo sapiens (human),KEGG,1,ACSM1,4 (4),0.0257,0.398,0,,5 (13),1,1,0.12,0.399
<i>N</i>-acetylglucosamine degradation II,HumanCyc,1,AMDHD2,4 (4),0.0257,0.398,0,,7 (9),1,1,0.12,0.399
ABC-family proteins mediated transport,Reactome,1,ABCB10,58 (58),0.315,1,1,HMDB0013461,11 (20),0.0852,1,0.124,0.399
Transport of small molecules,Reactome,4,ABCB10;APOA2;SLC2A2;SLCO2B1,641 (641),0.601,1,4,HMDB0000036;HMDB0010404;HMDB0000273;HMDB0013461,172 (219),0.0451,1,0.125,0.399
Amiodarone Action Pathway,SMPDB,1,MYLK,61 (61),0.328,1,1,HMDB0009888,11 (11),0.0852,1,0.128,0.399
Disopyramide Action Pathway,SMPDB,1,MYLK,61 (61),0.328,1,1,HMDB0009888,11 (11),0.0852,1,0.128,0.399
Procainamide (Antiarrhythmic) Action Pathway,SMPDB,1,MYLK,61 (61),0.328,1,1,HMDB0009888,11 (11),0.0852,1,0.128,0.399
Bopindolol Action Pathway,SMPDB,1,MYLK,61 (61),0.328,1,1,HMDB0009888,11 (11),0.0852,1,0.128,0.399
Timolol Action Pathway,SMPDB,1,MYLK,61 (61),0.328,1,1,HMDB0009888,11 (11),0.0852,1,0.128,0.399
Carteolol Action Pathway,SMPDB,1,MYLK,61 (61),0.328,1,1,HMDB0009888,11 (11),0.0852,1,0.128,0.399
Bevantolol Action Pathway,SMPDB,1,MYLK,61 (61),0.328,1,1,HMDB0009888,11 (11),0.0852,1,0.128,0.399
Practolol Action Pathway,SMPDB,1,MYLK,61 (61),0.328,1,1,HMDB0009888,11 (11),0.0852,1,0.128,0.399
Dobutamine Action Pathway,SMPDB,1,MYLK,61 (61),0.328,1,1,HMDB0009888,11 (11),0.0852,1,0.128,0.399
Isoprenaline Action Pathway,SMPDB,1,MYLK,61 (61),0.328,1,1,HMDB0009888,11 (11),0.0852,1,0.128,0.399
Levobunolol Action Pathway,SMPDB,1,MYLK,61 (61),0.328,1,1,HMDB0009888,11 (11),0.0852,1,0.128,0.399
Metipranolol Action Pathway,SMPDB,1,MYLK,61 (61),0.328,1,1,HMDB0009888,11 (11),0.0852,1,0.128,0.399
Mexiletine Action Pathway,SMPDB,1,MYLK,61 (61),0.328,1,1,HMDB0009888,11 (11),0.0852,1,0.128,0.399
Quinidine Action Pathway,SMPDB,1,MYLK,61 (61),0.328,1,1,HMDB0009888,11 (11),0.0852,1,0.128,0.399
Sotalol Action Pathway,SMPDB,1,MYLK,61 (61),0.328,1,1,HMDB0009888,11 (11),0.0852,1,0.128,0.399
Epinephrine Action Pathway,SMPDB,1,MYLK,61 (61),0.328,1,1,HMDB0009888,11 (11),0.0852,1,0.128,0.399
Betaxolol Action Pathway,SMPDB,1,MYLK,61 (61),0.328,1,1,HMDB0009888,11 (11),0.0852,1,0.128,0.399
Atenolol Action Pathway,SMPDB,1,MYLK,61 (61),0.328,1,1,HMDB0009888,11 (11),0.0852,1,0.128,0.399
Acebutolol Action Pathway,SMPDB,1,MYLK,61 (61),0.328,1,1,HMDB0009888,11 (11),0.0852,1,0.128,0.399
Propranolol Action Pathway,SMPDB,1,MYLK,61 (61),0.328,1,1,HMDB0009888,11 (11),0.0852,1,0.128,0.399
Pindolol Action Pathway,SMPDB,1,MYLK,61 (61),0.328,1,1,HMDB0009888,11 (11),0.0852,1,0.128,0.399
Penbutolol Action Pathway,SMPDB,1,MYLK,61 (61),0.328,1,1,HMDB0009888,11 (11),0.0852,1,0.128,0.399
Oxprenolol Action Pathway,SMPDB,1,MYLK,61 (61),0.328,1,1,HMDB0009888,11 (11),0.0852,1,0.128,0.399
Metoprolol Action Pathway,SMPDB,1,MYLK,61 (61),0.328,1,1,HMDB0009888,11 (11),0.0852,1,0.128,0.399
Esmolol Action Pathway,SMPDB,1,MYLK,61 (61),0.328,1,1,HMDB0009888,11 (11),0.0852,1,0.128,0.399
Bisoprolol Action Pathway,SMPDB,1,MYLK,61 (61),0.328,1,1,HMDB0009888,11 (11),0.0852,1,0.128,0.399
Bupranolol Action Pathway,SMPDB,1,MYLK,61 (61),0.328,1,1,HMDB0009888,11 (11),0.0852,1,0.128,0.399
Nebivolol Action Pathway,SMPDB,1,MYLK,61 (61),0.328,1,1,HMDB0009888,11 (11),0.0852,1,0.128,0.399
Amlodipine Action Pathway,SMPDB,1,MYLK,61 (61),0.328,1,1,HMDB0009888,11 (11),0.0852,1,0.128,0.399
Verapamil Action Pathway,SMPDB,1,MYLK,61 (61),0.328,1,1,HMDB0009888,11 (11),0.0852,1,0.128,0.399
Nitrendipine Action Pathway,SMPDB,1,MYLK,61 (61),0.328,1,1,HMDB0009888,11 (11),0.0852,1,0.128,0.399
Nisoldipine Action Pathway,SMPDB,1,MYLK,61 (61),0.328,1,1,HMDB0009888,11 (11),0.0852,1,0.128,0.399
Nimodipine Action Pathway,SMPDB,1,MYLK,61 (61),0.328,1,1,HMDB0009888,11 (11),0.0852,1,0.128,0.399
Ibutilide Action Pathway,SMPDB,1,MYLK,61 (61),0.328,1,1,HMDB0009888,11 (11),0.0852,1,0.128,0.399
Tocainide Action Pathway,SMPDB,1,MYLK,61 (61),0.328,1,1,HMDB0009888,11 (11),0.0852,1,0.128,0.399
Flecainide Action Pathway,SMPDB,1,MYLK,61 (61),0.328,1,1,HMDB0009888,11 (11),0.0852,1,0.128,0.399
Isradipine Action Pathway,SMPDB,1,MYLK,61 (61),0.328,1,1,HMDB0009888,11 (11),0.0852,1,0.128,0.399
Nifedipine Action Pathway,SMPDB,1,MYLK,61 (61),0.328,1,1,HMDB0009888,11 (11),0.0852,1,0.128,0.399
Nadolol Action Pathway,SMPDB,1,MYLK,61 (61),0.328,1,1,HMDB0009888,11 (11),0.0852,1,0.128,0.399
Carvedilol Action Pathway,SMPDB,1,MYLK,62 (62),0.332,1,1,HMDB0009888,11 (11),0.0852,1,0.129,0.401
Labetalol Action Pathway,SMPDB,1,MYLK,62 (62),0.332,1,1,HMDB0009888,11 (11),0.0852,1,0.129,0.401
Biosynthesis of specialized proresolving mediators (SPMs),Reactome,1,GSTM4,19 (19),0.116,0.958,1,HMDB0002183,35 (143),0.248,1,0.131,0.405
Arachidonic acid metabolism,Reactome,2,PON1;CYP8B1,60 (60),0.0576,0.666,1,HMDB0010404,89 (114),0.519,1,0.135,0.416
chrebp regulation by carbohydrates and camp,BioCarta,2,PKLR;ACSM1,42 (42),0.0302,0.463,0,,8 (12),1,1,0.136,0.419
Fosphenytoin (Antiarrhythmic) Action Pathway,SMPDB,1,MYLK,61 (61),0.328,1,1,HMDB0009888,12 (12),0.0926,1,0.136,0.419
superpathway of tryptophan utilization,HumanCyc,2,HAAO;IDO2,43 (43),0.0315,0.474,0,,59 (70),1,1,0.141,0.422
T-Cell Receptor and Co-stimulatory Signaling,Wikipathways,0,,30 (30),1,1,1,HMDB0009888,4 (4),0.0318,1,0.142,0.422
Heroin Metabolism Pathway,SMPDB,0,,4 (4),1,1,1,HMDB0041812,4 (5),0.0318,1,0.142,0.422
TCA Cycle Nutrient Utilization and Invasiveness of Ovarian Cancer,Wikipathways,1,EGFR,5 (5),0.032,0.474,0,,4 (4),1,1,0.142,0.422
Degradation pathway of sphingolipids_ including diseases,Wikipathways,1,HEXA,5 (5),0.032,0.474,0,,9 (13),1,1,0.142,0.422
Keratan sulfate degradation,Reactome,1,HEXA,5 (5),0.032,0.474,0,,3 (10),1,1,0.142,0.422
UDP-<i>N</i>-acetyl-D-glucosamine biosynthesis II,HumanCyc,1,GFPT1,5 (5),0.032,0.474,0,,9 (11),1,1,0.142,0.422
Fructose catabolism,Reactome,1,KHK,5 (5),0.032,0.474,0,,11 (15),1,1,0.142,0.422
asparagine degradation,HumanCyc,1,ASPG,5 (5),0.032,0.474,0,,10 (10),1,1,0.142,0.422
Neomycin_ kanamycin and gentamicin biosynthesis - Homo sapiens (human),KEGG,1,GCK,5 (5),0.032,0.474,0,,8 (81),1,1,0.142,0.422
Hypophosphatasia,SMPDB,1,AOX1,5 (5),0.032,0.474,0,,19 (20),1,1,0.142,0.422
Vitamin B6 Metabolism,SMPDB,1,AOX1,5 (5),0.032,0.474,0,,19 (20),1,1,0.142,0.422
Taurine and Hypotaurine Metabolism,SMPDB,1,CSAD,5 (5),0.032,0.474,0,,11 (12),1,1,0.142,0.422
Glucagon signaling pathway - Homo sapiens (human),KEGG,3,SLC2A2;PYGL;GCK,107 (107),0.0322,0.475,0,,21 (26),1,1,0.143,0.423
Plasma lipoprotein assembly_ remodeling_ and clearance,Reactome,1,APOA2,60 (60),0.323,1,1,HMDB0010404,13 (21),0.0999,1,0.143,0.423
a6b1 and a6b4 Integrin signaling,PID,2,CD9;EGFR,45 (45),0.0343,0.503,0,,3 (3),1,1,0.15,0.441
Warburg Effect,SMPDB,2,PKLR;SLC2A2,45 (45),0.0343,0.503,0,,52 (58),1,1,0.15,0.441
Digestion and absorption,Reactome,1,SLC2A2,26 (26),0.156,1,1,HMDB0000036,33 (45),0.235,1,0.158,0.455
Choline metabolism in cancer - Homo sapiens (human),KEGG,1,EGFR,98 (98),0.472,1,1,HMDB0010404,10 (11),0.0777,1,0.158,0.455
superpathway of conversion of glucose to acetyl CoA and entry into the TCA cycle,HumanCyc,2,PKLR;GCK,47 (48),0.0371,0.526,0,,33 (36),1,1,0.159,0.455
Fluoroacetic acid toxicity,Wikipathways,1,ACSS2,6 (6),0.0382,0.526,0,,2 (6),1,1,0.163,0.455
ethanol degradation IV,HumanCyc,1,ACSS2,6 (6),0.0382,0.526,0,,13 (13),1,1,0.163,0.455
Pre-NOTCH Processing in the Endoplasmic Reticulum,Reactome,1,POFUT1,6 (6),0.0382,0.526,0,,4 (4),1,1,0.163,0.455
Choline catabolism,Reactome,1,ALDH7A1,6 (6),0.0382,0.526,0,,13 (15),1,1,0.163,0.455
Alpha-oxidation of phytanate,Reactome,1,HACL1,6 (6),0.0382,0.526,0,,23 (27),1,1,0.163,0.455
GDP-glucose biosynthesis II,HumanCyc,1,GCK,6 (6),0.0382,0.526,0,,10 (11),1,1,0.163,0.455
Conjugation of benzoate with glycine,Reactome,1,ACSM1,6 (6),0.0382,0.526,0,,7 (8),1,1,0.163,0.455
Vitamin B6 metabolism - Homo sapiens (human),KEGG,1,AOX1,6 (6),0.0382,0.526,0,,19 (29),1,1,0.163,0.455
lysine degradation II (pipecolate pathway),HumanCyc,1,ALDH7A1,6 (6),0.0382,0.526,0,,21 (21),1,1,0.163,0.455
Nateglinide Action Pathway,SMPDB,1,SLC2A2,6 (6),0.0382,0.526,0,,4 (5),1,1,0.163,0.455
Glibenclamide Action Pathway,SMPDB,1,SLC2A2,6 (6),0.0382,0.526,0,,4 (5),1,1,0.163,0.455
Gliclazide Action Pathway,SMPDB,1,SLC2A2,6 (6),0.0382,0.526,0,,3 (5),1,1,0.163,0.455
PTK6 promotes HIF1A stabilization,Reactome,1,EGFR,6 (6),0.0382,0.526,0,,2 (2),1,1,0.163,0.455
Pancreas Function,SMPDB,1,SLC2A2,6 (6),0.0382,0.526,0,,3 (4),1,1,0.163,0.455
Repaglinide Action Pathway,SMPDB,1,SLC2A2,6 (6),0.0382,0.526,0,,4 (5),1,1,0.163,0.455
Refsum Disease,SMPDB,1,HACL1,6 (6),0.0382,0.526,0,,22 (24),1,1,0.163,0.455
Phytanic Acid Peroxisomal Oxidation,SMPDB,1,HACL1,6 (6),0.0382,0.526,0,,22 (24),1,1,0.163,0.455
Nicotine Metabolism,Wikipathways,1,AOX1,6 (6),0.0382,0.526,0,,10 (10),1,1,0.163,0.455
Focal Adhesion,Wikipathways,4,COL5A2;PPP1R12A;EGFR;MYLK,198 (198),0.0396,0.543,0,,1 (2),1,1,0.167,0.465
Ceramide signalling,Reactome,0,,3 (3),1,1,1,HMDB0013461,5 (5),0.0396,1,0.168,0.465
Necroptosis - Homo sapiens (human),KEGG,1,PYGL,159 (159),0.646,1,1,HMDB0013461,8 (10),0.0627,1,0.17,0.472
Methionine Cysteine metabolism,INOH,1,CSAD,24 (24),0.144,1,1,HMDB0000036,41 (45),0.284,1,0.172,0.475
Sensory processing of sound by outer hair cells of the cochlea,Reactome,2,EPB41L1;GSN,50 (50),0.0416,0.567,0,,6 (7),1,1,0.174,0.479
Aminosugars metabolism,EHMN,2,HEXA;SLC2A2,51 (51),0.0431,0.586,0,,37 (43),1,1,0.179,0.491
Cholesterol Biosynthesis with Skeletal Dysplasias,Wikipathways,1,LBR,7 (7),0.0445,0.588,0,,12 (14),1,1,0.183,0.491
oxidative ethanol degradation III,HumanCyc,1,ACSS2,7 (7),0.0445,0.588,0,,15 (15),1,1,0.183,0.491
CS/DS degradation,Reactome,1,HEXA,7 (7),0.0445,0.588,0,,4 (15),1,1,0.183,0.491
Fructose metabolism,Reactome,1,KHK,7 (7),0.0445,0.588,0,,16 (20),1,1,0.183,0.491
superpathway of choline degradation to L-serine,HumanCyc,1,ALDH7A1,7 (7),0.0445,0.588,0,,16 (16),1,1,0.183,0.491
chondroitin sulfate degradation (metazoa),HumanCyc,1,HEXA,7 (7),0.0445,0.588,0,,70 (131),1,1,0.183,0.491
Suppression of apoptosis,Reactome,1,RNF213,7 (7),0.0445,0.588,0,,2 (2),1,1,0.183,0.491
dermatan sulfate degradation (metazoa),HumanCyc,1,HEXA,7 (7),0.0445,0.588,0,,70 (131),1,1,0.183,0.491
Ethanol Degradation,SMPDB,1,ACSS2,7 (7),0.0445,0.588,0,,18 (18),1,1,0.183,0.491
dopamine degradation,HumanCyc,1,COMT,7 (7),0.0445,0.588,0,,17 (17),1,1,0.183,0.491
mechanism of gene regulation by peroxisome proliferators via ppara,BioCarta,2,APOA2;ME1,52 (52),0.0446,0.588,0,,1 (9),1,1,0.183,0.491
Pentose and glucuronate interconversions - Homo sapiens (human),KEGG,1,UGT2A3,34 (34),0.198,1,1,HMDB0039721,32 (58),0.229,1,0.186,0.497
Mitochondrial biogenesis,Reactome,2,ATP5MC2;ACSS2,53 (53),0.0462,0.607,0,,7 (8),1,1,0.188,0.5
3q29 copy number variation syndrome,Wikipathways,0,,86 (86),1,1,1,HMDB0000036,6 (17),0.0474,1,0.192,0.5
Neurodegeneration with brain iron accumulation (NBIA) subtypes pathway,Wikipathways,0,,44 (44),1,1,1,HMDB0013461,6 (23),0.0474,1,0.192,0.5
mRNA decay by 5_ to 3_ exoribonuclease,Reactome,0,,15 (15),1,1,1,HMDB0001107,6 (7),0.0474,1,0.192,0.5
Glycosylphosphatidylinositol (GPI)-anchor biosynthesis - Homo sapiens (human),KEGG,0,,26 (26),1,1,1,HMDB0011668,6 (16),0.0474,1,0.192,0.5
Acyl chain remodelling of PC,Reactome,0,,27 (27),1,1,1,HMDB0010404,6 (13),0.0474,1,0.192,0.5
Acyl chain remodeling of CL,Reactome,0,,6 (6),1,1,1,HMDB0010404,6 (12),0.0474,1,0.192,0.5
Hydrolysis of LPC,Reactome,0,,11 (11),1,1,1,HMDB0010404,6 (9),0.0474,1,0.192,0.5
phospholipids as signalling intermediaries,BioCarta,0,,33 (33),1,1,1,HMDB0013461,6 (7),0.0474,1,0.192,0.5
Biosynthesis of maresin-like SPMs,Reactome,0,,6 (6),1,1,1,HMDB0002183,6 (17),0.0474,1,0.192,0.5
Insulin Signalling,SMPDB,0,,17 (17),1,1,1,HMDB0009888,6 (7),0.0474,1,0.192,0.5
Selenoamino acid metabolism,Reactome,3,GNMT;INMT;HNMT,128 (128),0.0503,0.616,0,,48 (63),1,1,0.201,0.5
NAD Biosynthesis II (from tryptophan),Wikipathways,1,HAAO,8 (8),0.0507,0.616,0,,24 (24),1,1,0.202,0.5
palmitate biosynthesis,HumanCyc,1,FASN,8 (9),0.0507,0.616,0,,9 (10),1,1,0.202,0.5
Histidine catabolism,Reactome,1,HNMT,8 (8),0.0507,0.616,0,,22 (22),1,1,0.202,0.5
Linoleic acid (LA) metabolism,Reactome,1,ACSL1,8 (8),0.0507,0.616,0,,19 (24),1,1,0.202,0.5
GABA shunt,HumanCyc,1,ABAT,8 (8),0.0507,0.616,0,,13 (13),1,1,0.202,0.5
Lectin pathway of complement activation,Reactome,1,MBL2,8 (8),0.0507,0.616,0,,3 (9),1,1,0.202,0.5
Synthesis of Ketone Bodies,Reactome,1,AACS,8 (8),0.0507,0.616,0,,14 (14),1,1,0.202,0.5
glycogen biosynthesis,HumanCyc,1,GBE1,8 (8),0.0507,0.616,0,,5 (7),1,1,0.202,0.5
Conjugation of salicylate with glycine,Reactome,1,ACSM5,8 (8),0.0507,0.616,0,,7 (8),1,1,0.202,0.5
sucrose degradation,HumanCyc,1,KHK,8 (8),0.0507,0.616,0,,10 (12),1,1,0.202,0.5
cbl mediated ligand-induced downregulation of egf receptors pathway,BioCarta,1,EGFR,8 (8),0.0507,0.616,0,,1 (2),1,1,0.202,0.5
ethanol degradation II,HumanCyc,1,ACSS2,8 (8),0.0507,0.616,0,,12 (12),1,1,0.202,0.5
Galactosemia III,SMPDB,1,GCK,8 (8),0.0507,0.616,0,,19 (20),1,1,0.202,0.5
Galactosemia II (GALK),SMPDB,1,GCK,8 (8),0.0507,0.616,0,,19 (20),1,1,0.202,0.5
Intracellular Signalling Through Prostacyclin Receptor and Prostacyclin,SMPDB,1,MYLK,8 (8),0.0507,0.616,0,,9 (9),1,1,0.202,0.5
Citalopram Metabolism Pathway,SMPDB,1,AOX1,8 (8),0.0507,0.616,0,,17 (18),1,1,0.202,0.5
Glucose-Alanine Cycle,SMPDB,1,SLC2A2,8 (8),0.0507,0.616,0,,10 (11),1,1,0.202,0.5
Betaine Metabolism,SMPDB,1,ALDH7A1,8 (8),0.0507,0.616,0,,20 (22),1,1,0.202,0.5
Nucleotide Sugars Metabolism,SMPDB,1,GCK,8 (8),0.0507,0.616,0,,19 (20),1,1,0.202,0.5
Mitochondrial Beta-Oxidation of Medium Chain Saturated Fatty Acids,SMPDB,1,ACSM1,8 (8),0.0507,0.616,0,,25 (25),1,1,0.202,0.5
Butyrate Metabolism,SMPDB,1,ACSM1,8 (8),0.0507,0.616,0,,19 (19),1,1,0.202,0.5
Effects of nitric oxide,Wikipathways,1,AOX1,8 (8),0.0507,0.616,0,,7 (7),1,1,0.202,0.5
C21-steroid hormone biosynthesis and metabolism,EHMN,2,CYP27A1;AKR1D1,57 (57),0.0526,0.635,0,,46 (61),1,1,0.208,0.513
Regulation of actin cytoskeleton - Homo sapiens (human),KEGG,4,PPP1R12A;EGFR;GSN;MYLK,218 (218),0.053,0.638,0,,2 (5),1,1,0.209,0.515
Sensory processing of sound,Reactome,2,EPB41L1;GSN,58 (58),0.0543,0.651,0,,6 (7),1,1,0.212,0.516
ABC transporters in lipid homeostasis,Reactome,0,,18 (18),1,1,1,HMDB0013461,7 (11),0.055,1,0.215,0.516
COPI-independent Golgi-to-ER retrograde traffic,Reactome,0,,34 (34),1,1,1,HMDB0010404,7 (9),0.055,1,0.215,0.516
phospho-PLA2 pathway,Reactome,0,,2 (2),1,1,1,HMDB0010404,7 (7),0.055,1,0.215,0.516
Biosynthesis of maresins,Reactome,0,,8 (8),1,1,1,HMDB0002183,7 (23),0.055,1,0.215,0.516
EGFR interacts with phospholipase C-gamma,Reactome,1,EGFR,9 (9),0.0568,0.658,0,,2 (2),1,1,0.22,0.516
glycogenolysis,HumanCyc,1,PYGL,9 (9),0.0568,0.658,0,,6 (7),1,1,0.22,0.516
Synthesis of 5-eicosatetraenoic acids,Reactome,1,PON1,9 (9),0.0568,0.658,0,,13 (17),1,1,0.22,0.516
UDP-<i>N</i>-acetyl-D-galactosamine biosynthesis II,HumanCyc,1,GCK,9 (9),0.0568,0.658,0,,13 (16),1,1,0.22,0.516
EGFR-dependent Endothelin signaling events,PID,1,EGFR,9 (9),0.0568,0.658,0,,3 (3),1,1,0.22,0.516
Chylomicron assembly,Reactome,1,APOA2,9 (9),0.0568,0.658,0,,3 (4),1,1,0.22,0.516
Chylomicron remodeling,Reactome,1,APOA2,9 (9),0.0568,0.658,0,,4 (7),1,1,0.22,0.516
glutathione redox reactions I,HumanCyc,1,GPX7,9 (9),0.0568,0.658,0,,62 (100),1,1,0.22,0.516
NR1H2 & NR1H3 regulate gene expression linked to lipogenesis,Reactome,1,FASN,9 (9),0.0568,0.658,0,,3 (4),1,1,0.22,0.516
Clopidogrel Metabolism Pathway,SMPDB,1,PON1,9 (9),0.0568,0.658,0,,9 (9),1,1,0.22,0.516
Transfer of Acetyl Groups into Mitochondria,SMPDB,1,ME1,9 (9),0.0568,0.658,0,,20 (22),1,1,0.22,0.516
Nicotine Metabolism Pathway,SMPDB,1,AOX1,9 (9),0.0568,0.658,0,,20 (22),1,1,0.22,0.516
Clopidogrel Action Pathway,SMPDB,1,PON1,9 (9),0.0568,0.658,0,,9 (9),1,1,0.22,0.516
Folate-Alcohol and Cancer Pathway Hypotheses,Wikipathways,1,ALDH1L1,9 (9),0.0568,0.658,0,,11 (12),1,1,0.22,0.516
Non Ketotic Hyperglycinemia,SMPDB,1,GNMT,27 (27),0.161,1,1,HMDB0000128,54 (55),0.356,1,0.221,0.516
3-Phosphoglycerate dehydrogenase deficiency,SMPDB,1,GNMT,27 (27),0.161,1,1,HMDB0000128,54 (55),0.356,1,0.221,0.516
Glycine and Serine Metabolism,SMPDB,1,GNMT,27 (27),0.161,1,1,HMDB0000128,54 (55),0.356,1,0.221,0.516
Dimethylglycine Dehydrogenase Deficiency,SMPDB,1,GNMT,27 (27),0.161,1,1,HMDB0000128,54 (55),0.356,1,0.221,0.516
Hyperglycinemia_ non-ketotic,SMPDB,1,GNMT,27 (27),0.161,1,1,HMDB0000128,54 (55),0.356,1,0.221,0.516
Dimethylglycine Dehydrogenase Deficiency,SMPDB,1,GNMT,27 (27),0.161,1,1,HMDB0000128,54 (55),0.356,1,0.221,0.516
Sarcosinemia,SMPDB,1,GNMT,27 (27),0.161,1,1,HMDB0000128,54 (55),0.356,1,0.221,0.516
Dihydropyrimidine Dehydrogenase Deficiency (DHPD),SMPDB,1,GNMT,27 (27),0.161,1,1,HMDB0000128,54 (55),0.356,1,0.221,0.516
Linoleate metabolism,EHMN,1,GPX7,72 (72),0.374,1,1,HMDB0010404,21 (24),0.157,1,0.225,0.523
Other types of O-glycan biosynthesis - Homo sapiens (human),KEGG,2,OGT;POFUT1,47 (47),0.0371,0.526,0,,0 (0),1,1,0.0371,0.526
Acrosome Reaction and Sperm:Oocyte Membrane Binding,Reactome,1,CD9,6 (6),0.0382,0.526,0,,0 (0),1,1,0.0382,0.526
Amino Acid metabolism,Wikipathways,2,HNMT;ALDH7A1,91 (91),0.117,0.967,1,HMDB0000128,92 (108),0.531,1,0.235,0.533
mRNA decay by 3_ to 5_ exoribonuclease,Reactome,0,,16 (16),1,1,1,HMDB0001107,8 (10),0.0627,1,0.236,0.533
Deadenylation-dependent mRNA decay,Reactome,0,,56 (56),1,1,1,HMDB0001107,8 (11),0.0627,1,0.236,0.533
creatine biosynthesis,HumanCyc,0,,2 (2),1,1,1,HMDB0000128,8 (8),0.0627,1,0.236,0.533
Hyaluronan uptake and degradation,Reactome,1,HEXA,10 (10),0.0629,0.701,0,,5 (7),1,1,0.237,0.533
TCA cycle in senescence,Wikipathways,1,ME1,10 (10),0.0629,0.701,0,,10 (13),1,1,0.237,0.533
EGFR Transactivation by Gastrin,Reactome,1,EGFR,10 (10),0.0629,0.701,0,,2 (3),1,1,0.237,0.533
mevalonate pathway,HumanCyc,1,MVK,10 (10),0.0629,0.701,0,,17 (17),1,1,0.237,0.533
Neurotransmitter clearance,Reactome,1,COMT,10 (10),0.0629,0.701,0,,31 (33),1,1,0.237,0.533
nicotine degradation III,HumanCyc,1,AOX1,10 (10),0.0629,0.701,0,,13 (24),1,1,0.237,0.533
Ketone body metabolism,Reactome,1,AACS,10 (10),0.0629,0.701,0,,15 (16),1,1,0.237,0.533
Beta Oxidation of Very Long Chain Fatty Acids,SMPDB,1,ACSL1,10 (10),0.0629,0.701,0,,13 (14),1,1,0.237,0.533
Mitochondrial Beta-Oxidation of Long Chain Saturated Fatty Acids,SMPDB,1,ACSL1,10 (10),0.0629,0.701,0,,26 (26),1,1,0.237,0.533
Adrenoleukodystrophy_ X-linked,SMPDB,1,ACSL1,10 (10),0.0629,0.701,0,,13 (14),1,1,0.237,0.533
Carnitine-acylcarnitine translocase deficiency,SMPDB,1,ACSL1,10 (10),0.0629,0.701,0,,13 (14),1,1,0.237,0.533
Vitamin D Metabolism,Wikipathways,1,CYP27A1,10 (10),0.0629,0.701,0,,9 (9),1,1,0.237,0.533
Trans-sulfuration pathway,Wikipathways,1,CSAD,10 (10),0.0629,0.701,0,,14 (14),1,1,0.237,0.533
Lidocaine (Antiarrhythmic) Action Pathway,SMPDB,1,MYLK,63 (63),0.337,1,1,HMDB0009888,26 (26),0.19,1,0.24,0.539
Programmed Cell Death,Reactome,3,OGT;SEPTIN4;GSN,142 (142),0.0646,0.716,0,,11 (21),1,1,0.241,0.54
Peroxisomal protein import,Reactome,2,HACL1;NUDT7,64 (64),0.0646,0.716,0,,1 (1),1,1,0.241,0.54
GPCR downstream signalling,Reactome,1,EGFR,633 (633),0.985,1,3,HMDB0010404;HMDB0034927;HMDB0002183,118 (152),0.0662,1,0.243,0.543
Association Between Physico-Chemical Features and Toxicity Associated Pathways,Wikipathways,2,EGFR;MYLK,65 (65),0.0663,0.729,0,,9 (9),1,1,0.246,0.547
Glycolysis and Gluconeogenesis,EHMN,2,ALDH7A1;ME1,66 (67),0.0681,0.729,0,,48 (52),1,1,0.251,0.547
folate transformations,HumanCyc,1,ALDH1L1,11 (11),0.069,0.729,0,,21 (21),1,1,0.253,0.547
superoxide radicals degradation,HumanCyc,1,GPX7,11 (11),0.069,0.729,0,,10 (11),1,1,0.253,0.547
Glycogen synthesis,Reactome,1,GBE1,11 (11),0.069,0.729,0,,9 (10),1,1,0.253,0.547
Steroidogenesis,SMPDB,1,AKR1D1,11 (11),0.069,0.729,0,,40 (42),1,1,0.253,0.547
Apparent mineralocorticoid excess syndrome,SMPDB,1,AKR1D1,11 (11),0.069,0.729,0,,40 (42),1,1,0.253,0.547
3-Beta-Hydroxysteroid Dehydrogenase Deficiency,SMPDB,1,AKR1D1,11 (11),0.069,0.729,0,,40 (42),1,1,0.253,0.547
21-hydroxylase deficiency (CYP21),SMPDB,1,AKR1D1,11 (11),0.069,0.729,0,,40 (42),1,1,0.253,0.547
Corticosterone methyl oxidase I deficiency (CMO I),SMPDB,1,AKR1D1,11 (11),0.069,0.729,0,,40 (42),1,1,0.253,0.547
Corticosterone methyl oxidase II deficiency - CMO II,SMPDB,1,AKR1D1,11 (11),0.069,0.729,0,,40 (42),1,1,0.253,0.547
Adrenal Hyperplasia Type 5 or Congenital Adrenal Hyperplasia due to 17 Alpha-hydroxylase Deficiency,SMPDB,1,AKR1D1,11 (11),0.069,0.729,0,,40 (42),1,1,0.253,0.547
Adrenal Hyperplasia Type 3 or Congenital Adrenal Hyperplasia due to 21-hydroxylase Deficiency,SMPDB,1,AKR1D1,11 (11),0.069,0.729,0,,40 (42),1,1,0.253,0.547
Congenital Lipoid Adrenal Hyperplasia (CLAH) or Lipoid CAH,SMPDB,1,AKR1D1,11 (11),0.069,0.729,0,,40 (42),1,1,0.253,0.547
17-alpha-hydroxylase deficiency (CYP17),SMPDB,1,AKR1D1,11 (11),0.069,0.729,0,,40 (42),1,1,0.253,0.547
Lactose Degradation,SMPDB,1,SLC2A2,11 (11),0.069,0.729,0,,8 (9),1,1,0.253,0.547
Lactose Intolerance,SMPDB,1,SLC2A2,11 (11),0.069,0.729,0,,8 (9),1,1,0.253,0.547
11-beta-hydroxylase deficiency (CYP11B1),SMPDB,1,AKR1D1,11 (11),0.069,0.729,0,,40 (42),1,1,0.253,0.547
Golgi-to-ER retrograde transport,Reactome,0,,116 (116),1,1,1,HMDB0010404,9 (11),0.0702,1,0.257,0.55
Acetylation,Reactome,0,,2 (2),1,1,1,HMDB0001860,9 (14),0.0702,1,0.257,0.55
Aromatic amines can be N-hydroxylated or N-dealkylated by CYP1A2,Reactome,0,,1 (1),1,1,1,HMDB0001860,9 (10),0.0702,1,0.257,0.55
pyrimidine deoxyribonucleosides degradation,HumanCyc,0,,4 (4),1,1,1,HMDB0000273,9 (10),0.0702,1,0.257,0.55
Retinol metabolism - Homo sapiens (human),KEGG,2,AOX1;UGT2A3,68 (68),0.0718,0.755,0,,18 (25),1,1,0.261,0.552
22q11.2 copy number variation syndrome,Wikipathways,3,COMT;EGFR;SEPTIN5,149 (149),0.0723,0.755,0,,20 (30),1,1,0.262,0.552
Hyaluronan metabolism,Reactome,1,HEXA,12 (12),0.075,0.755,0,,5 (7),1,1,0.269,0.552
superpathway of geranylgeranyldiphosphate biosynthesis I (via mevalonate),HumanCyc,1,MVK,12 (12),0.075,0.755,0,,20 (21),1,1,0.269,0.552
Dimethyl-branched-chain fatty acid mitochondrial beta-oxidation,EHMN,1,ACADSB,12 (12),0.075,0.755,0,,10 (10),1,1,0.269,0.552
Lysine catabolism,Reactome,1,ALDH7A1,12 (12),0.075,0.755,0,,30 (32),1,1,0.269,0.552
Ethanol oxidation,Reactome,1,ACSS2,12 (12),0.075,0.755,0,,15 (15),1,1,0.269,0.552
Eicosanoids,Reactome,1,CYP8B1,12 (12),0.075,0.755,0,,10 (13),1,1,0.269,0.552
isoleucine degradation,HumanCyc,1,ACADSB,12 (12),0.075,0.755,0,,14 (16),1,1,0.269,0.552
Aspartate and asparagine metabolism,Reactome,1,ASPG,12 (12),0.075,0.755,0,,23 (24),1,1,0.269,0.552
Pregnenolone biosynthesis,Reactome,1,FDX1,12 (12),0.075,0.755,0,,11 (13),1,1,0.269,0.552
Nicotinamide salvaging,Reactome,1,CYP8B1,12 (12),0.075,0.755,0,,30 (37),1,1,0.269,0.552
lectin induced complement pathway,BioCarta,1,MBL2,12 (12),0.075,0.755,0,,2 (2),1,1,0.269,0.552
PECAM1 interactions,Reactome,1,INPP5D,12 (12),0.075,0.755,0,,2 (2),1,1,0.269,0.552
map kinase inactivation of smrt corepressor,BioCarta,1,EGFR,12 (12),0.075,0.755,0,,2 (2),1,1,0.269,0.552
17-Beta Hydroxysteroid Dehydrogenase III Deficiency,SMPDB,1,AKR1D1,12 (12),0.075,0.755,0,,32 (32),1,1,0.269,0.552
Mitochondrial iron-sulfur cluster biogenesis,Reactome,1,FDX1,12 (12),0.075,0.755,0,,6 (11),1,1,0.269,0.552
Androgen and Estrogen Metabolism,SMPDB,1,AKR1D1,12 (12),0.075,0.755,0,,32 (32),1,1,0.269,0.552
Aromatase deficiency,SMPDB,1,AKR1D1,12 (12),0.075,0.755,0,,32 (32),1,1,0.269,0.552
Alanine and aspartate metabolism,Wikipathways,1,ABAT,12 (12),0.075,0.755,0,,19 (20),1,1,0.269,0.552
Prolactin signaling pathway - Homo sapiens (human),KEGG,2,SLC2A2;GCK,70 (70),0.0755,0.758,0,,10 (11),1,1,0.27,0.552
Signal Transduction,Reactome,9,EGFR;NIPSNAP2;PEA15;HPN;FASN;PPP1R12A;POFUT1;LBR;MYLK,2431 (2432),0.984,1,4,HMDB0010404;HMDB0034927;HMDB0013461;HMDB0002183,206 (290),0.078,1,0.274,0.552
HDL remodeling,Reactome,0,,9 (9),1,1,1,HMDB0010404,10 (13),0.0777,1,0.276,0.552
p75 NTR receptor-mediated signalling,Reactome,0,,96 (96),1,1,1,HMDB0013461,10 (11),0.0777,1,0.276,0.552
Death Receptor Signalling,Reactome,0,,134 (134),1,1,1,HMDB0013461,10 (12),0.0777,1,0.276,0.552
Intracellular Signalling Through Adenosine Receptor A2b and Adenosine,SMPDB,0,,38 (38),1,1,1,HMDB0009888,10 (10),0.0777,1,0.276,0.552
Intracellular Signalling Through Adenosine Receptor A2a and Adenosine,SMPDB,0,,38 (38),1,1,1,HMDB0009888,10 (10),0.0777,1,0.276,0.552
Oxytocin signaling pathway - Homo sapiens (human),KEGG,3,PPP1R12A;EGFR;MYLK,154 (154),0.0781,0.765,0,,11 (12),1,1,0.277,0.552
Glycolysis,Reactome,2,PKLR;GCK,72 (73),0.0792,0.765,0,,21 (27),1,1,0.28,0.552
Glycine Serine metabolism,INOH,1,GNMT,40 (40),0.229,1,1,HMDB0000128,53 (68),0.351,1,0.283,0.552
Dopamine metabolism,Wikipathways,1,COMT,13 (13),0.081,0.765,0,,29 (33),1,1,0.285,0.552
GRB2 events in EGFR signaling,Reactome,1,EGFR,13 (13),0.081,0.765,0,,2 (2),1,1,0.285,0.552
Signaling by EGFRvIII in Cancer,Reactome,1,EGFR,13 (13),0.081,0.765,0,,5 (11),1,1,0.285,0.552
ERBB2 Activates PTK6 Signaling,Reactome,1,EGFR,13 (13),0.081,0.765,0,,2 (2),1,1,0.285,0.552
valine degradation,HumanCyc,1,ABAT,13 (13),0.081,0.765,0,,19 (20),1,1,0.285,0.552
UTP and CTP <i>de novo</i> biosynthesis,HumanCyc,1,CTPS1,13 (13),0.081,0.765,0,,11 (11),1,1,0.285,0.552
stearate biosynthesis,HumanCyc,1,ACSL1,13 (13),0.081,0.765,0,,15 (17),1,1,0.285,0.552
Galactose metabolism,INOH,1,GCK,13 (13),0.081,0.765,0,,14 (15),1,1,0.285,0.552
Degradation of cysteine and homocysteine,Reactome,1,CSAD,13 (13),0.081,0.765,0,,31 (40),1,1,0.285,0.552
noradrenaline and adrenaline degradation,HumanCyc,1,COMT,13 (13),0.081,0.765,0,,20 (20),1,1,0.285,0.552
Constitutive Signaling by EGFRvIII,Reactome,1,EGFR,13 (13),0.081,0.765,0,,5 (11),1,1,0.285,0.552
Lysine Degradation,SMPDB,1,ALDH7A1,13 (13),0.081,0.765,0,,26 (27),1,1,0.285,0.552
Folate malabsorption_ hereditary,SMPDB,1,ALDH1L1,13 (13),0.081,0.765,0,,28 (28),1,1,0.285,0.552
Hyperlysinemia I_ Familial,SMPDB,1,ALDH7A1,13 (13),0.081,0.765,0,,26 (27),1,1,0.285,0.552
Galactose Metabolism,SMPDB,1,GCK,13 (13),0.081,0.765,0,,31 (36),1,1,0.285,0.552
2-aminoadipic 2-oxoadipic aciduria,SMPDB,1,ALDH7A1,13 (13),0.081,0.765,0,,26 (27),1,1,0.285,0.552
Methylenetetrahydrofolate Reductase Deficiency (MTHFRD),SMPDB,1,ALDH1L1,13 (13),0.081,0.765,0,,28 (28),1,1,0.285,0.552
Methotrexate Action Pathway,SMPDB,1,ALDH1L1,13 (13),0.081,0.765,0,,29 (29),1,1,0.285,0.552
Folate Metabolism,SMPDB,1,ALDH1L1,13 (13),0.081,0.765,0,,28 (28),1,1,0.285,0.552
Pyridoxine dependency with seizures,SMPDB,1,ALDH7A1,13 (13),0.081,0.765,0,,26 (27),1,1,0.285,0.552
Saccharopinuria/Hyperlysinemia II,SMPDB,1,ALDH7A1,13 (13),0.081,0.765,0,,26 (27),1,1,0.285,0.552
Gemcitabine Action Pathway,SMPDB,1,CTPS1,13 (13),0.081,0.765,0,,8 (8),1,1,0.285,0.552
Glutaric Aciduria Type I,SMPDB,1,ALDH7A1,13 (13),0.081,0.765,0,,26 (27),1,1,0.285,0.552
Galactosemia,SMPDB,1,GCK,13 (13),0.081,0.765,0,,31 (36),1,1,0.285,0.552
Gemcitabine Metabolism Pathway,SMPDB,1,CTPS1,13 (13),0.081,0.765,0,,8 (8),1,1,0.285,0.552
Hyperlysinemia II or Saccharopinuria,SMPDB,1,ALDH7A1,13 (13),0.081,0.765,0,,26 (27),1,1,0.285,0.552
Caffeine and Theobromine metabolism,Wikipathways,0,,4 (4),1,1,1,HMDB0001860,11 (11),0.0852,1,0.295,0.566
Ca-dependent events,Reactome,0,,39 (39),1,1,1,HMDB0010404,11 (11),0.0852,1,0.295,0.566
Calcium Regulation in the Cardiac Cell,Wikipathways,0,,151 (151),1,1,1,HMDB0009888,11 (11),0.0852,1,0.295,0.566
Intra-Golgi and retrograde Golgi-to-ER traffic,Reactome,0,,186 (186),1,1,1,HMDB0010404,11 (13),0.0852,1,0.295,0.566
SHC1 events in EGFR signaling,Reactome,1,EGFR,14 (14),0.087,0.802,0,,4 (4),1,1,0.299,0.566
Methylation,Reactome,1,COMT,14 (14),0.087,0.802,0,,30 (38),1,1,0.299,0.566
Vitamin B5 (pantothenate) metabolism,Reactome,1,FASN,14 (14),0.087,0.802,0,,17 (17),1,1,0.299,0.566
Nicotinate and Nicotinamide Metabolism,SMPDB,1,AOX1,14 (14),0.087,0.802,0,,34 (35),1,1,0.299,0.566
Malonyl-coa decarboxylase deficiency,SMPDB,1,ABAT,14 (14),0.087,0.802,0,,35 (38),1,1,0.299,0.566
Malonic Aciduria,SMPDB,1,ABAT,14 (14),0.087,0.802,0,,35 (38),1,1,0.299,0.566
Hypoacetylaspartia,SMPDB,1,ABAT,14 (14),0.087,0.802,0,,34 (34),1,1,0.299,0.566
Propanoate Metabolism,SMPDB,1,ABAT,14 (14),0.087,0.802,0,,35 (38),1,1,0.299,0.566
Aspartate Metabolism,SMPDB,1,ABAT,14 (14),0.087,0.802,0,,34 (34),1,1,0.299,0.566
Methylmalonic Aciduria Due to Cobalamin-Related Disorders,SMPDB,1,ABAT,14 (14),0.087,0.802,0,,35 (38),1,1,0.299,0.566
Canavan Disease,SMPDB,1,ABAT,14 (14),0.087,0.802,0,,34 (34),1,1,0.299,0.566
Protein localization,Reactome,3,LDHD;HACL1;NUDT7,165 (165),0.0916,0.827,0,,4 (4),1,1,0.311,0.577
glutaryl-CoA degradation,HumanCyc,0,,4 (4),1,1,1,HMDB0001290,12 (12),0.0926,1,0.313,0.577
ERK Pathway in Huntington_s Disease,Wikipathways,1,EGFR,15 (15),0.0929,0.827,0,,1 (1),1,1,0.314,0.577
Airway smooth muscle cell contraction,Wikipathways,1,MYLK,15 (15),0.0929,0.827,0,,4 (7),1,1,0.314,0.577
Biogenic Amine Synthesis,Wikipathways,1,COMT,15 (15),0.0929,0.827,0,,17 (18),1,1,0.314,0.577
superpathway of pyrimidine ribonucleotides <i>de novo</i> biosynthesis,HumanCyc,1,CTPS1,15 (15),0.0929,0.827,0,,22 (23),1,1,0.314,0.577
ERBB2 Regulates Cell Motility,Reactome,1,EGFR,15 (15),0.0929,0.827,0,,1 (1),1,1,0.314,0.577
Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants,Reactome,1,EGFR,15 (15),0.0929,0.827,0,,6 (19),1,1,0.314,0.577
Glycosphingolipid biosynthesis - ganglio series - Homo sapiens (human),KEGG,1,HEXA,15 (15),0.0929,0.827,0,,7 (31),1,1,0.314,0.577
Glycosphingolipid biosynthesis - globo and isoglobo series - Homo sapiens (human),KEGG,1,HEXA,15 (15),0.0929,0.827,0,,3 (23),1,1,0.314,0.577
D-<i>myo</i>-inositol (1_3_4)-trisphosphate biosynthesis,HumanCyc,1,INPP5D,15 (15),0.0929,0.827,0,,8 (8),1,1,0.314,0.577
Signaling by Ligand-Responsive EGFR Variants in Cancer,Reactome,1,EGFR,15 (15),0.0929,0.827,0,,6 (19),1,1,0.314,0.577
Histidine Metabolism,SMPDB,1,HNMT,15 (15),0.0929,0.827,0,,40 (40),1,1,0.314,0.577
Histidinemia,SMPDB,1,HNMT,15 (15),0.0929,0.827,0,,40 (40),1,1,0.314,0.577
Mercaptopurine Metabolism Pathway,SMPDB,1,AOX1,15 (15),0.0929,0.827,0,,21 (24),1,1,0.314,0.577
1D-<i>myo</i>-inositol hexakisphosphate biosynthesis II (mammalian),HumanCyc,1,INPP5D,15 (15),0.0929,0.827,0,,11 (11),1,1,0.314,0.577
Cholesterol Biosynthesis Pathway,Wikipathways,1,MVK,15 (15),0.0929,0.827,0,,14 (14),1,1,0.314,0.577
Hepatocellular carcinoma - Homo sapiens (human),KEGG,3,EGFR;GSTM3;GSTM4,168 (168),0.0954,0.848,0,,9 (14),1,1,0.32,0.587
GRB2 events in ERBB2 signaling,Reactome,1,EGFR,16 (16),0.0988,0.86,0,,2 (2),1,1,0.327,0.593
PI3K events in ERBB2 signaling,Reactome,1,EGFR,16 (16),0.0988,0.86,0,,3 (4),1,1,0.327,0.593
Signaling by ERBB2 ECD mutants,Reactome,1,EGFR,16 (16),0.0988,0.86,0,,6 (8),1,1,0.327,0.593
Synthesis of Prostaglandins (PG) and Thromboxanes (TX),Reactome,1,CYP8B1,16 (16),0.0988,0.86,0,,39 (50),1,1,0.327,0.593
Omega-3 fatty acid metabolism,EHMN,1,ACSL1,16 (16),0.0988,0.86,0,,15 (16),1,1,0.327,0.593
Steroids metabolism,INOH,1,MVK,16 (16),0.0988,0.86,0,,27 (31),1,1,0.327,0.593
RAF-independent MAPK1/3 activation,Reactome,1,PEA15,16 (16),0.0988,0.86,0,,4 (4),1,1,0.327,0.593
Apoptotic factor-mediated response,Reactome,1,SEPTIN4,16 (16),0.0988,0.86,0,,2 (2),1,1,0.327,0.593
Cori Cycle,Wikipathways,1,SLC2A2,16 (16),0.0988,0.86,0,,18 (25),1,1,0.327,0.593
Biosynthesis of electrophilic ?-3 PUFA oxo-derivatives,Reactome,0,,2 (2),1,1,1,HMDB0002183,13 (28),0.0999,1,0.33,0.596
Heroin Action Pathway,SMPDB,0,,32 (32),1,1,1,HMDB0041812,13 (14),0.0999,1,0.33,0.596
Signaling by GPCR,Reactome,1,EGFR,706 (706),0.991,1,3,HMDB0010404;HMDB0034927;HMDB0002183,142 (190),0.102,1,0.334,0.602
Mitochondrial LC-Fatty Acid Beta-Oxidation,Wikipathways,1,ACSL1,17 (17),0.105,0.894,0,,2 (6),1,1,0.341,0.607
Glycosaminoglycan degradation,Wikipathways,1,HEXA,17 (17),0.105,0.894,0,,3 (5),1,1,0.341,0.607
Glycogen breakdown (glycogenolysis),Reactome,1,PYGL,17 (17),0.105,0.894,0,,9 (11),1,1,0.341,0.607
Selenocompound metabolism - Homo sapiens (human),KEGG,1,INMT,17 (17),0.105,0.894,0,,16 (27),1,1,0.341,0.607
Metabolism of folate and pterines,Reactome,1,ALDH1L1,17 (17),0.105,0.894,0,,20 (25),1,1,0.341,0.607
Heme degradation,Reactome,1,SLCO2B1,17 (17),0.105,0.894,0,,18 (19),1,1,0.341,0.607
Plasma lipoprotein assembly,Reactome,1,APOA2,17 (17),0.105,0.894,0,,10 (11),1,1,0.341,0.607
GAB1 signalosome,Reactome,1,EGFR,17 (17),0.105,0.894,0,,5 (6),1,1,0.341,0.607
Insulin secretion - Homo sapiens (human),KEGG,2,SLC2A2;GCK,86 (86),0.107,0.912,0,,10 (12),1,1,0.346,0.615
Digestion of dietary lipid,Reactome,0,,7 (7),1,1,1,HMDB0000036,14 (17),0.107,1,0.347,0.615
Inhibition of Signaling by Overexpressed EGFR,Reactome,1,EGFR,8 (8),0.0507,0.616,0,,0 (4),1,1,0.0507,0.616
Signaling by Overexpressed Wild-Type EGFR in Cancer,Reactome,1,EGFR,8 (8),0.0507,0.616,0,,0 (4),1,1,0.0507,0.616
SMAC_ XIAP-regulated apoptotic response,Reactome,1,SEPTIN4,8 (8),0.0507,0.616,0,,0 (0),1,1,0.0507,0.616
Phase I biotransformations_ non P450,Wikipathways,1,PON1,8 (8),0.0507,0.616,0,,0 (4),1,1,0.0507,0.616
Arginine and proline metabolism - Homo sapiens (human),KEGG,1,ALDH7A1,50 (51),0.278,1,1,HMDB0000128,60 (78),0.388,1,0.348,0.616
EGF-Ncore,Signalink,2,PEA15;INPP5D,56 (56),0.051,0.618,0,,0 (0),1,1,0.051,0.618
Fatty acid transporters,Wikipathways,1,ACSL1,18 (18),0.11,0.921,0,,1 (2),1,1,0.354,0.618
Estrogen metabolism,Wikipathways,1,COMT,18 (18),0.11,0.921,0,,19 (23),1,1,0.354,0.618
Formation of ATP by chemiosmotic coupling,Reactome,1,ATP5MC2,18 (18),0.11,0.921,0,,5 (5),1,1,0.354,0.618
Glycosphingolipid biosynthesis - globoseries,EHMN,1,HEXA,18 (18),0.11,0.921,0,,14 (22),1,1,0.354,0.618
MFAP5 effect on permeability and motility of endothelial cells via cytoskeleton rearrangement,Wikipathways,1,MYLK,18 (18),0.11,0.921,0,,1 (1),1,1,0.354,0.618
RHO GTPases Activate ROCKs,Reactome,1,PPP1R12A,18 (18),0.11,0.921,0,,5 (5),1,1,0.354,0.618
Fructose intolerance_ hereditary,SMPDB,1,KHK,18 (18),0.11,0.921,0,,28 (31),1,1,0.354,0.618
Fructose and Mannose Degradation,SMPDB,1,KHK,18 (18),0.11,0.921,0,,28 (31),1,1,0.354,0.618
Fructosuria,SMPDB,1,KHK,18 (18),0.11,0.921,0,,28 (31),1,1,0.354,0.618
Ebola Virus Pathway on Host,Wikipathways,3,MBL2;EGFR;GSN,130 (130),0.0522,0.631,0,,0 (0),1,1,0.0522,0.631
Creatine metabolism,Reactome,0,,11 (11),1,1,1,HMDB0000128,15 (15),0.114,1,0.362,0.633
Gastrin-CREB signalling pathway via PKC and MAPK,Reactome,1,EGFR,19 (19),0.116,0.958,0,,4 (5),1,1,0.366,0.634
GABA synthesis_ release_ reuptake and degradation,Reactome,1,ABAT,19 (19),0.116,0.958,0,,15 (17),1,1,0.366,0.634
fatty acid &beta;-oxidation (peroxisome),HumanCyc,1,ACSL1,19 (19),0.116,0.958,0,,61 (85),1,1,0.366,0.634
fatty acid &beta;-oxidation,HumanCyc,1,ACSL1,19 (19),0.116,0.958,0,,60 (84),1,1,0.366,0.634
Initiation of Nuclear Envelope (NE) Reformation,Reactome,1,LBR,19 (19),0.116,0.958,0,,6 (9),1,1,0.366,0.634
Glycosaminoglycan degradation - Homo sapiens (human),KEGG,1,HEXA,19 (19),0.116,0.958,0,,5 (27),1,1,0.366,0.634
Glucose metabolism,Reactome,2,PKLR;GCK,92 (93),0.12,0.982,0,,32 (39),1,1,0.374,0.645
PLC beta mediated events,Reactome,0,,50 (50),1,1,1,HMDB0010404,16 (17),0.122,1,0.378,0.645
G-protein mediated events,Reactome,0,,55 (55),1,1,1,HMDB0010404,16 (17),0.122,1,0.378,0.645
3-phosphoinositide degradation,HumanCyc,1,INPP5D,20 (20),0.122,0.988,0,,2 (5),1,1,0.379,0.645
One carbon pool by folate - Homo sapiens (human),KEGG,1,ALDH1L1,20 (20),0.122,0.988,0,,9 (9),1,1,0.379,0.645
Cellular hexose transport,Reactome,1,SLC2A2,20 (20),0.122,0.988,0,,4 (7),1,1,0.379,0.645
egf signaling pathway,BioCarta,1,EGFR,20 (20),0.122,0.988,0,,1 (1),1,1,0.379,0.645
sprouty regulation of tyrosine kinase signals,BioCarta,1,EGFR,20 (20),0.122,0.988,0,,3 (4),1,1,0.379,0.645
superpathway of D-<i>myo</i>-inositol (1_4_5)-trisphosphate metabolism,HumanCyc,1,INPP5D,20 (20),0.122,0.988,0,,11 (11),1,1,0.379,0.645
Mitochondrial Electron Transport Chain,SMPDB,1,ATP5MC2,20 (20),0.122,0.988,0,,17 (18),1,1,0.379,0.645
G alpha (i) signalling events,Reactome,0,,316 (316),1,1,2,HMDB0010404;HMDB0034927,77 (106),0.126,1,0.387,0.656
Fructose and mannose metabolism,EHMN,1,SLC2A2,21 (21),0.128,1,0,,28 (34),1,1,0.39,0.656
Glycosphingolipid biosynthesis - ganglioseries,EHMN,1,HEXA,21 (21),0.128,1,0,,18 (38),1,1,0.39,0.656
Branched-chain amino acid catabolism,Reactome,1,ACADSB,21 (21),0.128,1,0,,34 (39),1,1,0.39,0.656
E-cadherin signaling in keratinocytes,PID,1,EGFR,21 (21),0.128,1,0,,4 (4),1,1,0.39,0.656
Signaling by EGFR in Cancer,Reactome,1,EGFR,21 (21),0.128,1,0,,6 (19),1,1,0.39,0.656
pkc-catalyzed phosphorylation of inhibitory phosphoprotein of myosin phosphatase,BioCarta,1,MYLK,21 (21),0.128,1,0,,1 (3),1,1,0.39,0.656
Fc gamma R-mediated phagocytosis - Homo sapiens (human),KEGG,2,INPP5D;GSN,96 (97),0.128,1,0,,7 (8),1,1,0.392,0.656
16p11.2 proximal deletion syndrome,Wikipathways,0,,79 (79),1,1,1,HMDB0010404,17 (40),0.129,1,0.393,0.656
ABC transporters - Homo sapiens (human),KEGG,1,ABCB10,45 (45),0.254,1,1,HMDB0039721,88 (138),0.515,1,0.397,0.656
Arachidonic acid metabolism,EHMN,2,GPX7;SLC27A5,98 (98),0.133,1,0,,47 (53),1,1,0.4,0.656
Lysine degradation,INOH,1,ALDH7A1,22 (22),0.133,1,0,,33 (36),1,1,0.402,0.656
PKC-gamma calcium signaling pathway in ataxia,Wikipathways,1,CA8,22 (22),0.133,1,0,,4 (4),1,1,0.402,0.656
SHC1 events in ERBB2 signaling,Reactome,1,EGFR,22 (22),0.133,1,0,,7 (8),1,1,0.402,0.656
Signaling by ERBB2 TMD/JMD mutants,Reactome,1,EGFR,22 (22),0.133,1,0,,5 (6),1,1,0.402,0.656
Tryptophan metabolism,EHMN,1,ALDH7A1,22 (22),0.133,1,0,,72 (78),1,1,0.402,0.656
superpathway of pyrimidine deoxyribonucleotides <i>de novo</i> biosynthesis,HumanCyc,1,CTPS1,22 (22),0.133,1,0,,33 (34),1,1,0.402,0.656
Signal transduction by L1,Reactome,1,EGFR,22 (22),0.133,1,0,,4 (4),1,1,0.402,0.656
Terpenoid backbone biosynthesis - Homo sapiens (human),KEGG,1,MVK,22 (22),0.133,1,0,,20 (45),1,1,0.402,0.656
Regulation of necroptotic cell death,Reactome,1,OGT,22 (22),0.133,1,0,,6 (10),1,1,0.402,0.656
RIPK1-mediated regulated necrosis,Reactome,1,OGT,22 (22),0.133,1,0,,8 (14),1,1,0.402,0.656
Gluconeogenesis,SMPDB,1,SLC2A2,22 (22),0.133,1,0,,29 (34),1,1,0.402,0.656
Glycogenosis_ Type IA. Von gierke disease,SMPDB,1,SLC2A2,22 (22),0.133,1,0,,29 (34),1,1,0.402,0.656
Glycogenosis_ Type IC,SMPDB,1,SLC2A2,22 (22),0.133,1,0,,29 (34),1,1,0.402,0.656
Glycogen Storage Disease Type 1A (GSD1A) or Von Gierke Disease,SMPDB,1,SLC2A2,22 (22),0.133,1,0,,29 (34),1,1,0.402,0.656
Triosephosphate isomerase,SMPDB,1,SLC2A2,22 (22),0.133,1,0,,29 (34),1,1,0.402,0.656
Fructose-1_6-diphosphatase deficiency,SMPDB,1,SLC2A2,22 (22),0.133,1,0,,29 (34),1,1,0.402,0.656
Phosphoenolpyruvate carboxykinase deficiency 1 (PEPCK1),SMPDB,1,SLC2A2,22 (22),0.133,1,0,,29 (34),1,1,0.402,0.656
Glycogenosis_ Type IB,SMPDB,1,SLC2A2,22 (22),0.133,1,0,,29 (34),1,1,0.402,0.656
Type II diabetes mellitus,Wikipathways,1,SLC2A2,22 (22),0.133,1,0,,4 (4),1,1,0.402,0.656
Membrane Trafficking,Reactome,2,EGFR;RAB32,578 (578),0.894,1,1,HMDB0010404,20 (31),0.15,1,0.403,0.657
Caffeine metabolism - Homo sapiens (human),KEGG,0,,6 (6),1,1,1,HMDB0001860,18 (22),0.136,1,0.407,0.661
Alpha Linolenic Acid and Linoleic Acid Metabolism,SMPDB,0,,6 (6),1,1,1,HMDB0002183,18 (18),0.136,1,0.407,0.661
Di-unsaturated fatty acid beta-oxidation,EHMN,1,ACSL1,23 (23),0.139,1,0,,19 (19),1,1,0.413,0.668
Uptake and actions of bacterial toxins,Reactome,1,CD9,23 (23),0.139,1,0,,9 (11),1,1,0.413,0.668
Response of Mtb to phagocytosis,Reactome,1,RNF213,23 (23),0.139,1,0,,7 (11),1,1,0.413,0.668
UCH proteinases,Reactome,2,OGT;PSMB10,102 (102),0.141,1,0,,1 (3),1,1,0.418,0.673
Leukotriene metabolism,EHMN,2,ACSL1;ALDH7A1,102 (102),0.141,1,0,,25 (27),1,1,0.418,0.673
L1CAM interactions,Reactome,2,SHTN1;EGFR,102 (102),0.141,1,0,,7 (10),1,1,0.418,0.673
Focal adhesion - Homo sapiens (human),KEGG,3,PPP1R12A;EGFR;MYLK,201 (201),0.142,1,0,,1 (2),1,1,0.418,0.673
Synthesis of very long-chain fatty acyl-CoAs,Reactome,1,ACSL1,24 (24),0.144,1,0,,20 (27),1,1,0.424,0.68
Nicotinate metabolism,Reactome,1,CYP8B1,24 (24),0.144,1,0,,40 (50),1,1,0.424,0.68
SLC-mediated transmembrane transport,Reactome,2,SLC2A2;SLCO2B1,243 (243),0.469,1,2,HMDB0000036;HMDB0000273,139 (164),0.309,1,0.425,0.68
Urea cycle and metabolism of arginine_ proline_ glutamate_ aspartate and asparagine,EHMN,2,ABAT;ALDH7A1,105 (105),0.148,1,0,,93 (125),1,1,0.431,0.689
Opioid Signalling,Reactome,0,,91 (91),1,1,1,HMDB0010404,20 (23),0.15,1,0.434,0.689
Relationship between inflammation_ COX-2 and EGFR,Wikipathways,1,EGFR,25 (25),0.15,1,0,,1 (2),1,1,0.435,0.689
Saturated fatty acids beta-oxidation,EHMN,1,ACADSB,25 (25),0.15,1,0,,43 (43),1,1,0.435,0.689
NOTCH3 Activation and Transmission of Signal to the Nucleus,Reactome,1,EGFR,25 (25),0.15,1,0,,3 (3),1,1,0.435,0.689
Signaling by ERBB2 KD Mutants,Reactome,1,EGFR,25 (25),0.15,1,0,,6 (10),1,1,0.435,0.689
Glucuronidation,Reactome,1,UGT2A3,25 (25),0.15,1,0,,28 (31),1,1,0.435,0.689
Signaling by ERBB2 in Cancer,Reactome,1,EGFR,25 (25),0.15,1,0,,6 (10),1,1,0.435,0.689
Liver X receptor pathway,Wikipathways,1,FASN,10 (10),0.0629,0.701,0,,0 (1),1,1,0.0629,0.701
Glucuronidation,Wikipathways,1,UGT2A3,26 (26),0.156,1,0,,14 (14),1,1,0.445,0.703
Fertilization,Reactome,1,CD9,26 (26),0.156,1,0,,5 (5),1,1,0.445,0.703
retinol biosynthesis,HumanCyc,0,,19 (19),1,1,1,HMDB0002183,21 (37),0.157,1,0.447,0.704
Transport of nucleosides and free purine and pyrimidine bases across the plasma membrane,Reactome,0,,12 (12),1,1,1,HMDB0000273,21 (21),0.157,1,0.447,0.704
Transcriptional activation of mitochondrial biogenesis,Reactome,1,ACSS2,27 (27),0.161,1,0,,6 (7),1,1,0.455,0.713
Vitamin D3 (cholecalciferol) metabolism,EHMN,1,CYP27A1,27 (27),0.161,1,0,,12 (12),1,1,0.455,0.713
Sulfur amino acid metabolism,Reactome,1,CSAD,27 (27),0.161,1,0,,49 (67),1,1,0.455,0.713
Infection with Mycobacterium tuberculosis,Reactome,1,RNF213,27 (27),0.161,1,0,,30 (55),1,1,0.455,0.713
Selenium Micronutrient Network,Wikipathways,0,,86 (86),1,1,2,HMDB0001904;HMDB0002183,91 (107),0.165,1,0.462,0.722
One-carbon metabolism,Wikipathways,1,ALDH1L1,28 (28),0.166,1,0,,22 (25),1,1,0.465,0.722
Omega-6 fatty acid metabolism,EHMN,1,ACSL1,28 (28),0.166,1,0,,20 (23),1,1,0.465,0.722
FOXO-mediated transcription of oxidative stress_ metabolic and neuronal genes,Reactome,1,GCK,28 (28),0.166,1,0,,4 (4),1,1,0.465,0.722
Recycling pathway of L1,Reactome,1,SHTN1,28 (28),0.166,1,0,,5 (7),1,1,0.465,0.722
EGF,INOH,1,EGFR,28 (28),0.166,1,0,,2 (2),1,1,0.465,0.722
role of erbb2 in signal transduction and oncology,BioCarta,1,EGFR,28 (28),0.166,1,0,,2 (2),1,1,0.465,0.722
Free fatty acid receptors,Reactome,0,,5 (5),1,1,1,HMDB0002183,23 (24),0.17,1,0.472,0.728
Kynurenine Pathway and links to Cellular Senescence,Wikipathways,0,,3 (3),1,1,1,HMDB0001290,23 (25),0.17,1,0.472,0.728
Pyrimidine salvage,Reactome,0,,11 (11),1,1,1,HMDB0000273,23 (23),0.17,1,0.472,0.728
Caffeine Metabolism,SMPDB,0,,7 (7),1,1,1,HMDB0001860,23 (24),0.17,1,0.472,0.728
Synthesis of IP3 and IP4 in the cytosol,Reactome,1,INPP5D,29 (29),0.172,1,0,,11 (14),1,1,0.475,0.728
Downregulation of ERBB2 signaling,Reactome,1,EGFR,29 (29),0.172,1,0,,4 (4),1,1,0.475,0.728
Metabolism of porphyrins,Reactome,1,SLCO2B1,29 (29),0.172,1,0,,34 (43),1,1,0.475,0.728
Regulated Necrosis,Reactome,1,OGT,29 (29),0.172,1,0,,8 (16),1,1,0.475,0.728
Pyruvate metabolism,Reactome,1,ME1,29 (29),0.172,1,0,,24 (25),1,1,0.475,0.728
HIF-1-alpha transcription factor network,PID,2,GCK;ENG,66 (66),0.0681,0.729,0,,0 (0),1,1,0.0681,0.729
Dissolution of Fibrin Clot,Reactome,1,SERPINB6,11 (11),0.069,0.729,0,,0 (1),1,1,0.069,0.729
alpha-Linolenic acid metabolism - Homo sapiens (human),KEGG,0,,25 (25),1,1,1,HMDB0060376,24 (44),0.177,1,0.483,0.736
EGFR downregulation,Reactome,1,EGFR,30 (30),0.177,1,0,,5 (6),1,1,0.484,0.736
Pentose phosphate pathway - Homo sapiens (human),KEGG,1,RGN,30 (30),0.177,1,0,,25 (35),1,1,0.484,0.736
Trafficking of AMPA receptors,Reactome,1,EPB41L1,30 (30),0.177,1,0,,5 (6),1,1,0.484,0.736
Glutamate binding_ activation of AMPA receptors and synaptic plasticity,Reactome,1,EPB41L1,30 (30),0.177,1,0,,7 (8),1,1,0.484,0.736
Glyoxylate and dicarboxylate metabolism - Homo sapiens (human),KEGG,1,ACSS2,30 (30),0.177,1,0,,46 (62),1,1,0.484,0.736
Glycine_ serine_ alanine and threonine metabolism,EHMN,1,LDHD,78 (78),0.398,1,1,HMDB0000128,73 (88),0.45,1,0.488,0.741
Ethanol effects on histone modifications,Wikipathways,1,ACSS2,31 (31),0.183,1,0,,16 (21),1,1,0.493,0.746
Statin inhibition of cholesterol production,Wikipathways,1,APOA2,31 (31),0.183,1,0,,8 (17),1,1,0.493,0.746
Galactose metabolism - Homo sapiens (human),KEGG,1,GCK,31 (31),0.183,1,0,,30 (46),1,1,0.493,0.746
Metabolism of steroid hormones,Reactome,1,FDX1,31 (31),0.183,1,0,,33 (35),1,1,0.493,0.746
Glycerophospholipid metabolism - Homo sapiens (human),KEGG,0,,98 (98),1,1,1,HMDB0010404,25 (55),0.184,1,0.495,0.747
Valine Leucine Isoleucine degradation,INOH,1,ALDH7A1,32 (32),0.188,1,0,,36 (40),1,1,0.502,0.753
Interconversion of nucleotide di- and triphosphates,Reactome,1,CTPS1,32 (32),0.188,1,0,,44 (52),1,1,0.502,0.753
Osteopontin-mediated events,PID,1,GSN,32 (32),0.188,1,0,,4 (4),1,1,0.502,0.753
Citrate cycle,INOH,1,PKLR,32 (32),0.188,1,0,,35 (35),1,1,0.502,0.753
Glyoxylate metabolism and glycine degradation,Reactome,1,GNMT,32 (32),0.188,1,0,,32 (42),1,1,0.502,0.753
Caspase-mediated cleavage of cytoskeletal proteins,Reactome,1,GSN,12 (12),0.075,0.755,0,,0 (0),1,1,0.075,0.755
Platelet activation - Homo sapiens (human),KEGG,2,PPP1R12A;MYLK,124 (124),0.192,1,0,,14 (14),1,1,0.508,0.757
Mammary gland development pathway - Pregnancy and lactation (Stage 3 of 4),Wikipathways,1,EGFR,33 (33),0.193,1,0,,2 (3),1,1,0.511,0.757
Keratan sulfate/keratin metabolism,Reactome,1,HEXA,33 (33),0.193,1,0,,12 (19),1,1,0.511,0.757
Tyrosine metabolism,INOH,1,COMT,33 (33),0.193,1,0,,43 (44),1,1,0.511,0.757
EPO signaling pathway,PID,1,INPP5D,33 (33),0.193,1,0,,3 (3),1,1,0.511,0.757
Fructose and mannose metabolism - Homo sapiens (human),KEGG,1,KHK,33 (33),0.193,1,0,,31 (54),1,1,0.511,0.757
bioactive peptide induced signaling pathway,BioCarta,1,MYLK,33 (33),0.193,1,0,,3 (3),1,1,0.511,0.757
role of egf receptor transactivation by gpcrs in cardiac hypertrophy,BioCarta,1,EGFR,33 (33),0.193,1,0,,3 (3),1,1,0.511,0.757
Sialic acid metabolism,Reactome,1,NPL,33 (33),0.193,1,0,,18 (27),1,1,0.511,0.757
Regulation of MECP2 expression and activity,Reactome,1,LBR,34 (34),0.198,1,0,,3 (3),1,1,0.519,0.769
Apoptosis,Reactome,2,SEPTIN4;GSN,127 (127),0.199,1,0,,5 (8),1,1,0.52,0.769
Purine metabolism - Homo sapiens (human),KEGG,2,PKLR;URAD,129 (130),0.203,1,0,,78 (95),1,1,0.527,0.772
Vesicle-mediated transport,Reactome,2,EGFR;RAB32,617 (617),0.914,1,1,HMDB0010404,31 (66),0.223,1,0.527,0.772
Nuclear Receptors in Lipid Metabolism and Toxicity,Wikipathways,1,CYP8B1,35 (35),0.204,1,0,,6 (12),1,1,0.528,0.772
Vitamin D-sensitive calcium signaling in depression,Wikipathways,1,CYP27A1,35 (35),0.204,1,0,,13 (15),1,1,0.528,0.772
Nicotinate and nicotinamide metabolism - Homo sapiens (human),KEGG,1,AOX1,35 (35),0.204,1,0,,32 (55),1,1,0.528,0.772
Detoxification of Reactive Oxygen Species,Reactome,1,GPX7,35 (35),0.204,1,0,,20 (24),1,1,0.528,0.772
Arf6 signaling events,PID,1,EGFR,35 (35),0.204,1,0,,4 (4),1,1,0.528,0.772
angiotensin ii mediated activation of jnk pathway via pyk2 dependent signaling,BioCarta,1,EGFR,35 (35),0.204,1,0,,3 (3),1,1,0.528,0.772
N-cadherin signaling events,PID,1,GSN,36 (36),0.209,1,0,,5 (5),1,1,0.536,0.779
Trk receptor signaling mediated by PI3K and PLC-gamma,PID,1,EPB41L1,36 (36),0.209,1,0,,3 (3),1,1,0.536,0.779
African trypanosomiasis - Homo sapiens (human),KEGG,1,IDO2,36 (37),0.209,1,0,,8 (8),1,1,0.536,0.779
Citalopram Action Pathway,SMPDB,1,AOX1,36 (36),0.209,1,0,,26 (27),1,1,0.536,0.779
Nicotine Action Pathway,SMPDB,1,AOX1,36 (36),0.209,1,0,,29 (31),1,1,0.536,0.779
Vascular smooth muscle contraction - Homo sapiens (human),KEGG,2,PPP1R12A;MYLK,133 (133),0.213,1,0,,15 (16),1,1,0.542,0.786
GMCSF-mediated signaling events,PID,1,INPP5D,37 (37),0.214,1,0,,2 (2),1,1,0.544,0.786
trefoil factors initiate mucosal healing,BioCarta,1,EGFR,37 (37),0.214,1,0,,2 (2),1,1,0.544,0.786
RHOH GTPase cycle,Reactome,1,NIPSNAP2,37 (37),0.214,1,0,,1 (1),1,1,0.544,0.786
Glutaminolysis and Cancer,SMPDB,1,ME1,37 (37),0.214,1,0,,42 (44),1,1,0.544,0.786
B cell receptor signaling,INOH,2,PSMB10;IGHM,134 (134),0.215,1,0,,6 (7),1,1,0.546,0.788
Transmission across Chemical Synapses,Reactome,3,COMT;ABAT;EPB41L1,249 (249),0.219,1,0,,69 (78),1,1,0.551,0.794
Signaling events mediated by TCPTP,PID,1,EGFR,38 (38),0.219,1,0,,1 (1),1,1,0.552,0.794
sphingomyelin metabolism/ceramide salvage,HumanCyc,0,,8 (8),1,1,1,HMDB0002183,31 (55),0.223,1,0.557,0.797
superpathway of pyrimidine deoxyribonucleoside salvage,HumanCyc,0,,17 (17),1,1,1,HMDB0000273,31 (31),0.223,1,0.557,0.797
triacylglycerol degradation,HumanCyc,0,,15 (15),1,1,1,HMDB0002183,31 (54),0.223,1,0.557,0.797
pyrimidine deoxyribonucleosides salvage,HumanCyc,0,,5 (5),1,1,1,HMDB0000273,31 (31),0.223,1,0.557,0.797
phospholipases,HumanCyc,0,,41 (41),1,1,1,HMDB0002183,31 (55),0.223,1,0.557,0.797
Internalization of ErbB1,PID,1,EGFR,39 (39),0.224,1,0,,2 (2),1,1,0.559,0.798
Smooth Muscle Contraction,Reactome,1,MYLK,39 (39),0.224,1,0,,9 (9),1,1,0.559,0.798
Omega-3-Omega-6 FA synthesis,Wikipathways,1,ACSL1,14 (14),0.087,0.802,0,,0 (1),1,1,0.087,0.802
Fluid shear stress and atherosclerosis - Homo sapiens (human),KEGG,2,GSTM3;GSTM4,139 (139),0.227,1,0,,8 (8),1,1,0.564,0.804
Digestion,Reactome,0,,22 (22),1,1,1,HMDB0000036,32 (42),0.229,1,0.567,0.805
Ferroptosis,Wikipathways,1,ACSL1,40 (40),0.229,1,0,,19 (29),1,1,0.567,0.805
Interleukin-2 family signaling,Reactome,1,INPP5D,40 (40),0.229,1,0,,2 (2),1,1,0.567,0.805
Glycerophospholipid metabolism,EHMN,1,ALDH7A1,136 (136),0.589,1,1,HMDB0010404,62 (95),0.398,1,0.574,0.812
Aurora B signaling,PID,1,MYLK,41 (41),0.234,1,0,,2 (2),1,1,0.574,0.812
Ferroptosis - Homo sapiens (human),KEGG,1,ACSL1,41 (41),0.234,1,0,,21 (31),1,1,0.574,0.812
Metabolic reprogramming in colon cancer,Wikipathways,1,FASN,42 (42),0.239,1,0,,29 (35),1,1,0.581,0.819
Porphyrin and chlorophyll metabolism - Homo sapiens (human),KEGG,1,UGT2A3,42 (42),0.239,1,0,,41 (143),1,1,0.581,0.819
Stabilization and expansion of the E-cadherin adherens junction,PID,1,EGFR,42 (42),0.239,1,0,,3 (3),1,1,0.581,0.819
Fc Epsilon Receptor I Signaling in Mast Cells,SMPDB,1,INPP5D,42 (42),0.239,1,0,,13 (13),1,1,0.581,0.819
Class C/3 (Metabotropic glutamate/pheromone receptors),Reactome,0,,40 (40),1,1,1,HMDB0034927,34 (54),0.242,1,0.585,0.822
p73 transcription factor network,PID,2,FASN;PEA15,79 (79),0.0928,0.827,0,,0 (0),1,1,0.0928,0.827
ErbB receptor signaling network,PID,1,EGFR,15 (15),0.0929,0.827,0,,0 (0),1,1,0.0929,0.827
Metabolism of RNA,Reactome,0,,583 (584),1,1,1,HMDB0001107,35 (77),0.248,1,0.593,0.83
the visual cycle I (vertebrates),HumanCyc,0,,16 (16),1,1,1,HMDB0002183,35 (58),0.248,1,0.593,0.83
Galactose metabolism,EHMN,1,SLC2A2,44 (44),0.249,1,0,,43 (47),1,1,0.595,0.83
Signaling by NOTCH3,Reactome,1,EGFR,44 (44),0.249,1,0,,3 (3),1,1,0.595,0.83
Interleukin-3_ Interleukin-5 and GM-CSF signaling,Reactome,1,INPP5D,44 (44),0.249,1,0,,2 (3),1,1,0.595,0.83
PLK1 signaling events,PID,1,PPP1R12A,44 (44),0.249,1,0,,1 (1),1,1,0.595,0.83
Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling,PID,1,EGFR,44 (44),0.249,1,0,,2 (2),1,1,0.595,0.83
Phospholipid metabolism,Reactome,1,INPP5D,213 (213),0.752,1,1,HMDB0010404,50 (104),0.335,1,0.599,0.834
Class I PI3K signaling events,PID,1,INPP5D,45 (45),0.254,1,0,,4 (4),1,1,0.602,0.834
Integrin-linked kinase signaling,PID,1,PPP1R12A,45 (45),0.254,1,0,,3 (3),1,1,0.602,0.834
RhoA signaling pathway,PID,1,PPP1R12A,45 (45),0.254,1,0,,1 (1),1,1,0.602,0.834
Retinoid metabolism and transport,Reactome,1,APOA2,45 (45),0.254,1,0,,24 (37),1,1,0.602,0.834
ATM Signaling Network in Development and Disease,Wikipathways,1,LBR,46 (46),0.259,1,0,,1 (1),1,1,0.609,0.841
Signaling by MET,Reactome,1,HPN,46 (46),0.259,1,0,,7 (9),1,1,0.609,0.841
Insulin Pathway,PID,1,INPP5D,46 (46),0.259,1,0,,5 (5),1,1,0.609,0.841
sphingosine and sphingosine-1-phosphate metabolism,HumanCyc,0,,9 (9),1,1,1,HMDB0002183,37 (59),0.26,1,0.61,0.842
Carbohydrate digestion and absorption - Homo sapiens (human),KEGG,1,SLC2A2,47 (47),0.264,1,0,,19 (27),1,1,0.615,0.842
agrin in postsynaptic differentiation,BioCarta,1,EGFR,47 (47),0.264,1,0,,2 (2),1,1,0.615,0.842
Mercaptopurine Action Pathway,SMPDB,1,AOX1,47 (47),0.264,1,0,,78 (84),1,1,0.615,0.842
Azathioprine Action Pathway,SMPDB,1,AOX1,47 (47),0.264,1,0,,80 (86),1,1,0.615,0.842
NR1H2 and NR1H3-mediated signaling,Reactome,1,FASN,47 (47),0.264,1,0,,3 (4),1,1,0.615,0.842
Thioguanine Action Pathway,SMPDB,1,AOX1,47 (47),0.264,1,0,,79 (85),1,1,0.615,0.842
GPCR ligand binding,Reactome,0,,476 (476),1,1,2,HMDB0034927;HMDB0002183,125 (168),0.266,1,0.619,0.846
Signaling by EGFR,Reactome,1,EGFR,48 (48),0.268,1,0,,8 (9),1,1,0.621,0.849
Phosphatidylinositol phosphate metabolism,EHMN,0,,93 (93),1,1,1,HMDB0011668,39 (48),0.272,1,0.626,0.853
Biosynthesis of unsaturated fatty acids - Homo sapiens (human),KEGG,0,,27 (27),1,1,1,HMDB0002183,39 (74),0.272,1,0.626,0.853
Xenobiotics,Reactome,0,,21 (21),1,1,1,HMDB0001860,39 (51),0.272,1,0.626,0.853
Metabolism of fat-soluble vitamins,Reactome,1,APOA2,49 (49),0.273,1,0,,31 (49),1,1,0.628,0.853
Asparagine N-linked glycosylation,Reactome,3,NPL;GFPT1;AMDHD2,283 (283),0.278,1,0,,65 (121),1,1,0.633,0.858
Signaling by ERBB2,Reactome,1,EGFR,50 (50),0.278,1,0,,11 (15),1,1,0.634,0.858
Chondroitin sulfate/dermatan sulfate metabolism,Reactome,1,HEXA,50 (50),0.278,1,0,,12 (24),1,1,0.634,0.858
Neurotransmitter release cycle,Reactome,1,ABAT,50 (50),0.278,1,0,,41 (45),1,1,0.634,0.858
TFAP2 (AP-2) family regulates transcription of growth factors and their receptors,Reactome,1,EGFR,16 (16),0.0988,0.86,0,,0 (0),1,1,0.0988,0.86
G alpha (q) signalling events,Reactome,1,EGFR,221 (221),0.765,1,1,HMDB0002183,56 (64),0.367,1,0.637,0.862
The citric acid (TCA) cycle and respiratory electron transport,Reactome,2,ATP5MC2;ME1,162 (162),0.282,1,0,,46 (59),1,1,0.64,0.862
Inositol phosphate metabolism,Reactome,1,INPP5D,51 (51),0.282,1,0,,31 (44),1,1,0.64,0.862
RHOD GTPase cycle,Reactome,1,LBR,51 (51),0.282,1,0,,4 (4),1,1,0.64,0.862
Intrinsic Pathway for Apoptosis,Reactome,1,SEPTIN4,52 (52),0.287,1,0,,4 (5),1,1,0.645,0.866
Signaling events mediated by PTP1B,PID,1,EGFR,52 (52),0.287,1,0,,1 (1),1,1,0.645,0.866
Apoptotic execution phase,Reactome,1,GSN,52 (52),0.287,1,0,,2 (5),1,1,0.645,0.866
Downstream TCR signaling,Reactome,1,INPP5D,52 (52),0.287,1,0,,6 (9),1,1,0.645,0.866
Sensory processing of sound by inner hair cells of the cochlea,Reactome,1,EPB41L1,53 (53),0.292,1,0,,5 (6),1,1,0.651,0.868
Posttranslational regulation of adherens junction stability and dissassembly,PID,1,EGFR,53 (53),0.292,1,0,,3 (3),1,1,0.651,0.868
Synthesis of PIPs at the plasma membrane,Reactome,1,INPP5D,53 (53),0.292,1,0,,9 (17),1,1,0.651,0.868
keratinocyte differentiation,BioCarta,1,EGFR,53 (53),0.292,1,0,,3 (3),1,1,0.651,0.868
Pyruvate metabolism and Citric Acid (TCA) cycle,Reactome,1,ME1,53 (53),0.292,1,0,,38 (44),1,1,0.651,0.868
cGMP-PKG signaling pathway - Homo sapiens (human),KEGG,2,PPP1R12A;MYLK,167 (167),0.294,1,0,,10 (10),1,1,0.654,0.872
Signaling by PTK6,Reactome,1,EGFR,54 (54),0.296,1,0,,10 (10),1,1,0.657,0.873
Signaling by Non-Receptor Tyrosine Kinases,Reactome,1,EGFR,54 (54),0.296,1,0,,10 (10),1,1,0.657,0.873
Nucleotide salvage,Reactome,0,,23 (23),1,1,1,HMDB0000273,44 (45),0.301,1,0.663,0.879
Thromboxane A2 receptor signaling,PID,1,EGFR,56 (56),0.306,1,0,,12 (12),1,1,0.668,0.884
RHOJ GTPase cycle,Reactome,1,NIPSNAP2,56 (56),0.306,1,0,,4 (4),1,1,0.668,0.884
Proximal tubule transport,Wikipathways,1,SLC2A2,57 (57),0.31,1,0,,16 (28),1,1,0.673,0.889
Caspase Cascade in Apoptosis,PID,1,GSN,57 (57),0.31,1,0,,1 (2),1,1,0.673,0.889
Signaling by ERBB4,Reactome,1,EGFR,58 (58),0.315,1,0,,7 (9),1,1,0.678,0.894
Endometrial cancer - Homo sapiens (human),KEGG,1,EGFR,58 (58),0.315,1,0,,1 (1),1,1,0.678,0.894
Glycerophospholipid biosynthesis,Reactome,0,,130 (130),1,1,1,HMDB0010404,47 (94),0.318,1,0.683,0.899
SHP2 signaling,PID,1,EGFR,59 (59),0.319,1,0,,6 (6),1,1,0.683,0.899
Lysine metabolism,EHMN,1,ALDH7A1,60 (60),0.323,1,0,,42 (53),1,1,0.688,0.904
Oxidative phosphorylation,Wikipathways,1,ATP5MC2,61 (61),0.328,1,0,,5 (5),1,1,0.693,0.907
Arachidonic acid metabolism - Homo sapiens (human),KEGG,1,GPX7,61 (61),0.328,1,0,,66 (75),1,1,0.693,0.907
Coregulation of Androgen receptor activity,PID,1,GSN,61 (61),0.328,1,0,,2 (2),1,1,0.693,0.907
Glycerolipid metabolism - Homo sapiens (human),KEGG,1,ALDH7A1,61 (61),0.328,1,0,,13 (38),1,1,0.693,0.907
FOXO-mediated transcription,Reactome,1,GCK,62 (62),0.332,1,0,,10 (12),1,1,0.698,0.907
TLR JNK,INOH,1,PSMB10,62 (62),0.332,1,0,,1 (1),1,1,0.698,0.907
Fc-epsilon receptor I signaling in mast cells,PID,1,INPP5D,62 (62),0.332,1,0,,6 (8),1,1,0.698,0.907
Endometrial cancer,Wikipathways,1,EGFR,63 (63),0.337,1,0,,1 (4),1,1,0.703,0.907
Lysine degradation - Homo sapiens (human),KEGG,1,ALDH7A1,63 (63),0.337,1,0,,40 (50),1,1,0.703,0.907
TLR p38,INOH,1,PSMB10,63 (63),0.337,1,0,,1 (1),1,1,0.703,0.907
LPA receptor mediated events,PID,1,EGFR,63 (63),0.337,1,0,,5 (5),1,1,0.703,0.907
Integrins in angiogenesis,PID,1,COL5A2,63 (63),0.337,1,0,,2 (2),1,1,0.703,0.907
Vitamin B12 metabolism,Wikipathways,0,,51 (51),1,1,1,HMDB0001904,51 (61),0.34,1,0.707,0.907
Transcriptional Regulation by MECP2,Reactome,1,LBR,64 (64),0.341,1,0,,3 (4),1,1,0.708,0.907
Proteasome Degradation,Wikipathways,1,PSMB10,64 (64),0.341,1,0,,1 (1),1,1,0.708,0.907
RAB geranylgeranylation,Reactome,1,RAB32,65 (65),0.345,1,0,,3 (3),1,1,0.712,0.907
Mitochondrial protein import,Reactome,1,LDHD,65 (65),0.345,1,0,,4 (4),1,1,0.712,0.907
Hyperprolinemia Type II,SMPDB,0,,20 (20),1,1,1,HMDB0000128,52 (52),0.346,1,0.713,0.907
Ornithine Aminotransferase Deficiency (OAT Deficiency),SMPDB,0,,20 (20),1,1,1,HMDB0000128,52 (52),0.346,1,0.713,0.907
Creatine deficiency_ guanidinoacetate methyltransferase deficiency,SMPDB,0,,20 (20),1,1,1,HMDB0000128,52 (52),0.346,1,0.713,0.907
Prolidase Deficiency (PD),SMPDB,0,,20 (20),1,1,1,HMDB0000128,52 (52),0.346,1,0.713,0.907
Arginine and Proline Metabolism,SMPDB,0,,20 (20),1,1,1,HMDB0000128,52 (52),0.346,1,0.713,0.907
Arginine: Glycine Amidinotransferase Deficiency (AGAT Deficiency),SMPDB,0,,20 (20),1,1,1,HMDB0000128,52 (52),0.346,1,0.713,0.907
Hyperornithinemia with gyrate atrophy (HOGA),SMPDB,0,,20 (20),1,1,1,HMDB0000128,52 (52),0.346,1,0.713,0.907
L-arginine:glycine amidinotransferase deficiency,SMPDB,0,,20 (20),1,1,1,HMDB0000128,52 (52),0.346,1,0.713,0.907
Hyperornithinemia-hyperammonemia-homocitrullinuria [HHH-syndrome],SMPDB,0,,20 (20),1,1,1,HMDB0000128,52 (52),0.346,1,0.713,0.907
Guanidinoacetate Methyltransferase Deficiency (GAMT Deficiency),SMPDB,0,,20 (20),1,1,1,HMDB0000128,52 (52),0.346,1,0.713,0.907
Prolinemia Type II,SMPDB,0,,20 (20),1,1,1,HMDB0000128,52 (52),0.346,1,0.713,0.907
Hyperprolinemia Type I,SMPDB,0,,20 (20),1,1,1,HMDB0000128,52 (52),0.346,1,0.713,0.907
Signaling by NOTCH,Reactome,2,EGFR;POFUT1,189 (190),0.347,1,0,,12 (13),1,1,0.714,0.907
Collagen biosynthesis and modifying enzymes,Reactome,1,COL5A2,67 (67),0.354,1,0,,8 (10),1,1,0.721,0.912
TCR signaling in na&#xef;ve CD4+ T cells,PID,1,INPP5D,67 (67),0.354,1,0,,4 (4),1,1,0.721,0.912
Fc epsilon RI signaling pathway - Homo sapiens (human),KEGG,1,INPP5D,67 (68),0.354,1,0,,11 (11),1,1,0.721,0.912
Regulation of insulin secretion,Reactome,1,SLC2A2,67 (67),0.354,1,0,,22 (26),1,1,0.721,0.912
RAC1-PAK1-p38-MMP2 Pathway,Wikipathways,1,EGFR,68 (68),0.358,1,0,,1 (1),1,1,0.726,0.914
BCR signaling pathway,PID,1,INPP5D,68 (68),0.358,1,0,,4 (4),1,1,0.726,0.914
AMP-activated protein kinase (AMPK) signaling,Wikipathways,1,FASN,68 (68),0.358,1,0,,7 (7),1,1,0.726,0.914
Sterol regulatory element-binding proteins (SREBP) signaling,Wikipathways,1,FASN,68 (68),0.358,1,0,,3 (5),1,1,0.726,0.914
TLR NFkB,INOH,1,PSMB10,69 (69),0.362,1,0,,1 (1),1,1,0.73,0.917
Adipocytokine signaling pathway - Homo sapiens (human),KEGG,1,ACSL1,69 (69),0.362,1,0,,3 (7),1,1,0.73,0.917
superpathway of inositol phosphate compounds,HumanCyc,1,INPP5D,70 (70),0.366,1,0,,18 (26),1,1,0.734,0.919
CD22 mediated BCR regulation,Reactome,1,IGHM,70 (70),0.366,1,0,,2 (3),1,1,0.734,0.919
Epithelial cell signaling in Helicobacter pylori infection - Homo sapiens (human),KEGG,1,EGFR,70 (70),0.366,1,0,,5 (7),1,1,0.734,0.919
Folate Metabolism,Wikipathways,0,,69 (69),1,1,1,HMDB0001904,56 (66),0.367,1,0.735,0.919
Parkinson_s disease pathway,Wikipathways,1,SEPTIN5,71 (71),0.37,1,0,,3 (4),1,1,0.738,0.919
Non-small cell lung cancer,Wikipathways,1,EGFR,72 (72),0.374,1,0,,5 (7),1,1,0.742,0.919
Non-small cell lung cancer - Homo sapiens (human),KEGG,1,EGFR,72 (72),0.374,1,0,,6 (6),1,1,0.742,0.919
Melanoma - Homo sapiens (human),KEGG,1,EGFR,72 (72),0.374,1,0,,1 (1),1,1,0.742,0.919
Extra-nuclear estrogen signaling,Reactome,1,EGFR,73 (73),0.378,1,0,,22 (24),1,1,0.746,0.919
Inositol phosphate metabolism - Homo sapiens (human),KEGG,1,INPP5D,73 (73),0.378,1,0,,25 (47),1,1,0.746,0.919
TCR signaling,Reactome,1,INPP5D,73 (73),0.378,1,0,,7 (10),1,1,0.746,0.919
Diabetic cardiomyopathy - Homo sapiens (human),KEGG,2,GFPT1;ATP5MC2,203 (203),0.38,1,0,,26 (39),1,1,0.747,0.919
Head and Neck Squamous Cell Carcinoma,Wikipathways,1,EGFR,74 (74),0.383,1,0,,2 (4),1,1,0.75,0.919
RHOC GTPase cycle,Reactome,1,LBR,74 (74),0.383,1,0,,4 (4),1,1,0.75,0.919
RHOG GTPase cycle,Reactome,1,LBR,74 (74),0.383,1,0,,4 (4),1,1,0.75,0.919
Proteoglycans in cancer - Homo sapiens (human),KEGG,2,PPP1R12A;EGFR,205 (205),0.384,1,0,,5 (7),1,1,0.752,0.919
Glioma - Homo sapiens (human),KEGG,1,EGFR,75 (75),0.387,1,0,,4 (4),1,1,0.754,0.919
Thyroid hormone synthesis - Homo sapiens (human),KEGG,1,GPX7,75 (75),0.387,1,0,,20 (21),1,1,0.754,0.919
Gastric acid secretion - Homo sapiens (human),KEGG,1,MYLK,76 (76),0.391,1,0,,13 (14),1,1,0.758,0.919
Pancreatic cancer - Homo sapiens (human),KEGG,1,EGFR,76 (76),0.391,1,0,,2 (2),1,1,0.758,0.919
Nuclear Envelope (NE) Reassembly,Reactome,1,LBR,78 (78),0.398,1,0,,9 (12),1,1,0.765,0.919
Constitutive Signaling by Aberrant PI3K in Cancer,Reactome,1,EGFR,79 (79),0.402,1,0,,5 (18),1,1,0.769,0.919
B cell receptor signaling pathway - Homo sapiens (human),KEGG,1,INPP5D,80 (82),0.406,1,0,,4 (4),1,1,0.772,0.919
Potential therapeutics for SARS,Reactome,1,COMT,80 (80),0.406,1,0,,1 (2),1,1,0.772,0.919
Cell surface interactions at the vascular wall,Reactome,2,INPP5D;IGHM,215 (215),0.407,1,0,,9 (13),1,1,0.773,0.919
Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met),PID,1,INPP5D,81 (81),0.41,1,0,,4 (4),1,1,0.776,0.919
Rofecoxib Action Pathway,SMPDB,0,,30 (30),1,1,1,HMDB0010404,66 (72),0.417,1,0.782,0.919
Lumiracoxib Action Pathway,SMPDB,0,,30 (30),1,1,1,HMDB0010404,66 (72),0.417,1,0.782,0.919
Salicylate-sodium Action Pathway,SMPDB,0,,30 (30),1,1,1,HMDB0010404,66 (72),0.417,1,0.782,0.919
Valdecoxib Action Pathway,SMPDB,0,,30 (30),1,1,1,HMDB0010404,66 (72),0.417,1,0.782,0.919
Nabumetone Action Pathway,SMPDB,0,,30 (30),1,1,1,HMDB0010404,66 (72),0.417,1,0.782,0.919
Bromfenac Action Pathway,SMPDB,0,,30 (30),1,1,1,HMDB0010404,66 (72),0.417,1,0.782,0.919
Arachidonic Acid Metabolism,SMPDB,0,,30 (30),1,1,1,HMDB0010404,66 (71),0.417,1,0.782,0.919
Leukotriene C4 Synthesis Deficiency,SMPDB,0,,30 (30),1,1,1,HMDB0010404,66 (71),0.417,1,0.782,0.919
Flurbiprofen Action Pathway,SMPDB,0,,30 (30),1,1,1,HMDB0010404,66 (72),0.417,1,0.782,0.919
Trisalicylate-choline Action Pathway,SMPDB,0,,30 (30),1,1,1,HMDB0010404,66 (71),0.417,1,0.782,0.919
Nepafenac Action Pathway,SMPDB,0,,30 (30),1,1,1,HMDB0010404,66 (72),0.417,1,0.782,0.919
Salsalate Action Pathway,SMPDB,0,,30 (30),1,1,1,HMDB0010404,66 (72),0.417,1,0.782,0.919
Tiaprofenic Acid Action Pathway,SMPDB,0,,30 (30),1,1,1,HMDB0010404,66 (72),0.417,1,0.782,0.919
Glioblastoma signaling pathways,Wikipathways,1,EGFR,83 (83),0.418,1,0,,1 (3),1,1,0.782,0.919
EGFR Tyrosine Kinase Inhibitor Resistance,Wikipathways,1,EGFR,84 (84),0.422,1,0,,3 (5),1,1,0.786,0.919
PI Metabolism,Reactome,1,INPP5D,84 (84),0.422,1,0,,15 (29),1,1,0.786,0.919
Phenylbutazone Action Pathway,SMPDB,0,,30 (30),1,1,1,HMDB0010404,67 (72),0.422,1,0.786,0.919
Piroxicam Action Pathway,SMPDB,0,,30 (30),1,1,1,HMDB0010404,67 (72),0.422,1,0.786,0.919
Tenoxicam Action Pathway,SMPDB,0,,30 (30),1,1,1,HMDB0010404,67 (72),0.422,1,0.786,0.919
Diclofenac Action Pathway,SMPDB,0,,30 (30),1,1,1,HMDB0010404,67 (72),0.422,1,0.786,0.919
Antipyrine Action Pathway,SMPDB,0,,30 (30),1,1,1,HMDB0010404,67 (72),0.422,1,0.786,0.919
Etodolac Action Pathway,SMPDB,0,,30 (30),1,1,1,HMDB0010404,67 (72),0.422,1,0.786,0.919
Ketoprofen Action Pathway,SMPDB,0,,30 (30),1,1,1,HMDB0010404,67 (72),0.422,1,0.786,0.919
Acetylsalicylic Acid Action Pathway,SMPDB,0,,30 (30),1,1,1,HMDB0010404,67 (72),0.422,1,0.786,0.919
Diflunisal Action Pathway,SMPDB,0,,30 (30),1,1,1,HMDB0010404,67 (72),0.422,1,0.786,0.919
Acetaminophen  Action Pathway,SMPDB,0,,30 (30),1,1,1,HMDB0010404,67 (72),0.422,1,0.786,0.919
Sulindac Action Pathway,SMPDB,0,,30 (30),1,1,1,HMDB0010404,67 (72),0.422,1,0.786,0.919
Ketorolac Action Pathway,SMPDB,0,,30 (30),1,1,1,HMDB0010404,67 (72),0.422,1,0.786,0.919
Naproxen Action Pathway,SMPDB,0,,30 (30),1,1,1,HMDB0010404,67 (72),0.422,1,0.786,0.919
Etoricoxib Action Pathway,SMPDB,0,,30 (30),1,1,1,HMDB0010404,67 (72),0.422,1,0.786,0.919
Carprofen Action Pathway,SMPDB,0,,30 (30),1,1,1,HMDB0010404,67 (72),0.422,1,0.786,0.919
Fenoprofen Action Pathway,SMPDB,0,,30 (30),1,1,1,HMDB0010404,67 (72),0.422,1,0.786,0.919
Antrafenine Action Pathway,SMPDB,0,,30 (30),1,1,1,HMDB0010404,67 (72),0.422,1,0.786,0.919
Magnesium salicylate Action Pathway,SMPDB,0,,30 (30),1,1,1,HMDB0010404,67 (72),0.422,1,0.786,0.919
Lornoxicam Action Pathway,SMPDB,0,,30 (30),1,1,1,HMDB0010404,67 (72),0.422,1,0.786,0.919
Tolmetin Action Pathway,SMPDB,0,,30 (30),1,1,1,HMDB0010404,67 (72),0.422,1,0.786,0.919
Salicylic Acid Action Pathway,SMPDB,0,,30 (30),1,1,1,HMDB0010404,67 (72),0.422,1,0.786,0.919
Oxaprozin Action Pathway,SMPDB,0,,30 (30),1,1,1,HMDB0010404,67 (72),0.422,1,0.786,0.919
Indomethacin Action Pathway,SMPDB,0,,31 (31),1,1,1,HMDB0010404,67 (72),0.422,1,0.786,0.919
Meloxicam Action Pathway,SMPDB,0,,30 (30),1,1,1,HMDB0010404,67 (72),0.422,1,0.786,0.919
Suprofen Action Pathway,SMPDB,0,,30 (30),1,1,1,HMDB0010404,67 (72),0.422,1,0.786,0.919
Mefenamic Acid Action Pathway,SMPDB,0,,30 (30),1,1,1,HMDB0010404,67 (72),0.422,1,0.786,0.919
ErbB signaling pathway - Homo sapiens (human),KEGG,1,EGFR,85 (85),0.425,1,0,,4 (4),1,1,0.789,0.921
RAC2 GTPase cycle,Reactome,1,LBR,85 (85),0.425,1,0,,4 (4),1,1,0.789,0.921
Cristae formation,Reactome,1,ATP5MC2,18 (18),0.11,0.921,0,,0 (0),1,1,0.11,0.921
Other glycan degradation - Homo sapiens (human),KEGG,1,HEXA,18 (18),0.11,0.921,0,,0 (0),1,1,0.11,0.921
SREBF and miR33 in cholesterol and lipid homeostasis,Wikipathways,1,FASN,18 (18),0.11,0.921,0,,0 (0),1,1,0.11,0.921
CXCR4-mediated signaling events,PID,1,INPP5D,86 (86),0.429,1,0,,4 (4),1,1,0.792,0.923
Colorectal cancer - Homo sapiens (human),KEGG,1,EGFR,86 (86),0.429,1,0,,1 (1),1,1,0.792,0.923
Pyrimidine metabolism,EHMN,0,,135 (135),1,1,1,HMDB0000273,69 (77),0.432,1,0.794,0.924
Celecoxib Action Pathway,SMPDB,0,,36 (36),1,1,1,HMDB0010404,70 (76),0.436,1,0.798,0.925
Protein-protein interactions at synapses,Reactome,1,EPB41L1,88 (88),0.437,1,0,,2 (2),1,1,0.798,0.925
Regulation of PLK1 Activity at G2/M Transition,Reactome,1,PPP1R12A,88 (88),0.437,1,0,,5 (5),1,1,0.798,0.925
Gap junction - Homo sapiens (human),KEGG,1,EGFR,88 (88),0.437,1,0,,10 (11),1,1,0.798,0.925
Pancreatic adenocarcinoma pathway,Wikipathways,1,EGFR,89 (89),0.44,1,0,,1 (2),1,1,0.801,0.926
PD-L1 expression and PD-1 checkpoint pathway in cancer - Homo sapiens (human),KEGG,1,EGFR,89 (89),0.44,1,0,,4 (4),1,1,0.801,0.926
GABAergic synapse - Homo sapiens (human),KEGG,1,ABAT,89 (89),0.44,1,0,,9 (9),1,1,0.801,0.926
Organelle biogenesis and maintenance,Reactome,2,ATP5MC2;ACSS2,231 (231),0.443,1,0,,13 (16),1,1,0.804,0.926
Coronavirus disease - COVID-19 - Homo sapiens (human),KEGG,2,MBL2;EGFR,231 (232),0.443,1,0,,6 (10),1,1,0.804,0.926
RAB GEFs exchange GTP for GDP on RABs,Reactome,1,RAB32,90 (90),0.444,1,0,,4 (4),1,1,0.804,0.926
Thermogenesis - Homo sapiens (human),KEGG,2,ACSL1;ATP5MC2,232 (232),0.445,1,0,,19 (23),1,1,0.805,0.926
Integration of energy metabolism,Reactome,1,SLC2A2,91 (91),0.447,1,0,,29 (34),1,1,0.807,0.926
Collagen formation,Reactome,1,COL5A2,91 (91),0.447,1,0,,13 (16),1,1,0.807,0.926
ErbB signaling pathway,Wikipathways,1,EGFR,92 (92),0.451,1,0,,4 (5),1,1,0.81,0.926
Apoptosis Modulation and Signaling,Wikipathways,1,PEA15,92 (92),0.451,1,0,,1 (1),1,1,0.81,0.926
RAF/MAP kinase cascade,Reactome,2,PEA15;EGFR,235 (235),0.452,1,0,,22 (36),1,1,0.811,0.926
MAPK1/MAPK3 signaling,Reactome,2,PEA15;EGFR,236 (236),0.454,1,0,,22 (36),1,1,0.812,0.926
Complement system,Wikipathways,1,MBL2,93 (93),0.455,1,0,,2 (5),1,1,0.813,0.926
GnRH signaling pathway - Homo sapiens (human),KEGG,1,EGFR,93 (93),0.455,1,0,,6 (6),1,1,0.813,0.926
TNF-alpha signaling pathway,Wikipathways,1,PYGL,93 (93),0.455,1,0,,2 (3),1,1,0.813,0.926
Ibuprofen Action Pathway,SMPDB,0,,50 (50),1,1,1,HMDB0010404,74 (79),0.455,1,0.813,0.926
Antigen activates B Cell Receptor (BCR) leading to generation of second messengers,Reactome,1,IGHM,94 (94),0.458,1,0,,5 (8),1,1,0.816,0.928
RAC3 GTPase cycle,Reactome,1,LBR,94 (94),0.458,1,0,,6 (6),1,1,0.816,0.928
Xenobiotics metabolism,EHMN,0,,51 (51),1,1,1,HMDB0060326,75 (93),0.459,1,0.817,0.928
Calcium signaling pathway - Homo sapiens (human),KEGG,2,EGFR;MYLK,239 (240),0.46,1,0,,8 (11),1,1,0.817,0.928
Creation of C4 and C2 activators,Reactome,1,MBL2,95 (95),0.462,1,0,,3 (10),1,1,0.819,0.928
RHO GTPases activate PKNs,Reactome,1,PPP1R12A,96 (97),0.465,1,0,,14 (15),1,1,0.821,0.93
Neuronal System,Reactome,3,COMT;ABAT;EPB41L1,391 (391),0.467,1,0,,69 (78),1,1,0.822,0.931
Phosphatidylinositol signaling system - Homo sapiens (human),KEGG,1,INPP5D,97 (97),0.469,1,0,,19 (29),1,1,0.824,0.931
Prostate cancer - Homo sapiens (human),KEGG,1,EGFR,97 (97),0.469,1,0,,11 (11),1,1,0.824,0.931
Cellular response to chemical stress,Reactome,1,GPX7,99 (99),0.476,1,0,,33 (41),1,1,0.829,0.935
CD4 T cell receptor signaling-NFkB cascade,INOH,1,PSMB10,99 (99),0.476,1,0,,3 (4),1,1,0.829,0.935
PI5P_ PP2A and IER3 Regulate PI3K/AKT Signaling,Reactome,1,EGFR,100 (100),0.479,1,0,,7 (12),1,1,0.832,0.936
Parkinson disease - Homo sapiens (human),KEGG,2,ATP5MC2;SEPTIN5,249 (249),0.482,1,0,,19 (21),1,1,0.833,0.937
Amoebiasis - Homo sapiens (human),KEGG,1,SERPINB6,101 (102),0.482,1,0,,11 (13),1,1,0.834,0.937
Initial triggering of complement,Reactome,1,MBL2,102 (102),0.486,1,0,,4 (11),1,1,0.837,0.939
Protein digestion and absorption - Homo sapiens (human),KEGG,1,COL5A2,103 (103),0.489,1,0,,44 (47),1,1,0.839,0.939
Visual phototransduction,Reactome,1,APOA2,103 (103),0.489,1,0,,48 (68),1,1,0.839,0.939
Electron Transport Chain (OXPHOS system in mitochondria),Wikipathways,1,ATP5MC2,103 (103),0.489,1,0,,10 (12),1,1,0.839,0.939
MicroRNAs in cardiomyocyte hypertrophy,Wikipathways,1,MYLK,104 (104),0.493,1,0,,3 (3),1,1,0.841,0.94
Reproduction,Reactome,1,CD9,105 (106),0.496,1,0,,9 (11),1,1,0.844,0.94
Cargo recognition for clathrin-mediated endocytosis,Reactome,1,EGFR,105 (105),0.496,1,0,,8 (10),1,1,0.844,0.94
PI3K/AKT Signaling in Cancer,Reactome,1,EGFR,106 (106),0.499,1,0,,5 (21),1,1,0.846,0.94
ErbB1 downstream signaling,PID,1,EGFR,106 (106),0.499,1,0,,7 (7),1,1,0.846,0.94
Parathyroid hormone synthesis_ secretion and action - Homo sapiens (human),KEGG,1,EGFR,106 (106),0.499,1,0,,9 (10),1,1,0.846,0.94
Post-translational protein phosphorylation,Reactome,1,APOA2,107 (107),0.502,1,0,,2 (2),1,1,0.848,0.94
Pre-NOTCH Expression and Processing,Reactome,1,POFUT1,107 (108),0.502,1,0,,11 (12),1,1,0.848,0.94
Purine nucleotides nucleosides metabolism,INOH,1,PKLR,107 (107),0.502,1,0,,77 (80),1,1,0.848,0.94
Negative regulation of the PI3K/AKT network,Reactome,1,EGFR,107 (107),0.502,1,0,,8 (14),1,1,0.848,0.94
Thermogenesis,Wikipathways,1,ACSL1,108 (108),0.506,1,0,,17 (25),1,1,0.85,0.942
HIF-1 signaling pathway - Homo sapiens (human),KEGG,1,EGFR,109 (109),0.509,1,0,,13 (15),1,1,0.853,0.944
SARS-CoV Infections,Reactome,1,COMT,111 (111),0.515,1,0,,13 (26),1,1,0.857,0.947
Respiratory electron transport_ ATP synthesis by chemiosmotic coupling_ and heat production by uncoupling proteins.,Reactome,1,ATP5MC2,113 (113),0.522,1,0,,17 (25),1,1,0.861,0.951
Class A/1 (Rhodopsin-like receptors),Reactome,0,,346 (346),1,1,1,HMDB0002183,90 (113),0.523,1,0.862,0.951
MAPK family signaling cascades,Reactome,2,PEA15;EGFR,270 (270),0.525,1,0,,22 (36),1,1,0.863,0.951
ESC Pluripotency Pathways,Wikipathways,1,EGFR,116 (116),0.531,1,0,,4 (5),1,1,0.867,0.954
Rab regulation of trafficking,Reactome,1,RAB32,116 (116),0.531,1,0,,6 (6),1,1,0.867,0.954
Spinal Cord Injury,Wikipathways,1,EGFR,117 (117),0.534,1,0,,5 (9),1,1,0.869,0.955
Glycosaminoglycan metabolism,Reactome,1,HEXA,119 (119),0.54,1,0,,30 (60),1,1,0.873,0.958
Fragile X Syndrome,Wikipathways,1,ABAT,119 (119),0.54,1,0,,3 (6),1,1,0.873,0.958
AMPK signaling pathway - Homo sapiens (human),KEGG,1,FASN,120 (120),0.543,1,0,,17 (23),1,1,0.875,0.959
Integrin,INOH,1,COL5A2,124 (124),0.555,1,0,,2 (2),1,1,0.882,0.965
Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs),Reactome,1,APOA2,124 (124),0.555,1,0,,3 (3),1,1,0.882,0.965
Signaling by the B Cell Receptor (BCR),Reactome,1,IGHM,126 (126),0.561,1,0,,10 (14),1,1,0.885,0.967
Deubiquitination,Reactome,2,OGT;PSMB10,290 (290),0.564,1,0,,3 (10),1,1,0.887,0.968
Lysosome - Homo sapiens (human),KEGG,1,HEXA,128 (128),0.566,1,0,,3 (4),1,1,0.888,0.969
Relaxin signaling pathway - Homo sapiens (human),KEGG,1,EGFR,129 (129),0.569,1,0,,6 (6),1,1,0.89,0.97
Signaling by Nuclear Receptors,Reactome,2,FASN;EGFR,294 (295),0.571,1,0,,42 (49),1,1,0.891,0.97
Angiopoietin Like Protein 8 Regulatory Pathway,Wikipathways,1,FASN,131 (131),0.575,1,0,,5 (9),1,1,0.893,0.97
Platelet degranulation ,Reactome,1,CD9,131 (131),0.575,1,0,,9 (9),1,1,0.893,0.97
FoxO signaling pathway - Homo sapiens (human),KEGG,1,EGFR,131 (131),0.575,1,0,,4 (5),1,1,0.893,0.97
CD4 T cell receptor signaling,INOH,1,PSMB10,132 (132),0.578,1,0,,6 (7),1,1,0.895,0.97
Dopaminergic synapse - Homo sapiens (human),KEGG,1,COMT,132 (132),0.578,1,0,,12 (12),1,1,0.895,0.97
Oxidative phosphorylation - Homo sapiens (human),KEGG,1,ATP5MC2,133 (133),0.58,1,0,,14 (16),1,1,0.896,0.97
Response to elevated platelet cytosolic Ca2+,Reactome,1,CD9,136 (136),0.589,1,0,,10 (11),1,1,0.901,0.972
Apoptosis - Homo sapiens (human),KEGG,1,SEPTIN4,136 (136),0.589,1,0,,4 (4),1,1,0.901,0.972
Complement cascade,Reactome,1,MBL2,137 (137),0.591,1,0,,4 (12),1,1,0.902,0.972
Apelin signaling pathway - Homo sapiens (human),KEGG,1,MYLK,137 (137),0.591,1,0,,8 (9),1,1,0.902,0.972
Estrogen signaling pathway - Homo sapiens (human),KEGG,1,EGFR,137 (138),0.591,1,0,,8 (8),1,1,0.902,0.972
Huntington disease - Homo sapiens (human),KEGG,2,GPX7;ATP5MC2,306 (306),0.593,1,0,,5 (6),1,1,0.903,0.972
G2/M Transition,Reactome,1,PPP1R12A,138 (138),0.594,1,0,,8 (9),1,1,0.903,0.972
Pathways of neurodegeneration - multiple diseases - Homo sapiens (human),KEGG,3,GPX7;ATP5MC2;SEPTIN5,475 (475),0.599,1,0,,20 (32),1,1,0.906,0.972
Mitotic G2-G2/M phases,Reactome,1,PPP1R12A,140 (140),0.599,1,0,,8 (9),1,1,0.906,0.972
JAK STAT pathway and regulation,INOH,2,PSMB10;EGFR,310 (310),0.6,1,0,,2 (2),1,1,0.907,0.972
Clathrin-mediated endocytosis,Reactome,1,EGFR,142 (142),0.604,1,0,,12 (17),1,1,0.909,0.972
Direct p53 effectors,PID,1,EGFR,142 (142),0.604,1,0,,1 (1),1,1,0.909,0.972
HATs acetylate histones,Reactome,1,OGT,142 (142),0.604,1,0,,2 (2),1,1,0.909,0.972
RHO GTPase Effectors,Reactome,2,PPP1R12A;MYLK,313 (314),0.605,1,0,,24 (29),1,1,0.909,0.972
Male infertility,Wikipathways,1,PON1,145 (145),0.612,1,0,,4 (4),1,1,0.913,0.974
Breast cancer - Homo sapiens (human),KEGG,1,EGFR,147 (147),0.617,1,0,,3 (3),1,1,0.915,0.975
Phospholipase D signaling pathway - Homo sapiens (human),KEGG,1,EGFR,147 (148),0.617,1,0,,9 (11),1,1,0.915,0.975
Gastric cancer - Homo sapiens (human),KEGG,1,EGFR,149 (149),0.622,1,0,,3 (4),1,1,0.917,0.976
RHOA GTPase cycle,Reactome,1,LBR,149 (149),0.622,1,0,,4 (4),1,1,0.917,0.976
Hepatitis B infection,Wikipathways,1,SLC10A1,152 (152),0.63,1,0,,1 (1),1,1,0.921,0.979
Breast cancer pathway,Wikipathways,1,EGFR,154 (154),0.634,1,0,,4 (4),1,1,0.923,0.98
Cushing syndrome - Homo sapiens (human),KEGG,1,EGFR,155 (155),0.637,1,0,,12 (13),1,1,0.924,0.98
Hepatitis C - Homo sapiens (human),KEGG,1,EGFR,157 (157),0.642,1,0,,1 (2),1,1,0.926,0.982
Hemostasis,Reactome,4,CD9;INPP5D;IGHM;SERPINB6,677 (677),0.645,1,0,,42 (67),1,1,0.928,0.982
Sudden Infant Death Syndrome (SIDS) Susceptibility Pathways,Wikipathways,1,GCK,159 (159),0.646,1,0,,13 (15),1,1,0.928,0.982
CDC42 GTPase cycle,Reactome,1,LBR,160 (160),0.649,1,0,,4 (4),1,1,0.929,0.982
Hepatitis B - Homo sapiens (human),KEGG,1,SLC10A1,162 (162),0.653,1,0,,1 (1),1,1,0.931,0.983
Signaling by Rho GTPases,Reactome,4,LBR;PPP1R12A;MYLK;NIPSNAP2,688 (689),0.658,1,0,,24 (29),1,1,0.933,0.984
BMP Signaling Pathway in Eyelid Development,Wikipathways,1,EGFR,20 (20),0.122,0.988,0,,0 (0),1,1,0.122,0.988
Protein processing in endoplasmic reticulum - Homo sapiens (human),KEGG,1,DNAJC10,170 (171),0.671,1,0,,1 (6),1,1,0.939,0.989
Pathways in cancer - Homo sapiens (human),KEGG,3,EGFR;GSTM3;GSTM4,531 (531),0.674,1,0,,26 (31),1,1,0.94,0.989
Signaling by Rho GTPases_ Miro GTPases and RHOBTB3,Reactome,4,LBR;PPP1R12A;MYLK;NIPSNAP2,704 (705),0.675,1,0,,24 (29),1,1,0.94,0.989
Axon guidance,Reactome,2,SHTN1;EGFR,356 (356),0.675,1,0,,11 (17),1,1,0.94,0.989
Muscle contraction,Reactome,1,MYLK,174 (174),0.68,1,0,,15 (16),1,1,0.942,0.989
Amyotrophic lateral sclerosis - Homo sapiens (human),KEGG,2,GPX7;ATP5MC2,364 (364),0.687,1,0,,10 (14),1,1,0.945,0.991
Ras signaling,Wikipathways,1,EGFR,184 (184),0.7,1,0,,7 (7),1,1,0.95,0.994
Neurotransmitter receptors and postsynaptic signal transmission,Reactome,1,EPB41L1,185 (185),0.702,1,0,,21 (24),1,1,0.95,0.994
RAC1 GTPase cycle,Reactome,1,LBR,185 (185),0.702,1,0,,6 (6),1,1,0.95,0.994
VEGF,INOH,1,EGFR,188 (188),0.708,1,0,,3 (4),1,1,0.952,0.995
Nervous system development,Reactome,2,SHTN1;EGFR,379 (379),0.709,1,0,,11 (17),1,1,0.953,0.995
Mitotic Anaphase,Reactome,1,LBR,195 (195),0.721,1,0,,11 (14),1,1,0.957,0.997
Mitotic Metaphase and Anaphase,Reactome,1,LBR,196 (196),0.723,1,0,,11 (14),1,1,0.957,0.997
Infectious disease,Reactome,4,CD9;COMT;RNF213;EGFR,750 (750),0.723,1,0,,75 (127),1,1,0.958,0.997
Sensory Perception,Reactome,3,APOA2;EPB41L1;GSN,585 (585),0.737,1,0,,49 (69),1,1,0.962,1
Rap1 signaling pathway - Homo sapiens (human),KEGG,1,EGFR,210 (210),0.747,1,0,,5 (5),1,1,0.965,1
Ub-specific processing proteases,Reactome,1,PSMB10,214 (214),0.754,1,0,,1 (2),1,1,0.967,1
ESR-mediated signaling,Reactome,1,EGFR,216 (217),0.757,1,0,,27 (30),1,1,0.968,1
cAMP signaling pathway - Homo sapiens (human),KEGG,1,PPP1R12A,216 (216),0.757,1,0,,22 (25),1,1,0.968,1
PIP3 activates AKT signaling,Reactome,1,EGFR,218 (218),0.76,1,0,,15 (21),1,1,0.969,1
Purine metabolism,EHMN,1,ATP5MC2,222 (222),0.766,1,0,,86 (94),1,1,0.97,1
Human cytomegalovirus infection - Homo sapiens (human),KEGG,1,EGFR,225 (225),0.771,1,0,,5 (6),1,1,0.972,1
Ras signaling pathway - Homo sapiens (human),KEGG,1,EGFR,232 (232),0.781,1,0,,7 (7),1,1,0.974,1
RHO GTPase cycle,Reactome,2,LBR;NIPSNAP2,442 (442),0.785,1,0,,6 (6),1,1,0.975,1
Neddylation,Reactome,1,PSMB10,236 (236),0.787,1,0,,4 (4),1,1,0.976,1
Signaling by Interleukins,Reactome,1,INPP5D,240 (240),0.793,1,0,,4 (7),1,1,0.977,1
MAPK Signaling Pathway,Wikipathways,1,EGFR,246 (246),0.801,1,0,,5 (5),1,1,0.979,1
Shigellosis - Homo sapiens (human),KEGG,1,EGFR,246 (246),0.801,1,0,,9 (14),1,1,0.979,1
Signaling by Receptor Tyrosine Kinases,Reactome,2,HPN;EGFR,464 (464),0.808,1,0,,35 (53),1,1,0.98,1
Endocytosis - Homo sapiens (human),KEGG,1,EGFR,252 (252),0.808,1,0,,3 (6),1,1,0.98,1
Intracellular signaling by second messengers,Reactome,1,EGFR,259 (259),0.817,1,0,,22 (28),1,1,0.982,1
Platelet activation_ signaling and aggregation,Reactome,1,CD9,263 (263),0.822,1,0,,22 (28),1,1,0.983,1
Antigen processing: Ubiquitination & Proteasome degradation,Reactome,1,RNF213,265 (265),0.824,1,0,,4 (5),1,1,0.984,1
Innate Immune System,Reactome,5,MBL2;PYGL;VAT1;GSN;SERPINB6,1064 (1065),0.829,1,0,,57 (119),1,1,0.984,1
Post-translational protein modification,Reactome,7,NPL;PSMB10;RAB32;APOA2;GFPT1;OGT;AMDHD2,1425 (1425),0.829,1,0,,96 (182),1,1,0.985,1
Chromatin modifying enzymes,Reactome,1,OGT,271 (271),0.831,1,0,,15 (17),1,1,0.985,1
Chromatin organization,Reactome,1,OGT,271 (271),0.831,1,0,,15 (17),1,1,0.985,1
Prion disease - Homo sapiens (human),KEGG,1,ATP5MC2,273 (273),0.833,1,0,,5 (5),1,1,0.985,1
Diseases of signal transduction by growth factor receptors and second messengers,Reactome,1,EGFR,274 (274),0.834,1,0,,18 (71),1,1,0.985,1
Extracellular matrix organization,Reactome,1,COL5A2,287 (287),0.848,1,0,,21 (30),1,1,0.988,1
Adaptive Immune System,Reactome,3,INPP5D;RNF213;IGHM,719 (719),0.852,1,0,,27 (51),1,1,0.988,1
MAPK signaling pathway - Homo sapiens (human),KEGG,1,EGFR,294 (294),0.855,1,0,,5 (5),1,1,0.989,1
Cell Cycle_ Mitotic,Reactome,2,LBR;PPP1R12A,523 (524),0.858,1,0,,34 (40),1,1,0.989,1
Class I MHC mediated antigen processing & presentation,Reactome,1,RNF213,316 (316),0.875,1,0,,14 (21),1,1,0.992,1
Human papillomavirus infection - Homo sapiens (human),KEGG,1,EGFR,331 (331),0.887,1,0,,3 (3),1,1,0.993,1
PI3K-Akt signaling pathway,Wikipathways,1,EGFR,339 (340),0.893,1,0,,3 (4),1,1,0.994,1
PI3K-Akt signaling pathway - Homo sapiens (human),KEGG,1,EGFR,353 (354),0.902,1,0,,3 (4),1,1,0.995,1
Disease,Reactome,4,CD9;COMT;RNF213;EGFR,1029 (1029),0.909,1,0,,91 (198),1,1,0.996,1
Alzheimer disease - Homo sapiens (human),KEGG,1,ATP5MC2,369 (369),0.912,1,0,,9 (16),1,1,0.996,1
Cell Cycle,Reactome,2,LBR;PPP1R12A,621 (622),0.916,1,0,,35 (44),1,1,0.996,1
Immune System,Reactome,8,RNF213;PYGL;IGHM;INPP5D;SERPINB6;GSN;MBL2;VAT1,1827 (1828),0.919,1,0,,65 (147),1,1,0.997,1
M Phase,Reactome,1,LBR,382 (383),0.919,1,0,,22 (26),1,1,0.997,1
Developmental Biology,Reactome,2,SHTN1;EGFR,676 (676),0.938,1,0,,20 (30),1,1,0.998,1
Cytokine Signaling in Immune system,Reactome,1,INPP5D,471 (471),0.956,1,0,,9 (21),1,1,0.999,1
Cellular responses to stress,Reactome,1,GPX7,553 (554),0.975,1,0,,55 (74),1,1,1,1
Metabolism of proteins,Reactome,7,NPL;PSMB10;RAB32;APOA2;GFPT1;OGT;AMDHD2,1934 (1935),0.975,1,0,,131 (288),1,1,1,1
Cellular responses to external stimuli,Reactome,1,GPX7,568 (569),0.977,1,0,,57 (76),1,1,1,1
Generic Transcription Pathway,Reactome,3,LBR;EGFR;GCK,1177 (1178),0.985,1,0,,41 (55),1,1,1,1
RNA Polymerase II Transcription,Reactome,3,LBR;EGFR;GCK,1306 (1307),0.993,1,0,,44 (62),1,1,1,1
Gene expression (Transcription),Reactome,3,LBR;EGFR;GCK,1438 (1439),0.997,1,0,,49 (74),1,1,1,1
Phosphatidylcholine catabolism,Wikipathways,0,,0 (0),1,1,2,HMDB0010404;HMDB0013461,6 (9),0.000907,1,0.000907,1
Oligodendrocyte specification and differentiation_ leading to myelin components for CNS,Wikipathways,0,,0 (0),1,1,1,HMDB0013461,8 (11),0.0627,1,0.0627,1
Pyrimidine metabolism and related diseases,Wikipathways,0,,0 (0),1,1,1,HMDB0000273,14 (37),0.107,1,0.107,1
Biomarkers for pyrimidine metabolism disorders,Wikipathways,0,,0 (0),1,1,1,HMDB0000273,15 (34),0.114,1,0.114,1
Hypothesized Pathways in Pathogenesis of Cardiovascular Disease,Wikipathways,1,ENG,25 (25),0.15,1,0,,0 (0),1,1,0.15,1
Syndecan-3-mediated signaling events,PID,1,EGFR,26 (26),0.156,1,0,,0 (1),1,1,0.156,1
ALK1 signaling events,PID,1,ENG,26 (26),0.156,1,0,,0 (0),1,1,0.156,1
Interleukin receptor SHC signaling,Reactome,1,INPP5D,27 (27),0.161,1,0,,0 (0),1,1,0.161,1
IL3-mediated signaling events,PID,1,INPP5D,28 (28),0.166,1,0,,0 (0),1,1,0.166,1
NOTCH-Ncore,Signalink,1,POFUT1,28 (28),0.166,1,0,,0 (0),1,1,0.166,1
Extracellular vesicle-mediated signaling in recipient cells,Wikipathways,1,EGFR,30 (30),0.177,1,0,,0 (0),1,1,0.177,1
Hippo-Merlin Signaling Dysregulation,Wikipathways,2,PPP1R12A;EGFR,120 (120),0.182,1,0,,0 (0),1,1,0.182,1
Apoptosis - multiple species - Homo sapiens (human),KEGG,1,SEPTIN4,32 (32),0.188,1,0,,0 (0),1,1,0.188,1
Regulation of Glucokinase by Glucokinase Regulatory Protein,Reactome,1,GCK,32 (32),0.188,1,0,,0 (0),1,1,0.188,1
Inflammatory Response Pathway,Wikipathways,1,IGHM,33 (33),0.193,1,0,,0 (0),1,1,0.193,1
Urea cycle and metabolism of amino groups,Wikipathways,0,,0 (0),1,1,1,HMDB0000128,28 (32),0.203,1,0.203,1
rac1 cell motility signaling pathway,BioCarta,1,MYLK,36 (36),0.209,1,0,,0 (0),1,1,0.209,1
Apoptotic cleavage of cellular proteins,Reactome,1,GSN,38 (38),0.219,1,0,,0 (0),1,1,0.219,1
Various types of N-glycan biosynthesis - Homo sapiens (human),KEGG,1,HEXA,39 (39),0.224,1,0,,0 (31),1,1,0.224,1
Signaling events mediated by HDAC Class III,PID,1,ACSS2,39 (39),0.224,1,0,,0 (0),1,1,0.224,1
Bladder cancer,Wikipathways,1,EGFR,40 (40),0.229,1,0,,0 (0),1,1,0.229,1
Gastrin,NetPath,1,EGFR,41 (41),0.234,1,0,,0 (0),1,1,0.234,1
Bladder cancer - Homo sapiens (human),KEGG,1,EGFR,41 (41),0.234,1,0,,0 (0),1,1,0.234,1
Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors,Reactome,1,EGFR,41 (41),0.234,1,0,,0 (0),1,1,0.234,1
Ectoderm Differentiation,Wikipathways,2,OGT;SERPINB6,142 (142),0.234,1,0,,0 (0),1,1,0.234,1
AndrogenReceptor,NetPath,2,EGFR;GSN,142 (142),0.234,1,0,,0 (0),1,1,0.234,1
miRNA targets in ECM and membrane receptors,Wikipathways,1,COL5A2,43 (43),0.244,1,0,,0 (0),1,1,0.244,1
Syndecan-1-mediated signaling events,PID,1,COL5A2,43 (43),0.244,1,0,,0 (1),1,1,0.244,1
Collagen chain trimerization,Reactome,1,COL5A2,44 (44),0.249,1,0,,0 (0),1,1,0.249,1
RAGE,NetPath,1,EGFR,45 (45),0.254,1,0,,0 (0),1,1,0.254,1
Aryl Hydrocarbon Receptor Netpath,Wikipathways,1,EGFR,46 (46),0.259,1,0,,0 (2),1,1,0.259,1
Aryl Hydrocarbon Receptor Pathway,Wikipathways,1,EGFR,46 (46),0.259,1,0,,0 (1),1,1,0.259,1
Envelope proteins and their potential roles in EDMD physiopathology,Wikipathways,1,LBR,46 (46),0.259,1,0,,0 (0),1,1,0.259,1
Proteasome - Homo sapiens (human),KEGG,1,PSMB10,46 (46),0.259,1,0,,0 (0),1,1,0.259,1
Validated transcriptional targets of deltaNp63 isoforms,PID,1,FASN,47 (47),0.264,1,0,,0 (0),1,1,0.264,1
Exercise-induced Circadian Regulation,Wikipathways,1,GSTM3,48 (48),0.268,1,0,,0 (0),1,1,0.268,1
IL-3 signaling pathway,Wikipathways,1,INPP5D,49 (49),0.273,1,0,,0 (0),1,1,0.273,1
EGF-EGFR signaling pathway,Wikipathways,2,INPP5D;EGFR,162 (162),0.282,1,0,,0 (0),1,1,0.282,1
JAK-STAT signaling pathway - Homo sapiens (human),KEGG,2,EGFR;AOX1,162 (162),0.282,1,0,,0 (0),1,1,0.282,1
IL3,NetPath,1,INPP5D,51 (51),0.282,1,0,,0 (0),1,1,0.282,1
Netrin-UNC5B signaling pathway,Wikipathways,1,INPP5D,52 (52),0.287,1,0,,0 (0),1,1,0.287,1
hiv-1 nef: negative effector of fas and tnf,BioCarta,1,GSN,53 (53),0.292,1,0,,0 (0),1,1,0.292,1
IL-4 signaling pathway,Wikipathways,1,INPP5D,54 (54),0.296,1,0,,0 (0),1,1,0.296,1
TGF-beta Receptor Signaling,Wikipathways,1,ENG,55 (55),0.301,1,0,,0 (0),1,1,0.301,1
Neurexins and neuroligins,Reactome,1,EPB41L1,57 (57),0.31,1,0,,0 (0),1,1,0.31,1
mapkinase signaling pathway,BioCarta,1,GCK,57 (57),0.31,1,0,,0 (0),1,1,0.31,1
Focal Adhesion-PI3K-Akt-mTOR-signaling pathway,Wikipathways,3,COL5A2;EGFR;SLC2A2,302 (302),0.311,1,0,,0 (2),1,1,0.311,1
Notch,NetPath,1,POFUT1,58 (58),0.315,1,0,,0 (0),1,1,0.315,1
TGF-beta receptor signaling in skeletal dysplasias,Wikipathways,1,ENG,59 (59),0.319,1,0,,0 (0),1,1,0.319,1
Kit receptor signaling pathway,Wikipathways,1,INPP5D,59 (59),0.319,1,0,,0 (0),1,1,0.319,1
IL-1 JNK,INOH,1,PSMB10,62 (62),0.332,1,0,,0 (0),1,1,0.332,1
Leptin,NetPath,1,EGFR,62 (62),0.332,1,0,,0 (0),1,1,0.332,1
IL4,NetPath,1,INPP5D,63 (63),0.337,1,0,,0 (0),1,1,0.337,1
IL-1 NFkB,INOH,1,PSMB10,64 (64),0.341,1,0,,0 (0),1,1,0.341,1
DroToll-like,INOH,1,PSMB10,65 (65),0.345,1,0,,0 (1),1,1,0.345,1
IL4-mediated signaling events,PID,1,INPP5D,65 (65),0.345,1,0,,0 (0),1,1,0.345,1
IL-1 p38,INOH,1,PSMB10,66 (66),0.349,1,0,,0 (0),1,1,0.349,1
Beta1 integrin cell surface interactions,PID,1,COL5A2,66 (66),0.349,1,0,,0 (0),1,1,0.349,1
AGE-RAGE pathway,Wikipathways,1,EGFR,66 (66),0.349,1,0,,0 (0),1,1,0.349,1
TNF,INOH,1,PSMB10,67 (67),0.354,1,0,,0 (0),1,1,0.354,1
Regulation of Telomerase,PID,1,EGFR,68 (68),0.358,1,0,,0 (0),1,1,0.358,1
Prolactin,NetPath,1,EGFR,70 (70),0.366,1,0,,0 (0),1,1,0.366,1
KitReceptor,NetPath,1,INPP5D,70 (70),0.366,1,0,,0 (0),1,1,0.366,1
Adherens junction - Homo sapiens (human),KEGG,1,EGFR,71 (71),0.37,1,0,,0 (0),1,1,0.37,1
Alpha6Beta4Integrin,NetPath,1,EGFR,71 (71),0.37,1,0,,0 (0),1,1,0.37,1
Hedgehog,INOH,1,PSMB10,72 (72),0.374,1,0,,0 (0),1,1,0.374,1
Parkin-Ubiquitin Proteasomal System pathway,Wikipathways,1,SEPTIN5,73 (73),0.378,1,0,,0 (0),1,1,0.378,1
Viral carcinogenesis - Homo sapiens (human),KEGG,2,HPN;GSN,203 (204),0.38,1,0,,0 (0),1,1,0.38,1
Neutrophil degranulation,Reactome,4,PYGL;VAT1;GSN;SERPINB6,486 (487),0.386,1,0,,0 (0),1,1,0.386,1
Regulatory circuits of the STAT3 signaling pathway,Wikipathways,1,EGFR,78 (78),0.398,1,0,,0 (0),1,1,0.398,1
Notch,INOH,1,PSMB10,78 (78),0.398,1,0,,0 (0),1,1,0.398,1
Complement and coagulation cascades - Homo sapiens (human),KEGG,1,MBL2,85 (85),0.425,1,0,,0 (1),1,1,0.425,1
Androgen receptor signaling pathway,Wikipathways,1,EGFR,89 (89),0.44,1,0,,0 (0),1,1,0.44,1
TNFalpha,NetPath,2,PPP1R12A;EGFR,234 (234),0.449,1,0,,0 (0),1,1,0.449,1
Staphylococcus aureus infection - Homo sapiens (human),KEGG,1,MBL2,94 (96),0.458,1,0,,0 (2),1,1,0.458,1
Pathways Regulating Hippo Signaling,Wikipathways,1,EGFR,98 (98),0.472,1,0,,0 (0),1,1,0.472,1
Hematopoietic cell lineage - Homo sapiens (human),KEGG,1,CD9,98 (99),0.472,1,0,,0 (0),1,1,0.472,1
B Cell Receptor Signaling Pathway,Wikipathways,1,INPP5D,98 (98),0.472,1,0,,0 (0),1,1,0.472,1
JAK-STAT-Core,Signalink,1,EGFR,104 (104),0.493,1,0,,0 (0),1,1,0.493,1
EGF-Core,Signalink,1,EGFR,105 (105),0.496,1,0,,0 (0),1,1,0.496,1
HCMV Early Events,Reactome,1,EGFR,109 (109),0.509,1,0,,0 (2),1,1,0.509,1
HCMV Infection,Reactome,1,EGFR,113 (113),0.522,1,0,,0 (3),1,1,0.522,1
Gastrin signaling pathway,Wikipathways,1,EGFR,114 (114),0.525,1,0,,0 (0),1,1,0.525,1
TGF-beta super family signaling pathway canonical,INOH,1,PSMB10,115 (115),0.528,1,0,,0 (0),1,1,0.528,1
Biochemical Pathways Part I,Wikipathways,0,,0 (0),1,1,4,HMDB0000036;HMDB0000128;HMDB0000273;HMDB0001290,465 (469),0.53,1,0.53,1
Wnt Canonical,INOH,1,PSMB10,120 (120),0.543,1,0,,0 (0),1,1,0.543,1
Wnt Mammals,INOH,1,PSMB10,120 (120),0.543,1,0,,0 (0),1,1,0.543,1
BCR,NetPath,1,IGHM,129 (129),0.569,1,0,,0 (0),1,1,0.569,1
Regulation of toll-like receptor signaling pathway,Wikipathways,1,MBL2,145 (145),0.612,1,0,,0 (2),1,1,0.612,1
Non-alcoholic fatty liver disease - Homo sapiens (human),KEGG,1,PKLR,150 (150),0.625,1,0,,0 (2),1,1,0.625,1
Phagosome - Homo sapiens (human),KEGG,1,MBL2,151 (152),0.627,1,0,,0 (1),1,1,0.627,1
Nonalcoholic fatty liver disease,Wikipathways,1,PKLR,155 (155),0.637,1,0,,0 (4),1,1,0.637,1
TGF_beta_Receptor,NetPath,1,ENG,173 (173),0.677,1,0,,0 (0),1,1,0.677,1
Vitamin D Receptor Pathway,Wikipathways,1,CD9,184 (184),0.7,1,0,,0 (1),1,1,0.7,1
IL-7 signaling,INOH,1,EGFR,185 (185),0.702,1,0,,0 (0),1,1,0.702,1
EPO signaling,INOH,1,EGFR,186 (186),0.704,1,0,,0 (0),1,1,0.704,1
TCR,NetPath,1,INPP5D,243 (244),0.797,1,0,,0 (0),1,1,0.797,1
EGFR1,NetPath,2,EGFR;GSN,454 (455),0.798,1,0,,0 (0),1,1,0.798,1
MicroRNAs in cancer - Homo sapiens (human),KEGG,1,EGFR,310 (310),0.87,1,0,,0 (0),1,1,0.87,1
VEGFA-VEGFR2 Signaling Pathway,Wikipathways,1,ENG,433 (433),0.943,1,0,,0 (0),1,1,0.943,1